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Abstract
This research focuses on two theories: (i) competing risks and (ii) random effect (frailty)
models. The theory of competing risks provides a structure for inference in problems where
cases are subject to several types of failure. Random effects in competing risk models consist
of two underlying distributions: the conditional distribution of the response variables, given
the random effect, depending on the explanatory variables each with a failure type specific
random effect; and the distribution of the random effect. In this situation, the distribution of
interest is the unconditional distribution of the response variable, which may or may not have
a tractable form. The parametric competing risk model, in which it is assumed that the failure
times are coming from a known distribution, is widely used such as Weibull, Gamma and
other distributions. The Gamma distribution has been widely used as a frailty distribution,
perhaps due to its simplicity since it has a closed form expression of the unconditional hazard
function. However, it is unrealistic to believe that a few parametric models are suitable for
all types of failure time.
This research focuses on a distribution free of the multivariate frailty models. Another
approach used to overcome this problem is using finite mixture of parametric frailty especially
those who have a closed form of unconditional survival function. In addition, the advantages
and disadvantages of a parametric competing risk models with multivariate parametric
and/or non-parametric frailty (correlated random effects) are investigated. In this research,
four main models are proposed: first, an application of a new computation and analysis of
a multivariate frailty with competing risk model using Cholesky decomposition of the Log-
normal frailty. Second, a correlated Inverse Gaussian frailty in the presence of competing risks
model. Third, a non-parametric multivariate frailty with parametric competing risk model
is proposed. Finally, a simulation study of finite mixture of Inverse Gaussian frailty showed
the ability of this model to fit different frailty distribution. One main issue in multivariate
analysis is the time it needs to fit the model. The proposed non-parametric model showed a
significant time decrease in estimating the model parameters (about 80% less time compared
the Log-Normal frailty with nested loops). A real data of recurrence of breast cancer is used
as the applications of these models.
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Chapter 1
Introduction
The term survival analysis summarises statistical models and methods for analysing lifetime
data or time-to-event data. These models are frequently employed in a variety of disciplines
including Bio-statistics, Epidemiology, Engineering, Social Sciences and Economics. Survival
analysis differs from other statistical procedures in many features; one of these features
is the incompleteness of the survival times due to the censoring mechanism that gives a
mixture of discrete and continuous data. Another difference is the shape of the distribution
of the survival times that are non-negative random variables and usually skewed to right.
The proportional hazards models (PH) by Cox (1972) which assume that covariates have a
multiplicative effect on the hazard have dominated survival analysis. In addition, accelerated
failure time models are also used for the analysis of survival data by modelling the survival
time it-self and the covariates are assumed to act directly on it. During recent decades, these
models have been extended to become suitable for handling more complex survival data so
as to include frailty models and competing risks models. They provide a powerful tool to
analyse models with repeated measures, clustered survival data and multiple types of failure.
One of the main assumptions in analysing survival data is that all subjects have the same risk
of failure, which means that populations are homogeneous. However, this is usually not true
as different subjects could have different hazards. In univariate survival data, frailty models
are used to take into account the heterogeneity between subjects due to exclusion of some
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important covariates in the model. In multivariate survival data, frailty models are used
when there are repeated measures or clustering. Repeated data occur in case of longitudinal
data or multiple recurrences of an event for the same individual. Competing risks models are
another form of multivariate survival data where the censoring variable is decomposed into
different variables. For each type of failure the subject experiences the event of that failure
or is censored.
Competing risks with frailty models frequently arise in a number of substantive scientific
research areas, particularly within the Social Sciences, Bio-statistics and Epidemiology. These
models combine two theories: (i) competing risks and (ii) random effect (or frailty) models.
The theory of competing risks provides a structure for reference to problems where cases are
subject to several types of failure, i.e. multiple causes of failure. There are two approaches
to analyse competing risks models in the literature. One places emphasis on cause specific
hazard functions and sub-distribution functions, while the other uses the concept of latent
failure times, where there is an inherent failure time for each type of failure, and only one
such time, the smallest, is observable. Both approaches arrive at the same inference, using
different notation (Kalbfleisch and Prentice, 2002 and Kundu, 2004). The concept of latent
failure times is the one employed in this thesis.
Random effects in competing risk models consist of two underlying distributions: the
conditional distribution of the response variables (i.e. failure types), given the random effect,
depending on the explanatory variables each with a failure type specific random effect; and the
distribution of the random effect in the population (i.e. frailty distribution). In this situation,
the distribution of interest is the unconditional distribution of the response variables which
may or may not have a tractable form.
2
Chapter 1. Introduction
Due to its simplicity, the parametric competing risk model where the failure times have a
known distribution with monotonically increasing or decreasing baseline hazard and known
distribution of random effect, is widely used in practice (Hougaard, 2000, Lambert et al.,
2004 and Oskrochi and Crouchley, 2004), but it is unrealistic to believe that a few parametric
models are suitable for all types of failure time. Unlike the parametric models, a distribution
free model for the random effect in which only the baseline hazard follows a specific
distribution will be less demanding in term of assumptions and would be more robust. In
this situation the unconditional distribution of the competing risks does not have a tractable
form and hence a more complex non-linear multivariate optimisation procedure is needed
for parameter estimation (Oskrochi and Davies, 1997). One should differentiate between
the ways frailty introduced into the model. In univariate failure time, frailty is included
to accommodate heterogeneity between individuals. When individuals in the same group
or cluster are assumed to share the same frailty then it accommodates the heterogeneity
between clusters not individuals, the so-called shared frailty. Another way to include frailty
is by assuming different frailties for different individuals or for different competing risks.
In correlated frailty models, frailties are correlated through a covariance matrix and have
the same set of marginal distributions but not coming from a multivariate distribution. In
multivariate frailty models, frailties have a multivariate distribution with a general correlation
structure between the frailties.
This study will investigate the methodology and the applications of competing risk models
with multivariate frailty. In the first stage, the Chloeskey decomposition is applied in
analysing competing risks model for censored survival data with multivariate Log-Normal
frailty to a real data of breast cancer. In the second stage, a correlated Inverse Gaussian
frailty as well as a multivariate Inverse Gaussian frailty is proposed. In the third stage, a
methodology for analysing a competing risk model with non-parametric multivariate frailty
3
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is proposed. In the last stage, a finite mixture of Inverse Gaussian frailty is proposed. The
advantages and disadvantages of competing risk model with non-parametric and/or semi-
parametric multivariate frailty is compared using simulations data as well as real data.
In Chapter 2, a general introduction to survival analysis and its main characteristics is
summarized along with a description of a set of survival data on the recurrence of breast
cancer in the UK, which is used throughout the thesis to demonstrate the development of
the proposed models. In Chapter 3, a literature review of the univariate frailty models is
conducted. Chapter 4 generalises these models to suite correlated and multivariate frailty
models in the presence of competing risks in cases of parametric as well as non-parametric
frailty. In chapter 5, a different approach is used to fit frailty models by decomposing the
frailty distribution as a finite mixture model (semi-parametric model). Finally, chapter 6
concludes the main results and discusses the advantages and disadvantages of the proposed
methodologies.
4
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Survival Analysis
The term ”survival analysis” is used for describing data that measure the time to some event.
The statistical analysis of survival data or ’time-to-event’ has applications in disciplines as
diverse as Medicine, Social Sciences, Engineering, Epidemiology, Economics, as well as many
others. Time-to-event could mean the time until some electrical component fails, time of
remission of a certain disease after treatment, or time from graduation until employment.
These applications have ensured that survival analysis has expanded rapidly in the last three
decades. In this study, the applications are within the biomedical framework where real data
from medical fields are used and our subjects are individuals. Two features of survival data
make them differ from the data used in classical methods (e.g. general linear models). First,
there is a mixture of discrete and continuous variables. The time-to-event is the continuous
part and the censoring is the discrete part. An individual is said to be censored if s/he does
not experience the time of interest before the end of the study: for example, a patient with
breast cancer may stay alive after the termination of the study. Second, in classical methods,
the dependent variable is modelled through a link function with a linear combination of the
explanatory variables. In survival analysis, the model is built either by the hazard function,
which represents the failure rate at time t; for example, proportional hazard model (PH) Cox
(1972), or by the survival function which represents the probability of surviving beyond time
(t), for example, accelerated failure time (AFT) (Lawless, 1982). These two models coincide
in the case of Weibull distribution.
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2.1 Definitions
2.1.1 Definition. Let T be a non-negative random variable that represents the survival
time (failure time, lifetime), of a subject, with probability density function (p.d.f) f(t), and
cumulative distribution function (c.d.f) F (t) = Pr(T ≤ t).
If T is absolutely continuous then the probability density function is
f(t) = lim
∆t→0+
P (Failure occurs in[t, t+ ∆t))
∆t
.
2.1.2 Definition. The survival function S(t) = Pr(T ≥ t), is the probability of an
individual surviving beyond time t, or more generally, the probability that the event of
interest has not occurred by duration t.
From the definition, if it is a continuous random variable then,
S(t) = Pr(T ≥ t) =
∫ ∞
t
f(u)du.
If T is discrete with mass points at tj with probability mass function (p.m.f)fj = P (T = tj)
then, for tj ≤ t < tj+1,
S(t) =
∑
i≥j
f(ti).
2.1.3 Definition. If T is an absolutely continuous random variable then, the hazard
function is given by
h(t) = lim
∆t→0
Pr(t ≤ T < t+ ∆t|T ≥ t)
∆t
=
f(t)
S(t)
, (2.1.1)
which represents the probability of failure at time t given that the individual survives up to
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time t. If T is a discrete random variable, then the hazard function is given by
h(t) = P (T ≥ t|T = t) = Pr(T = t)
P (T ≥ t)
=
f(t)
S(t−)
,
where S(t−) = lim
x→t−
S(x) (t−: from left). Moreover,
S(t) =
j∏
i=1
S(ti+1)
S(ti)
=
j∏
i=1
S(ti)− fi
S(ti)
=
j∏
i=1
(
1− fi
S(ti)
)
and hence,
S(t) =
j∏
i=1
(1− h(ti)) .
2.1.4 Definition. If T is an absolutely continuous random variable then, the cumulative
hazard function c.h.f is
H(t) =
∫ t
0
h(u)du = − logS(t). (2.1.2)
Or equivalently,
S(t) = e−H(t) = exp
[
−
∫ t
0
h(u)du
]
.
The p.d.f f(t) can be written in terms of the hazard and the cumulative hazard function,
f(t) = h(t)exp[−H(t)].
If T is discrete,
7
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H(t) =
∑
i≤j
h(ti)
Sometime it is desirable to find the mean or the expected lifetime of subjects, for instance if
T is a continuous random variable with p.d.f f(t) then expected value of T is
µ =
∫ ∞
0
tf(t)dt.
Another way to get this expected value is by integrating the survival function, assuming that
the event of interest is bound to occur (i.e. S(∞) = 0)
µ =
∫ ∞
0
S(t)dt.
2.2 Censoring
As mentioned above, censoring is one of the reasons that survival analysis differs from
standard statistical analysis, so censored data are those observations whose time-to-event is
not observed before the end of the study. There are three different mechanisms of censoring:
type I, type II, and random censoring. In type I censoring, a sample of n subjects is followed
for a specific time T ∗ under the control of the researcher, so that the total duration of the
study is fixed whilst the number of subjects who experience the event of interest is random,
the actual failure time ti cannot be observed if ti > T
∗. This type of censoring is usually used
in medical applications. The opposite of this mechanism, type II censoring, occurs when a
sample of n subjects is followed until the failure time of the first r(r ≤ n) of the subjects is
observed. This type of censoring is usually used in industrial applications. Another possible
mechanism of censoring is random censoring, where each subject has associated with it a
potential censoring time Ci and a potential survival time Ti, which are usually assumed to
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be independent of one another (the so-called independent censoring). This type of censoring
will be the main censoring mechanism that is used within this thesis. Usually, the observed
variables are Yi = min(Ti, Ci), and the indicator variable δi.
Yi =
{
Ti if Ti ≤ Ci
Ci if Ti > Ci
, and δi =
{
1 if Ti ≤ Ci
0 if Ti > Ci.
The observed data takes the form, (y1, δ1), ..., (yn, δn), and possibly some factors (independent
variables). There are three different kinds of censoring, right-censoring, left-censoring, and
interval-censoring:
Right-censoring : when subjects leave the study or the study ends before observing their
survival (failure) time. It is only known that their survival time Ti lies in an interval (t,∞).
Throughout this thesis, right-censoring is assumed.
Left-censoring : when subjects experience the event (failure) before a certain duration. It is
only known that their survival time Ti lies in an interval [0, t).
Interval-censoring : when it is not clear when the event occurred. It is only known that the
time-to-event occurred within some interval [t1, t2). For more information see Lee and Wang
(2003).
2.3 Non-parametric survival distribution
When it is difficult to determine the distribution of the survival time, or no assumption
about the distribution is made, non-parametric or distribution-free survival time approaches
represent viable alternatives. In this case, the empirical distribution function is used to
estimate the survival function assuming that all subjects have experienced failure (i.e., no
censored data). The empirical survival function is given by
S̃(t) =
Number of subjects with survival times ≥ t
Number of subjects in the data set
.
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The following subsections give a briefly review of the two most popular estimators of the
survival function using both censored and uncensored data.
2.3.1 Life-table estimator
In the case of some subjects with censored time, the empirical function is not applicable any
more. Life-table estimator divides the study time into, usually equal intervals. The interval
width and number of intervals varies from one study to another depending on the length
of the study and the number of observations. Suppose that (t1, ..., tk) are the boundaries of
these intervals and let di,ci and ni denote the number of failures, number of censored subjects
and number of subjects who are at risk during the interval [ti, ti+1) respectively. Assuming
that the censoring is uniformly distributed along the interval, the average number of subjects
at risk during the interval [ti, ti+1) is n
∗
i = ni − ci/2, and hence the probability of failure is
di/n
∗
i . For t ∈ [tj, tj+1), and j = 1, ..., k, the life-table estimator of the survival function is
given by
j∏
i=1
(
1− di
n∗i
)
.
2.3.2 Product-limit estimator
Kaplan and Meier (1958) provided a special case of the life-table estimator, where the interval
boundaries are chosen so that there is at least one failure. Suppose that (t(1), ..., t(m))are the
ordered time points in which there is at least one failure so that, t(1) < t(2) < · · · < t(m). For
t ∈ [t(j), t(j+1)), and j = 1, ...,m, the product-limit estimator of the survival function is given
10
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by
j∏
i=1
(
1− di
ni
)
.
2.4 Parametric survival distribution
Although the non-parametric methods mentioned above are widely used in applications and
do not require any specific assumptions they are unsuitable for handling complex data sets
with explanatory variables, and if the distribution of the survival time is known, the inferences
will be more accurate. This section reviews some of the most commonly used distributions for
survival time. Actually, any non-negative random variable, whether discrete or continuous,
can be used to describe the survival time, while in this thesis our focus will be on continuous
distributions. Other random variables defined over the real line can be used say, x ∈ (−∞,∞)
such that x = log(t) or equivalently t = ex. There are some distributions that have been used
frequently in the literature of survival analysis, such as the Exponential, Weibull, Gamma,
Log-Normal and Log-Logistic distributions. For each distribution, the probability density
function, survival function, hazard function, expected value and the variance of survival time
are summarised in Table 2.1.
The Log-Normal and the Gamma distributions are generally less convenient computationally,
but are still frequently applied, as well as non-parametric approaches, such as the product
limit estimator suggested by Kaplan and Meier (1958) and related techniques. The
advantages and disadvantages of different parametric, semi-parametric and non-parametric
models as methodologies for statistical inference can be found in books such as Kalbfleisch
and Prentice (2002), Miller (1981), Lawless (1982), Cox and Oakes (1984) and Klein and
Moeschberger (1997).
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2.4.1 Exponential distribution
The simplest distribution for survival time is the Exponential distribution (T ∼ EXP (λ)),
especially used in reliability analysis in engineering applications. The p.d.f, the mean and
the variance of T are given in Table 2.1. It is used to model data with a constant failure
rate (indicated by the hazard plot which is simply equal to a constant). The exponential
distribution is a member of the exponential family. It has a unique property of “lack of
memory”, because of its constant hazard rate λ. The probability to failure within a particular
time interval depends only on the length, not on the location of this interval. In real-world
applications, the assumption of a constant rate is rarely satisfied.
2.4.2 Weibull distribution
The Weibull model is the most widely used parametric survival model. The Weibull
distribution was introduced by Weibull (1939); it is an important generalisation of the
exponential distribution with two positive parameters T ∼ Weib(α, λ), where α is the shape
parameter and λ is the scale parameter. Its first parameter allows different failure rates; if
it is less than one this indicates a decreasing hazard function while a value more than one
indicates an increasing hazard function, but if it is one then the distribution becomes the
exponential distribution and the hazard function is constant. Figure 2.1 describes the density
and the hazard curves of the Weibull distribution with a scale parameter that equals one with
different values of the shape parameter . The Weibull model also has another property in
the sense that if the plot of log(−log(Ŝ(t))) against log(t) shows a linear trend, that would
suggest Weibull model. Ŝ(t) is the empirical survival function which can be obtained the by
the Kaplan-Meier estimate.
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2.4.3 Gamma distribution
Another possible distribution of the survival time is the Gamma distribution T ∼ Γ(α, λ)
with two positive parameters: α the shape parameter and 1
λ
the scale parameter. Like the
Weibull distribution, it includes the Exponential distribution as a special case when α = 1.
The Gamma distribution is of limited use in survival analysis because the Gamma models
do not have closed-form expressions neither for the survival nor the hazard function, if α is
not an integer since both include the incomplete Gamma integral (If α is an integer then the
distribution reduces to Erlang distribution). Its maximum likelihood estimation is difficult to
get and involves incomplete Gamma integrals. This requires additional numerical calculations
in parameter estimation. It can be shown that the limit of its hazard as time goes to infinity
is equal to the shape parameter ( lim
t→∞
h(t) = λ). The Gamma hazard increases monotonically
if α > 1, from a value of zero at the origin to a maximum of λ; and is constant if α = 1;
and decreases monotonically if α < 1, from infinity at the origin to an asymptotic value of
λ. Figure 2.2 describes the density and the hazard curves of the Gamma distribution with a
scale parameter which equals one with different values of the shape parameter.
2.4.4 Log-Normal distribution
A random variable has a log-Normal distribution if the logarithm of the random variable is
normally distributed T ∼ LogN(µ, σ2) if and only if log(T ) ∼ N(µ, σ2). The log-Normal
distribution is self-replicating under multiplication and division. That is, multiplying or
dividing Log-Normal random variables will result in Log-Normal distributions. The hazard
function of the log-Normal differs from the previous two distributions; it starts from zero
at t = 0, increases to a maximum and then decreases and approaches zero as time goes to
infinity. The decreasing form of the hazard function as time increases makes the distribution
13
Chapter 2. Survival Analysis
unsuitable to model lifetime data in most medical applications. However, the Log-Normal
distribution can be very useful for representing lifetimes for situations with non-monotonic
hazards such as the analysis of electrical insulation or time to occurrence of lung cancer
among smokers. Figure 2.3 shows the density and the hazard curves of the Log-Normal
distribution with a location parameter which equals one with different values of the shape
parameter. It is similar to the Gamma distribution in the complexity of the hazard function
since numerical integration needs to be used to fit the distribution.
2.4.5 Log-Logistic distribution
The Log-Logistic distribution is the probability distribution of a random variable whose
logarithm has a logistic distribution T ∼ LogL(α, λ). It is one of the parametric survival
time models in which the hazard rate may be decreasing (if λ ≤ 1), increasing, or hump-
shaped (if λ > 1), that is, it initially increases and then decreases. Figure 2.4 describes the
density and the hazard curve of the log-logistic distribution with scale parameter equals one
with different values of the shape parameter. It has also another property that if the plot of
the logit of the survival function S(t), (log( S(t)
1−S(t))) against log(t) has a linear trend then it
is an indication of log-logistic model.
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(a) Weibull densities
(b) Weibull hazards
Figure 2.1: Weibull densities and hazards with scale parameter λ = 1 and shape parameter
α = (0.5, 1, 1.5)
15
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(a) Gamma densities
(b) Gamma hazards
Figure 2.2: Gamma densities and hazards with scale parameter λ = 1 and shape parameter
α = (0.5, 1, 1.5)
.
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(a) Log-Normal densities
(b) Log-Normal hazards
Figure 2.3: Log-Normal densities and hazards with location parameter (µ = 1) and shape
parameter(α = (0.5, 1, 1.5))
.
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(a) Log-Logistic densities
(b) Log-Logistic hazards
Figure 2.4: Log-Logistic densities and hazards with scale parameter λ = 1 and shape parameter
α = (0.5, 1, 1.5)
.
18
T
a
b
le
2
.1
:
S
om
e
co
m
m
on
p
ar
am
et
ri
c
su
rv
iv
al
d
is
tr
ib
u
ti
on
al
on
g
w
it
h
th
ei
r
as
so
ci
a
te
d
fu
n
ct
io
n
s
D
is
tr
ib
u
ti
o
n
P
ro
b
a
b
il
it
y
d
e
n
si
ty
fu
n
ct
io
n
f
(t
)
S
u
rv
iv
a
l
fu
n
ct
io
n
S
(t
)
H
a
za
rd
fu
n
ct
io
n
h
(t
)
C
u
m
.
h
a
za
rd
fu
n
ct
io
n
H
(t
)
M
e
a
n
E
(T
)
V
a
ri
a
n
ce
V
a
r(
T
)
E
x
p
o
n
e
n
ti
a
l
λ
ex
p(
−
λ
t)
,
λ
>
0,
t
≥
0
ex
p(
−
λ
t)
λ
λ
t
(1
/λ
)
( 1/λ
2
)
W
e
ib
u
ll
α
λ
tα
−
1
ex
p(
−
λ
tα
),
α
,λ
>
0,
t
≥
0
ex
p(
λ
tα
)
α
λ
tα
−
1
λ
tα
Γ
(1
+
(1
/
α
))
λ
(1
/
α
)
Γ
(1
+
2
/
α
)−
Γ
(1
+
1
/
α
)2
λ
(2
/
α
)
G
a
m
m
a
1
Γ
(α
)
λ
α
tα
−
1
ex
p(
−
λ
t)
,
α
,λ
>
0,
t
≥
0
1
−
Iα
(λ
t)
∗
λ
α
tα
−
1
ex
p
(−
λ
t)
(1
−
I α
(λ
t)
)Γ
(α
)
—
–
α λ
α λ
2
L
o
g
-N
o
rm
a
l
ex
p
(
1
2
σ
2
(l
n
(t
)−
µ
)2
)
tσ
√
2
π
,
σ
>
0,
t
≥
0
1
−
Φ
( ln(t
)−
µ
σ
) ∗∗
f
(t
)
S
(t
)
—
–
ex
p(
µ
+
σ
2 2
)
(e
σ
2
−
1)
e(
σ
2
+
2
µ
)
L
o
g
-L
o
g
is
ti
c
α
λ
tα
−
1
(1
+
λ
tα
)2
,
α
,λ
>
0,
t
≥
0
1
1
+
λ
tα
α
λ
tα
−
1
1
+
λ
tα
ln
(1
+
λ
tα
)
π
cs
c(
π
/
α
)
α
λ
(1
/
α
)
,
if
α
>
1
2
α
π
cs
c(
2
π α
)−
π
2
cs
c2
(
π α
)
α
2
λ
(2
/
α
)
,
if
α
>
2
*I
α
(t
)
=
∫ t 0(1/
Γ
(α
))
x
α
−
1
e−
x
d
x
is
th
e
in
co
m
p
le
te
G
am
m
a
fu
n
ct
io
n
,
**
Φ
(·)
is
th
e
cu
m
u
la
ti
ve
d
is
tr
ib
u
ti
on
fu
n
ct
io
n
of
st
an
d
ar
d
N
or
m
al
d
is
tr
ib
u
ti
on
.
19
Chapter 2. Survival Analysis
2.5 Likelihood function
In order to estimate the parameters involved in the survival analysis models, the likelihood
function is usually used. Since the observed data takes the form,(t1,δ1), ..., (tn, δn), where
(ti, δi) are respectively the survival time and the censoring indicator for the i
th individual,
the likelihood function L(θ; ti) is given by
L(θ; ti) =
n∏
i=1
[f(ti)]
δi [S(ti)]
1−δi .
Using the relation in (2.1.2) the likelihood function becomes
L(θ; ti) =
n∏
i=1
[h(ti)]
δiS(ti). (2.5.1)
The maximum likelihood estimator of θ is the value in the parameter space that maximises
the likelihood function or equivalently the log-likelihood function which is given by
`(θ; ti) =
n∑
i=1
δi log[h(ti)] + log[S(ti)]. (2.5.2)
Example 2.1 Assume the survival times follow the Weibull distribution T ∼ Weib(α, λ),
then from Table 2.1, the probability density function, the hazard, and the survival function
are given by
f(t) = αλtα−1exp(λtα), h(t) = αλtα−1, S(t) = exp(λtα).
Applying formula (2.5.2), the log-likelihood is
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`(λ, α; ti) =
n∑
i=1
δi log[αλt
α−1
i ] + λt
α
i ,
and consequently,
`(λ, α; ti) = r log(αλ) + (α− 1)
n∑
i=1
δi log ti − λ
n∑
i=1
tαi ,
where r =
∑n
i=1 δi is the number of uncensored individuals. Differentiating the log-likelihood
function and setting it to zero, the maximum likelihood estimators of λ and α are given by
λ̂ =
r∑n
i=1 t
α̂
i
, and
r
α̂
+
n∑
i=1
δi log ti − λ̂
n∑
i=1
tα̂i log ti = 0.
The values of λ̂ and α̂ can be found by an iterative numerical procedure such as the Newton-
Raphson algorithm.
2.6 Proportional hazard models
Many studies focus on determining the risk factors affecting the survival times of individuals
or subjects. Cox (1972) introduced the proportional hazard model (PH) in order to estimate
the effects of such risk factors or covariates influencing survival time data. It assumes that
the covariates have a multiplicative effect on the hazard. The proportional hazard model is
the most popular model for survival data and has been used extensively in the literature.
The proportional hazard model is given by
h(ti,xi) = h0(ti) exp(x
′
iβ). (2.6.1)
where h0(t) is the baseline hazard function corresponding to the hazard function of a subject
with covariate variables xi equal to 0, and β is a (p× 1) vector of unknown parameters.
21
Chapter 2. Survival Analysis
If the proportionality assumption is not satisfied, an alternative way to include the effect of
covariates is using additive models. The hazard function then takes the form
h(ti,xi) = h0(ti) + x
′
iβ. (2.6.2)
For more details, see (Lin and Ying, 1994) and (Beamonte and Bermdez, 2003). A more
general model that includes both types is called an additive-multiplicative model (Lin and
Ying, 1995).
Example 2.2 Assume the survival times follow the Weibull distribution T ∼ Weib(α, λ).
Then h0(ti) = αt
α−1
i , and under the assumption of multiplicative hazard model, and setting
λ = exp(x
′
iβ) and r =
∑n
i=1 δi,
h(ti,xi) = αt
α−1
i exp(x
′
iβ), and S(ti,xi) = exp(−tαi exp(x
′
iβ)).
Consequently, the log-likelihood is given by
`(β, α; ti) = r(log(α) + x
′
iβ) + (α− 1)
n∑
i=1
δi log ti −
n∑
i=1
tαi exp(x
′
iβ). (2.6.3)
2.7 Accelerated failure time models
Another way to estimate the effect of covariates on the survival time is through modelling the
survival time by accelerated failure time (AFT). The covariates are assumed to act directly
on survival times. The proportional hazard model is given by
S(ti,xi) = S0(ti exp(x
′
iβ)), (2.7.1)
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where S0(t) is the baseline survival function corresponding to the survival function of a
subject with covariate variables xi equal to 0. Another way to represent (2.7.1) is using the
survival time,
T = T0 exp(x
′
iβ),
where T0 has survival function S0(t). The AFT model assumes the effect of covariates is
multiplicative with respect to survival time. The AFT models are similar to the usual linear
regression model
log(Ti) = x
′
iβ + σεi,
where β is the unknown regression coefficient and x
′
i is the vector of observed covariates. The
random errors εi is assumed to be independently and identically distributed with the mean
zero and standard deviation one. If there are no censored data, the model can be readily
estimated by ordinary least squares. One can simply generate a new variable, Y = log(T ),
and use the linear regression model with Y as the dependent variable. If the error εi is
normally distributed, the OLS estimates will also be maximum likelihood estimates of the
model parameters. Survival data usually have at least some censored observations, and
these are difficult to handle with OLS. Alternatively, one can use Maximum Likelihood
Estimation (MLE) method with different distribution assumption. For each distribution of
εi, there is a corresponding distribution for T . For instance, if the survival times follow the
Weibull distribution T ∼ Weib(α, λ), then y = log(T ) has the extreme-value distribution
y ∼ ext(a, b), where a = log λ and b = 1/α , therefore,
`(β, b; yi) = −r log(b) +
n∑
i=1
δi
(
yi − x
′
iβ
b
)
−
n∑
i=1
exp
(
yi − x
′
iβ
b
)
.
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The following table lists some distributions of εi and their corresponding distributions of T .
Distribution of εi Distribution of T
Extreme value (2 parameters) Weibull
Extreme value (1 parameter) Exponential
Log-gamma Gamma
Logistic Log-logistic
Normal Log-normal
Table 2.2: Some distributions of εi and their corresponding distributions of T in modelling AFT.
2.8 Breast cancer recurrence data
This section describes a set of survival data on the recurrence of breast cancer in the UK
which will be used throughout the thesis to demonstrate the development of the proposed
models. The data used in this study was collected and provided by Research division of
Christie Hospital in Manchester U.K. and includes more than 2850 women who were referred
to the Christie Hospital, U.K. during 1985 and 1995, by their GPs with diagnosis of breast
cancer. The data also includes the subsequent monitoring of these women up to 2001. This is
an observational data set, hence, no randomisation or clinical trial was involved. Recurrence
in this study is defined as clinical recurrence of breast cancer (i.e. after remission). The
data were checked for values that were out of range, incorrect sequence of events or dates,
and logical inconsistencies such as discrepancy between date of death and date of follow-up.
As the result of this check a few individuals were excluded from the data set. The event
of interest in this study is the first recurrence time of breast cancer in patients after initial
treatment (surgery). There are three types of recurrence: Type one, local recurrence which
cancerous tumour cells remain in the original site and grow over time. Type two, regional
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recurrence of breast cancer is more serious because it usually indicates that the cancer has
spread past the breast, into the axillary (underarm) lymph nodes and beyond. Type three,
metastasis, where secondary cancer cells metastasise spread to other parts of the body and
cause tumour. In this study, the response variable is the time from initial treatment to either
local, regional recurrence or metastasis. In addition to these three observed recurrence times,
other situations considered where the recurrence time was not observed because the patient
was either symptomless at the end date of the study (independent right censoring) or the
patient dropped out for some reason before the end of the study. The patients in this study
can be classified into six categories:
1. patients who were alive when last seen with no disease and no recurrence (right
censoring)
2. patients who experienced a local recurrence (LR) as the first recurrence (T1)
3. patients who experienced a regional recurrence (RR) as the first recurrence (T2)
4. patients who experienced metastasis (MT) as the first recurrence (T3)
5. patients who died from breast cancer (DB) (i.e. drop-out due to the breast cancer)
before the first recurrence (T4) was observed
6. patients who died from other causes (DO) (i.e. drop-outs due to other causes) before
the first recurrence (T5) was observed
More details are in Appendix A. It is generally assumed that the right censoring mechanism
is independent of the recurrence time (Kalbfleisch and Prentice, 2002). However, this
assumption may not apply to both types of drop-outs. For instance, patients diagnosed with
an advanced stage of breast cancer may die due to that cancer before any clinical recurrence
of it. Similarly, patients with severe sickness tend to have shorter survival time and are more
likely to die from other diseases due to general weakness. Ignoring such informative drop-outs
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while employing the commonly used estimation procedures based on treating drop-outs as
independent right censored observations tends to underestimate the parameters of interest.
Hence, in this study drop-outs were not treated as right censored observations. Some of the
variables which have been observed for these patients to act as potential covariates are: age,
stage of the disease at first diagnosis, type of surgery, histology, the cohort of initial surgery,
chemotherapy, menopausal status, radiotherapy and side of the body. More details about the
data are given in chapter three.
2.9 Summary
This chapter summarised the main features of the survival data and the methods available in
estimating the survival and hazard functions. Both parametric and non-parametric estimates
of the survival function are described. Estimating the empirical survival function by Product-
limit estimator can be used to judge the best fit for the survival function. Matching the graph
of empirical survival function with those in figure 2.1 to figure 2.4 can be used to decide the
parametric survival function. One of the limitations of these models is that they implicitly
assume homogeneity of study populations which may not be true. Adding covariates to the
model may relax this assumption. There are two ways to estimate the effects of covariates
or risk factors influencing survival time data, proportional hazard models and accelerated
failure time models. The proportional hazard models assume that the covariates have a
multiplicative effect on the hazard. Whereas in accelerated failure time models, the covariates
are assumed to act directly on survival times. An extension of these models is by including
random effects which will be discussed in the next chapter.
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Frailty Models in the literature
3.1 Introduction
In this chapter, first, a literature review of the frailty models in survival analysis and the
distributions used in modelling frailty is given. Second, the models discussed are applied to
a simulation data and to the breast cancer data presented in the previous chapter. Standard
methods in survival analysis implicitly assume homogeneity of study populations. That
means that all subjects have the same degree of failure risk and that the survival times
are independently and identically distributed. Models with covariates relax this assumption
by introducing observed sources of heterogeneity. But it is not realistic to assume that all
relevant risk factors or covariates were measured and included in the model. Either the
relevant risk factors are unknown or they are known but it may be costly to measure them.
Unmeasured covariates or omitted risk factors generate a between-subject variation usually
referred to as frailty (unobserved heterogeneity). Frailty models can be viewed as an extension
of Cox proportional hazard, (Cox, 1972). Considering these omitted risks as random variables
with a probability, a joint distribution of failure time and the frailty could be generated and
since the frailty is unobservable (i.e. no data on that) it has to be integrated out. In the
context of survival analysis, a frailty model is a mixed-effects model where the frailty is the
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random effect component which usually has a multiplicative effect on its hazard function.
Vaupel et al. (1979) introduced the term frailty as a measure of susceptibility to all causes
of death to describe mortality in non-homogeneous populations and used it in univariate
survival models. Clayton (1978) applied the idea of the frailty model to the multivariate
situation of chronic disease incidence in families, but he did not use the term ”frailty”.
3.2 Linear mixed models
Linear mixed models (LMMs) are statistical models for continuous responses in which the
residuals are assumed to be normally distributed but may not be independent or have constant
variance. Therefore, they provide the flexibility for modelling not only the means of the data,
but the variances and covariances as well. In a linear mixed-effects model, responses from
a subject are assumed to be the sum of fixed and random effects. A factor is considered
to be fixed if all levels or categories that are of interest are included in the study. A factor
is considered to be random if the levels or categories included in the study represent a
random sample from a larger population of values. The random effects contribute only to
the covariance structure of the data. It often introduces correlations between cases. Such
correlations are usually encountered in studies where data are grouped in clusters or in
longitudinal and repeated measures studies with multiple observations for the same subject.
If only fixed effects are included in the model, then the dependent variable Y is modelled in
relation to several explanatory variables by
Y = Xβ+ ε and ε ∼N(0,Σ), (3.2.1)
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where Y is (n × 1) vector, ε is (n × 1) vector of residuals with variance-covariance matrix
Σ, β is (p × 1) vector of unknown parameters, and X is (n × p) design matrix, the matrix
of explanatory variables. If the intercept is included in the model, then a vector of ones
should be included in the design matrix. If the model contains only continuous explanatory
variables, it is usually called a regression model while models containing only qualitative
variables are called Analysis of Variance models (ANOVA). Both of these models are special
cases of the general linear model, where both types of explanatory variables could be included
in the model. In general linear models, the response variables are assumed to be independent
and normally distributed with common variance, and link function µi = E(Yi) = Xiβ. In
longitudinal and cluster data, it is more appropriate to include both fixed and random effects
in the model, which is extension of the model given in (3.2.1). The the random effect is
included as follows
Yi = Xiβ+Zibi + εi,
bi ∼N(0,D) and εi ∼N(0,Σi).
(3.2.2)
where Yi is (ni × 1) vector of responses of individual or cluster i, (i = 1, ..., N), εi is (ni × 1)
vector of residuals with variance-covariance matrix Σi, β is (p× 1) vector of fixed effect, bi
is (q × 1) vector of random effect, Xi and Zi are (ni × p) and (ni × q) matrices of known
covariates and D is (q × q) covariance matrix of the random effect. Maximum likelihood
(ML) and restricted maximum likelihood (REML) estimation are the methods commonly
used to estimate the model parameters. For more information about linear mixed models
see Verbeke and Molenberghs (2000), McCulloch and Searle (2001) and Muller and Stewart
(2006). For statistical software fitting Linear mixed models see West et al. (2007).
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3.3 Model Identifiability
A statistical model should be identifiable to make a valid inference about its parameters.
A model is considered to be identifiable if its parameter values uniquely determine the
probability distribution of the data and the probability distribution of the data determines
the parameter values uniquely. The identifiability as defined in Casella and Berger (2002)
3.3.1 Definition. A parameter θ for a family of distributions {f(x|θ) : θ ∈ Θ} is identifiable
if distinct values of θ correspond to distinct p.d.fs. That is, if θ 6= θ′ , then f(x|θ) is not the
same function of x as f(x|θ′).
One of the most common source of model non-identifiability is a poorly defined model. Over-
parameterisation of the model usually creates such a problem.
3.4 Univariate frailty models
In the frailty framework, when there is only one time-point measure and no clustering
of individuals, univariate frailty models are used to take into account the heterogeneity
between individuals due to the exclusion of important covariates in the model. In LMMs,
random effects are usually included when there is clustering or repeated measures while in
survival analysis random effects (frailty) are included to account for unobserved heterogeneity
between subjects. Vaupel et al. (1979) proposed a univariate frailty model to survival analysis
assuming a Gamma distribution to account for unobserved heterogeneity, i.e, assuming that
different subjects have different frailties so that subjects which are more frail tend to have
shorter survival time than those which are less frail. Many authors have discussed the
univariate frailty models. (See for example, Lancaster and Nickell (1980), Heckman and
Singer (1984, 1985), Vaupel and Yashin (1985), Hougaard (1984, 1986a,b, 2000), Vaupel
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(1990), Aalen (1988, 1992) and Richardson and Green (1997)).
There are different ways to include the random effect (frailty) in survival analysis. Under the
assumption of proportional hazard, the multiplicative frailty effects model which is commonly
used in the literature, the frailty acts multiplicatively on the underlying baseline hazard
function. In this case the conditional hazard function on the random effect z takes the form
h(ti,xi|z) = zh(ti,xi) = zh0(ti)exp(x
′
iβ). (3.4.1)
where h0(ti) is the baseline hazard, xi is the vector of covariates of the i
th subject, and β is
the fixed effect vector. In (3.4.1), Z is assumed to have some density g(z, θ) with parameter
vector θ, E[Z] = 1 and V [Z] = τ 2. Any other value for this expectation could be used since
it would be absorbed into the baseline hazard function. The conditional survival function is
given by
S(ti,xi|z) = exp
(
−
∫ t
0
h(s,xi|z)ds
)
= exp
(
−z
∫ t
0
h(s,xi)ds
)
= exp
(
−zH0(ti)ex
′
iβ
)
.
(3.4.2)
The unconditional survival function is given
S(ti,xi) =
∫ ∞
0
S(ti,xi|z)g(z)dz =
∫ ∞
0
exp
(
−zH0(ti)ex
′
iβ
)
g(z)dz,
and, hence,
S(ti,xi) = LZ [H0(ti)ex
′
iβ]. (3.4.3)
where LZ [.] is the Laplace transformation with respect to the random variable Z and H0(ti)
31
Chapter 3. Frailty Models in the literature
is the cumulative baseline hazard function. This model is identifiable when the the expected
value of Z is finite (Elbers and Ridder, 1982). An alternative way to write the above model
is by setting (u = log z) in (3.4.1), the conditional hazard can be written as
h(ti,xi|u) = h0(ti)exp(x
′
iβ + u). (3.4.4)
This model is a special case of the LMMs (3.2.2) (intercept model) where the design matrix
of the random effect contains only a column vector of ones. Frailty models differ from
LMMs in several ways: First, they do not include residual components ε. In the frailty
models the residual variability is modelled through the survival distribution. Secondly, the
expected survival time, given the random effects, is not equal to the linear combination
of covariates as LMMs. Thirdly, the inferential methods of frailty models have been less
developed than LMMs due to the incompleteness of data due to censoring and truncation
especially in multivariate models with non-Gaussian frailty distribution. This thesis focuses
on multiplicative frailty models. However, other types of frailty models exist such as additive
frailty models, where the frailty acts additively on the baseline hazard function. The hazard
function as defined by Cai and Zeng (2011)takes the form
h(ti,xi|z) = h0(ti) + x
′
iβ + z.
For more details, see Lin and Ying (1994), Korsgaard and Andersen (1998), Peterson (1998),
Li (2002), Zhong and Li (2004), Pipper and Martinussen (2004), Yin and Ibrahim (2005),
Yin (2007) and Cai and Zeng (2011). Another way to include the frailty effect in the survival
analysis is through accelerated failure time (AFT) models. Many authors considered AFT
frailty models namely, Anderson and Louis (1995); Keiding et al. (1997), Klein et al. (1999),
Pan (2001), Lambert and Collett (2002), Lambert et al. (2004), Chang (2004), Zhang and
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Peng (2007) and Xu and Zhang (2009, 2010). In general, any distribution with positive
range, mean one and finite variance is a suitable candidate to represent the frailty distribution.
Gamma and Inverse Gaussian distributions are the mostly used distributions in the literature
since they provide a closed form expression for the unconditional survival function.
3.4.1 Gamma frailty model
The Gamma distribution is a member of the exponential family and from a computational and
analytical point of view; it is convenient as a frailty distribution and it is easy to derive the
closed form expressions of survival and the hazard function. This is due to the simplicity of the
Laplace transform. Therefore, most published work on frailty analysis assumes the Gamma
distribution because it is mathematically attractive. This includes both the frequentist
approach as well as the Bayesian approach. (See Clayton (1978), Clayton and Cuzick (1985),
Vaupel et al. (1979), Oakes (1982), Crowder (1985), Scallan (1987), Yashin et al. (1995), dos
Santos et al. (1995), Congdon (1995), Shih and Louis (1995), Sahu et al. (1997), Hougaard
(1995, 2000), Yin and Ibrahim (2005), Perperoglou et al. (2006), Balakrishnan and Peng
(2006), Duchateau and Janssen (2008), Peng and Zhang (2008), Jonker et al. (2009), Xu and
Zhang (2010) and Molenberghs and Verbeke (2011)). For a comparison between the Bayesian
approach and the frequentist approach see David et al. (2007).
Weibull hazard with Gamma frailty
Assume the survival times follow the Weibull distribution T ∼ Weib(α, λ), and the frailty
follows a Gamma distribution with unit mean and variance τ 2, Z ∼ Γ(1/τ 2, τ 2). (Without
loss of generality, any other value for the expectation could be absorbed into the baseline
hazard function). For the Weibull distribution, the baseline hazard is h0(t) = αλt
α−1. The
effect of covariates is modelled through the scale parameter of the Weibull distribution,
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λ = exp(x
′
iβ). According to (3.4.2) the conditional survival function is given by
S(ti,xi|z) = exp
(
−zH0(ti)ex
′
iβ
)
= exp
(
−ztαi ex
′
iβ
)
.
The unconditional survival and hazard functions are given by
S(ti,xi) = [1 + τ
2H0(ti)e
x
′
iβ]−(1/τ
2) = [1 + τ 2tαi e
x
′
iβ]−(1/τ
2).
h(ti,xi) =
h0(ti)e
x
′
iβ
1 + τ 2H0(ti)ex
′
iβ
=
αtα−1i e
x
′
iβ
1 + τ 2tαi e
x
′
iβ
. (3.4.5)
3.4.2 Inverse Gaussian frailty model
The inverse Gaussian distribution is named so because it satisfies the inverse relationship
with the Gaussian distribution. There are many similarities between the statistics derived
from this distribution and those of the Normal distribution. It is a member of the exponential
family and like the Gamma distribution it is mathematically attractive. It was presented as
an alternative to the Gamma distribution by Hougaard (1984) since it makes the population
homogeneous with time, whereas for Gamma the relative heterogeneity is constant. It is not
popular like Gamma frailty especially in multivariate frailty framework since the summation
of Inverse Gaussian usually is not an Inverse Gaussian (reproductivity property). However,
many authors have considered it. (See, Manton et al. (1986), Whitmore and Lee (1991), Klein
et al. (1992a), Lam and Kuk (1997), Keiding et al. (1997), Price and Manatunga (2001),
Economou and Caroni (2005), Jeong and Oakes (2005), Kheiri et al. (2007), Duchateau and
Janssen (2008) and Chen and Lio (2008)). The probability density function of the Inverse
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Gaussian distribution T ∼ IG(α, λ) with location parameter µ and scale parameter λ is
f(t) =
√
λ
2π
t−3/2 exp
{
− λ
2µ2t
(t− µ)2
}
The mean and the variance are
E[T ] = µ, V [T ] =
µ3
λ
Figure 3.1 describes the density of the Inverse Gaussain distribution with a scale parameter
which equals one with different values of the shape parameter.
Figure 3.1: Inverse Gaussian densities with scale parameter λ = 1 and shape parameter α =
(0.5, 1, 1.5, 5)
Weibull hazard with Inverse Gaussian frailty
Assume the survival times follow the Weibull distribution, T ∼ Weib(α, λ), and the frailty
model is an Inverse Gaussian distribution with unit mean and variance τ 2, Z ∼ IG(1, 1/τ 2).
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The unconditional survival and hazard functions are given by
S(ti,xi)= exp
(
1
τ 2
(1−
√
1 + 2τ 2H0(ti)ex
′
iβ
)
= exp
(
1
τ 2
(1−
√
1 + 2τ 2tαi e
x
′
iβ
)
.
h(ti,xi) =
h0(ti)e
x
′
iβ(
1 + 2τ 2H0(ti)ex
′
iβ
)1/2 = αtα−1i ex
′
iβ(
1 + 2τ 2tαi e
x
′
iβ
)1/2 . (3.4.6)
3.4.3 Log-Normal frailty models
Because of its relation to the Normal distribution, the Log-Normal distribution is frequently
used for frailty in the literature. Assuming a Log-Normal distribution is equivalent to
assuming Normal distribution for the additive frailty model incorporated in the exponent of
the hazard function of the Cox model. For models (3.4.1), the frailty distribution is assumed
to follow the Log-Normal distribution, whilst for models (3.4.4), the frailty distribution is
Normal. One of the difficulties of the Log-Normal frailty distribution is that the Laplace
transform does not have a simple form and hence no explicit form of the unconditional
likelihood exists. The Log-Normal distribution was mainly developed by McGilchrist and
Aisbett (1991). Many authors considered the Log-Normal frailty models in multivariate
frailty models. (See, McGilchrist (1993), Lillard (1993), Lillard et al. (1995), Xue and
Brookmeyer (1996), Sastry (1997), Gustafson (1997), Vaida and Xu (2000), Ripatti and
Palmgren (2000), Ripatti et al. (2002), Huang and Wolfe (2002) Stefanescu and Turnbull
(2006) and Duchateau and Janssen (2008)).
36
Chapter 3. Frailty Models in the literature
3.4.4 Weibull hazard with Log-Normal frailty
Assume the survival times follow the Weibull distribution and the frailty has a Log-Normal
random variable Z with mean µ and variance τ 2, Z ∼ LogN(µ, τ 2). In Log-Normal frailty,
the inclusion of the frailty in the model is usually done by using W = LN(Z) which has
Normal distribution, W ∼ N(µ∗, σ2). In this case, the mean and the variance of the frailty
are related to those of the normal distribution through the following relations:
µ = E[Z] = eµ
∗+σ2/2,
τ 2 = V [Z] = e2µ
∗+σ2(eσ
2 − 1).
(3.4.7)
There are two forms of Log-Normal frailty in the literature. Depending on the restriction on
the frailty expected value, either the mean of frailty is one, i.e., E[Z]=µ = 1 or the mean
of the log of frailty is zero, i.e., E[W ] = E[LN(Z)] = µ∗ = 0. These restrictions are set to
assure model identifiability. If the effect of covariates is modelled through the scale parameter
of the Weibull distribution λ = exp(x
′
iβ+w), then the conditional survival function is given
by
S(ti,xi|z) = exp
(
−zH0(ti)ex
′
iβ
)
= exp
(
−tαex
′
iβ+w
)
.
Unfortunately, the unconditional survival and hazard functions do not have a closed form
and numerical integration is needed to integrate out the frailty variable. The contribution of
the ith individual to the conditional likelihood is given by
Li(ti, δi,xi|z) = (zh0(ti)ex
′
iβ)δie−zH0(ti)e
x
′
iβ .
where ti is the survival time or the censoring time of the i
th individual, δi is the censoring
indicator, Z is the unobserved random effects (frailties), xi is the vector of the observed
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covariate, and h0(ti) is the baseline hazard. Assuming the conditional independence of the
survival times given the frailty, the unconditional (marginal) likelihood function is
Li(ti, δi,xi) =
∫
R+
(zh0(ti)e
x
′
iβ)δie−zH0(ti)e
x
′
iβf(z, τ)dz.
where f(z, τ) is the p.d.f of the frailty distribution. In the case of Log-Normal frailty, the
marginal likelihood of the ith individual is given by
Li(ti, δi,xi) =
∫
R
(αtα−1i e
x
′
iβ+w)δi exp(tαi e
x
′
iβ+w)
1
τ
√
2π
e−
w2
2τ2 dw.
A numerical integration such as Gauss quadrature integration could be used to integrate out
the frailty
∫ ∞
−∞
f(x)dx ≈
K∑
k=1
πke
x2kf(xk).
where xk and πk are the zeros of Hermite polynomials and their corresponding weight factors
respectively. To make this integration simpler and less time consuming from a computational
point of view one can set Y = W
2τ
, the simplified likelihood is given by
Li(ti, δi,xi) =
∫
R
(αtα−1i e
x
′
iβ+τy
√
2)δi exp(tαi e
x
′
iβ+τy
√
2)
1√
π
e−y
2
dy
≈
K∑
k=1
π∗k(αt
α−1
i e
x
′
iβ+τy
∗
k)δi exp(tαi e
x
′
iβ+τy
∗
k), (3.4.8)
where y∗k = yk
√
2 and π∗k = πk/
√
π. Either the likelihood is maximise directly using an
iterative method, say Newton-Raphson or using the EM-algorithm by considering (3.4.8) as
a finite mixture. To use the EM-algorithm the vector of survival time T is assumed to be
observed part whilst the vector ζ = (ζ1, ..., ζn) to be unobservable random variables, where
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ζi = (ζi1, ..., ζiK) such that ζik is unity if ti comes from component k and 0 otherwise. So,
given all of the data Y = (T, ζ) and the set of the parameter of interest φ = (β, τ, α), the
complete likelihood of is
L(Y ,φ) =
n∏
i=1
K∏
k=1
[πkfik(ti,xi)]
ζik ,
and the complete log-likelihood is
`(Y ,φ) =
n∑
i=1
K∑
k=1
ζik log πk +
n∑
i=1
K∑
k
ζik log fk(y,xi). (3.4.9)
where fik(ti,xi) = (αt
α−1
i e
x
′
iβ+τy
∗
k)δi exp(tαi e
x
′
iβ+τy
∗
k). The EM-algorithm starts by estimating
the missing quantities in E-step and then maximisation in M-step.
E-Step. Suppose that φ = (β, τ, α) are known. Then the missing quantities ζ are replaced
by their conditional expectations, conditioned on the parameters and on the observed data
T. The conditional expectation of the kth component of ζi is just the conditional probability
that the observation ti comes from the k
th component of the mixture, conditioned on the
parameters and the observed data. Let the conditional expectation of the kth component of
ζ be ζ̃ik. Then
ζ̃ik =
wkfik(ti,xi)∑m
k=1wkfik(ti,xi)
.
M-Step. Suppose that the missing ζi are now known. The estimates of the parameters
φ = (β, τ, α) can then be obtained by maximising the log-likelihood function ` in (3.4.9).
This procedure works fine if the score equations have closed form, but the problem here
is that the score equations cannot be solved analytically and ` needs to be maximised
iteratively. Similar procedures can be found in LMMs assuming a Normal random effect
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and the conditional distribution belongs to the exponential family Bock and Aitkin (1981),
Hsu (2000), McLachlan and Krishnan (2008) and Aitkin et al. (2009).
3.4.5 Non-parametric frailty models
Most of the recently published work about non-parametric frailty is from the Bayesian
prospective. The unknown frailty distribution is modelled non-parametrically using a
Dirichlet process (see, Manda 2011, Cai 2010, Naskar et al. 2005 and Pennell and Dunson
(2006)). Alternatively, a semi-parametric survival frailty model can be obtained by assuming
a non-parametric baseline hazard (see, Clayton (1988), Klein (1992b), Li and Lin (2000) and
Vaida and Xu (2000)). Naskar (2008) introduced a non-parametric Dirichlet process for the
distribution of frailty along with the assumption of a non-parametric baseline hazard function.
This thesis focuses on the frequentist approach since no prior distributions of the model
parameters is assumed. In the next section, simulations will show how the model inferences
are not robust against mis-specifying of the frailty distribution. This is also supported by the
literature. Heckman and Singer (1982a) induced interest in non-parametric representation
of frailty (also see, Laird 1978, Heckman and Singer 1984, Davies and Crouchley 1984). The
theoretical result of the non-parametric characterisation of the frailty distribution within
maximum likelihood estimation is narrowed to a finite number of mass points. Also from the
empirical experience it has been shown that the number of mass points tends to be small
(Davies, 1993). For univariate frailty models, see (dos Santos et al. 1995, Aitkin 1999 and
Aitkin et al. 2009). The Weibull hazard with non-parametric frailty model can be written as
Li(ti, δi,xi)≈
K∑
k=1
πk(αt
α−1
i e
x
′
iβ+γk)δi exp(tαi e
x
′
iβ+γk). (3.4.10)
where 0 < πk < 1 and
∑K
k=1 πk = 1. This model is similar to the Weibull survival time
with Log-Normal frailty model given in (3.4.8) except that K and (γ, π) are no longer given
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and have to be estimated like other parameters. The mean and variance of the frailty have
been absorbed into the non-parametric representation of the model. For the EM-algorithm,
same argument as for (3.4.8) could be used to estimate the mixture in (3.4.10) as before,
except that the zeros of Hermite polynomials and their corresponding weights are considered
as parameter and need to be estimated.
3.5 Univariate simulations
Simulation studies are used to assess the performance of a proposed model, especially if there
is a lack of theoretical background. In simulations, the researchers know the true parameters
values and use them to generate the data. This data is used to fit the parameters using the
proposed model; if the original parameters values are retrieved then the proposed model is
acknowledged. However, real data sets are used to show the applicability of the proposed
model, but it does not evaluate its performance. Recurrence of breast cancer data is used
as an application of the proposed models in this thesis. It is an observational study where
recurrence is defined as clinical recurrence of breast cancer after remission where the event
of interest is the first recurrence of breast cancer. There are five possible outcomes, local
recurrence, regional recurrence, metastasis, died from breast cancer or died from other causes.
This section test the performance of the models mentioned above using simulated data (using
a self-written GAUSS code), while the next section demonstrates the applications of these
models to the breast cancer data. The model is fitted by maximum likelihood estimation
method based on numerical integration not the EM-algorithm. The simulated data have been
generated from a univariate frailty models assuming Weibull baseline hazard and different
frailty distributions including Gamma, Inverse Gaussian and Log-Normal distribution. The
simulations are divided into three parts: First, simulation of Log-Normal frailty model with
Weibull baseline hazard. Second, simulation of Log-Normal, Gamma and Inverse Gaussian
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frailty model with Weibull baseline hazard fitted by Log-Normal frailty using model (3.4.8).
Third, simulation of Log-Normal, Gamma, Inverse Gaussian and arbitrary (non-parametric)
frailty model with Weibull baseline hazard fitted non-parametrically using model (3.4.10).
First, a simulated data of failure times that follow a Weibull distributions T ∼ Weib(α, λ) and
censoring times follow a Weibull distribution C ∼ Weib(θ, α) assuming random censoring.
The distribution of the log of frailty W = Log(Z) is assumed to be Normal with mean zero
and variance σ2, W ∼ N(0, σ2). Two different sets of parameters were used to check the
model estimation. Different types of explanatory variables were generated, Xi1 is a continuous
random variable from Uniform distribution Xi1 ∼ Uni(0, 1), Xi2 is a dichotomous, and Xi3
is a qualitative variable with three categories which was converted to two dummy variable
Xi3,1 and Xi3,2.
Xi2 =
{
1 if ui1 < 0.3
0 if ui1 ≥ 0.3
and Xi3 =

1 if ui2 < 0.4
2 if 0.4 ≤ ui2 < 0.6
3 if ui2 > 0.6
where Uij ∼ Uni(0, 1), j=1,2. The linear predictors are generated as
x
′
iβ = β0 + xi1β1 + xi2β2 + xi3,1β3 + xi3,2β4.
The failure times were generated as Ti = (− log(ui3)/λi)1/α, where λi = exp(x
′
iβ + W )
and W is the log of frailty with W ∼ N(0, σ2) and ui3 ∼ Uni(0, 1). The censoring times
were generated as Ci = (− log(ui4)/θ)1/α, where ui4 ∼ Uni(0, 1) and finally the survival
times are Yi = min(Ti, Ci). Two sets of parameters are used to generate the failure and
censoring times with censoring rate of 20%. The above models are estimated using the
maximisation procedure in Gauss program ‘MAXLIK’. A Gaussian quadrature integration
with 32 quadrature points was used to integrate out the frailty, the code is in appendix C. For
each set of parameters 600 data sets each with sample sizes of 500 and 5000 are simulated.
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The results are shown in Table 3.1. Obviously, the estimation method and the GAUSS code
managed to retrieve the true parameters values especially with the large sample size. The
standard errors are much smaller in case of sample size 5000 than 500.
Parameter True values
Sample size
True values
Sample size
500 5000 500 5000
Mean Mean Mean Mean
(S.e) (S.e) (S.e) (S.e)
α 1 1.066 1.003 0.5 0.550 0.503
(0.310) (0.038) (0.157) (0.030)
σ2 1 1.097 1.004 1.5 1.689 1.508
(0.596) (0.084) (0.713) (0.147)
β0 -4 -4.212 -4.011 3 3.354 3.019
(1.024) (0.148) (1.150) (0.215)
β1 1 1.052 1.007 0.8 0.872 0.808
(0.382) (0.090) (0.415) (0.111)
β2 -2 -2.144 -2.007 -1 -1.104 -1.005
(0.699) (0.092) (0.406) (0.090)
β3 4 4.259 4.013 0.7 0.762 0.703
(1.233) (0.160) (0.317) (0.074)
β4 2 2.128 2.009 -2 -2.209 -2.011
(0.689) (0.102) (0.720) (0.145)
Table 3.1: Simulation data of Weibull baseline hazard generated with Log-Normal frailty and
fitted by Log-normal, 600 data sets each with sample sizes of 500 and 5000.
Second, to test the robustness of the parameters estimate against mis-specifying the frailty
distribution, different frailty distribution were generated such as Gamma, Inverse-Gaussian,
and Log-Normal distribution and fitted by Log-Normal distribution. Table 3.2 shows
these simulations. Clearly, the results are not robust against the mis-specifying of frailty
distribution. There is a big difference between Gamma frailty and Log-Normal especially in
estimating the frailty variance τ 2. However, there is a big similarity between Log-Normal
and Inverse Gaussian frailties. More simulations that support these conclusions are given in
chapter five. The standard errors are smaller in case of Log-Normal and Inverse Gaussian
frailty than the Gamma frailty. This is also another indication of the similarity between
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Log-Normal and Inverse Gaussian and different from the Gamma distribution.
Parameter True values
Log-Normal Gamma Inverse Gaussian
500 5000 500 5000 500 5000
Mean Mean Mean Mean Mean Mean
(S.e) (S.e) (S.e) (S.e) (S.e) (S.e)
α 1 1.066 1.003 1.596 1.282 1.030 0.979
(0.310) (0.038) (0.633) (0.102) (0.261) (0.031)
τ 2 1 1.097 1.004 2.427 1.847 0.855 0.786
(0.596) (0.084) (1.220) (0.208) (0.510) (0.072)
β0 -4 -4.212 -4.011 -6.931 -5.680 -4.470 -4.285
(1.024) (0.148) (2.561) (0.418) (0.983) (0.133)
β1 1 1.052 1.007 1.537 1.288 1.011 0.978
(0.382) (0.090) (0.819) (0.157) (0.308) (0.080)
β2 -2 -2.144 -2.007 -3.212 -2.564 -2.065 -1.955
(0.699) (0.092) (1.352) (0.218) (0.561) (0.082)
β3 4 4.259 4.013 6.363 5.113 4.121 3.918
(1.233) (0.160) (2.550) (0.409) (1.089) (0.132)
β4 2 2.128 2.009 3.205 2.568 2.060 1.959
(0.689) (0.102) (1.369) (0.219) (0.537) (0.086)
Table 3.2: Log-Normal, Gamma and Inverse Gaussian frailty model with Weibull baseline hazard
and four covariates simulated data fitted by Log-Normal frailty, 600 data sets each with sample
sizes of 500 and 5000.
Third, to check the ability of non-parametric frailty model in capturing the parameters
estimates, a simulated data with different frailty distribution is generated and fitted by non-
parametric frailty. Four different frailty distribution are generated, Log-Normal, Gamma,
Inverse Gaussian and arbitrary (a discrete random variable with expect value equals one).
Table 3.3 presents the parameters’ estimates using five mass points of the non-parametric
frailty. These results are very close when the model is fitted with four mass points. Appendix
A gives the parameters estimates using one, two, three, four or five mass points along
with their log-likelihood. Obviously, the non-parametric frailty is capable of capturing the
parameters’ estimates regardless of the original distribution of frailty. The mass points and
their corresponding weights are represented by γi and πi, (i = 1, . . . , 5) respectively. The
standard errors are smaller in case of sample size of 5000.
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P
ar
am
et
er
T
ru
e
va
lu
es Log-Normal Gamma Inverse Gaussian Arbitrary
Sample size Sample size Sample size Sample size
500 5000 500 5000 500 5000 500 5000
Mean Mean Mean Mean Mean Mean Mean Mean
(S.e) (S.e) (S.e) (S.e) (S.e) (S.e) (S.e) (S.e)
β1 1 1.041 0.982 1.018 0.991 1.051 0.987 1.048 0.981
(0.330) (0.097) (0.333) (0.105) (0.347) (0.095) (0.372) (0.115)
β2 -2 -2.104 -1.963 -2.072 -1.990 -2.106 -1.973 -2.092 -1.962
(0.388) (0.140) (0.360) (0.121) (0.421) (0.144) (0.429) (0.164)
β3 4 4.181 3.924 4.127 3.96 8 4.220 3.950 4.195 3.923
(0.705) (0.266) (0.596) (0.230) (0.741) (0.266) (0.789) (0.318)
β4 2 2.079 1.963 2.065 1.983 2.103 1.975 2.093 1.961
(0.386) (0.144) (0.378) (0.128) (0.428) (0.145) (0.463) (0.173)
α 1 1.046 0.981 1.034 0.992 1.055 0.988 1.048 0.982
(0.171) (0.064) (0.144) (0.054) (0.180) (0.064) (0.186) (0.077)
γ1 -1.351 -1.381 -1.329 -0.850 -1.344 -1.332 -1.284 -1.214
(1.202) (1.267) (2.044) (6.282) (1.137) (1.141) (1.333) (1.050)
γ2 -1.314 -1.346 -1.354 -0.632 -1.219 -1.170 -1.241 -1.105
(1.097) (2.541) (2.113) (6.226) (0.984) (0.971) (1.190) (1.059)
γ3 -1.430 -1.461 -1.534 -1.184 -1.476 -1.273 -1.534 -1.448
(1.293) (1.312) (2.231) (6.495) (1.212) (1.103) (1.509) (1.273)
γ4 -1.462 -1.413 -1.773 -1.288 -1.398 -1.427 -1.490 -1.489
(1.407) (1.381) (2.325) (6.371) (1.315) (1.104) (1.281) (1.196)
γ5 -1.607 -1.439 -1.797 -1.348 -1.599 -1.508 -1.701 -1.577
(1.364) (1.382) (2.380) (6.197) (1.264) (1.177) (1.418) (1.225)
π1 0.195 0.196 0.212 0.207 0.200 0.190 0.198 0.196
(0.137) (0.136) (0.169) (0.153) (0.144) (0.134) (0.134) (0.116)
π2 0.193 0.202 0.191 0.222 0.196 0.204 0.197 0.197
(0.138) (0.128) (0.160) (0.143) (0.139) (0.138) (0.129) (0.121)
π3 0.203 0.207 0.206 0.202 0.201 0.204 0.194 0.199
(0.141) (0.137) (0.168) (0.154) (0.152) (0.142) (0.123) (0.112)
π4 0.200 0.197 0.195 0.189 0.197 0.204 0.203 0.204
(0.146) (0.136) (0.168) (0.152) (0.145) (0.141) (0.127) (0.119)
π5 0.208 0.197 0.195 0.181 0.206 0.198 0.208 0.205
(0.145) (0.135) (0.160) (0.146) (0.150) (0.141) (0.131) (0.116)
Table 3.3: Log-Normal, Gamma, Inverse Gaussian and arbitrary frailty model with Weibull
baseline hazard and four covariates simulated data, fitted by non-parametric frailty, 600 data sets
each with sample sizes of 500 and 5000.
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3.6 Results on breast cancer recurrence data
This is to illustrate the relationship of the models discussed above to the breast cancer data
given in chapter two and appendix A. The study included 2850 patients. Their status at
the time of first recurrence is given in 3.4. Around 38% of them experienced one of the five
types of failures (competing risks). Metastasis and regional recurrence are the most frequent
failure type with 15.8% and 9.2% respectively.
Failure Type N Percent
LOCAL RECURRENCE 169 5.9%
REGIONAL RECURRENCE 261 9.2%
METASTASIS 451 15.8%
DIED FROM BREAST CANCER 185 6.5%
DIED FROM OTHER CAUSES 128 4.5%
CENSORED 1656 58.1%
Total 2850 100.0%
Table 3.4: Patients status at time of first recurrence.
stage(I) tumour size less than 2cm and no nodes involved.
stage(II) tumour size between 2cm and 5cm and no nodes involved, or tumour size less
than 5cm with nodes.
stage(III) tumour size more than 5cm with or without nodes.
stage(IV) any tumour size with the presence of distant metastasis, i.e., disease elsewhere
other than the breast or local nodes.
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Variable Categories N %
STAGE
STAGE1 2107 73.9
STAGE2 457 16.0
STAGE3 179 6.3
STAGE4 107 3.8
SURGERY TYPE
NONE 45 1.6
INCISION BIOPSY 186 6.5
EXCISION BIOPSY 712 25.0
SIMPLE MASTECTOMY 543 19.1
RADICAL MASTECTOMY 36 1.3
WIDE LOCAL EXCISION AND
AXILLARY CLEARANCE 479 16.8
SURGERY AFTER NEO ADJUVANT
CHEMOTHERAPY 73 2.6
RADICAL MAST AND AXILLARY
CLEARANCE 776 27.2
HISTOLOGY
DUCTAL 1856 65.1
LOBULAR 336 11.8
DCIS (Ductal Carcinoma In Situ) 412 14.5
OTHER 246 8.6
DATE OF PRIMARY BEFORE 1990 1130 39.6
SURGERY 1990+ 1720 60.4
ANY NEO OR ADJUVANT NO 1525 53.5
CHEMOTHERAPY YES 1325 46.5
MENOPAUSAL STATUS
PRE 788 27.6
POST 2062 72.4
ANY ADJUVANT NO 1813 63.6
RADIOTHERAPY YES 1037 36.4
SIDE OF THE BODY
RIGHT 1354 47.5
LEFT 1496 52.5
Age
Mean ± SD
58.11 ± 12.97
Table 3.5: Independent variables included in the models.
47
Chapter 3. Frailty Models in the literature
For the models used to fit this data, the qualitative variables are converted into dummy
variables and set the first category as the reference category except for Surgery type the last
category is used as the reference, see appendix A. Since this chapter focuses on univariate
frailty, death due to breast cancer is considered as the event of interest and all other
recurrences as independent censored observations. For simple models, three different software
packages are used to fit the models, Gauss, R and STATA. For advanced models, a self-written
code in both Gauss and R are used, see appendix C. STATA was used only to check the codes
written in Gauss and R since it contains a build in univariate frailty models especially for
Gamma and Inverse Gaussian. In multivariate case only Gauss program was used to fit the
model parameters. The optimisation procedure in Gauss showed robustness in reaching the
maximum likelihood estimates, while the optimisation procedure in R was sensitive to the
parameters’ initial values. Table 3.6 summarises the regression analysis of the data using
three different models. The first model is the Cox proportional model which does not assume
any parametric distribution for the baseline hazard function, model (2.6.1). The second
model is an independent Weibull model where the distribution of baseline hazard function is
Weibull and no frailty, model (2.6.3). The third model assumes Weibull distribution baseline
hazard function and Gamma frailty distribution as model (3.4.5). It is clear that the results
in the first and second columns of Table 3.6 for the Cox proportional hazard as close to those
of the Wiebull hazard which is a well-known result in the literature. To compare the second
model (i.e. reference model) with the third model (i.e. frailty model), a test of τ 2 = 0 vs
τ 2 6= 0, where τ 2 is the variance of the frailty distribution is used. The likelihood ratio test
is
−2log
(
likelihood(reference)
likelihood(frailty)
)
= (3785.24− 3764.17) = 21.07,
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which has a chi-square distribution with one degree of freedom. In this case the frailty model
is preferred to the reference model since (P-value < 0.0005). Figure 3.2 shows the hazards
of death due to breast cancer after initial treatment, for an average individual (function
evaluated at the mean value of the covariates), for each of the independent and the frailty
models. In the case of the independent model, the hazard of death due to breast cancer
seems unrealistic as it reaches its peak directly after initial treatment and then decreases
over time. In contrast, the frailty model displays a more realistic hazard function for death
due to breast cancer, whereas the lowest hazard level is directly after initial treatment and
then the hazard increases with time. The hazard of death due to breast cancer is always
lower when employing the frailty model which is expected as the effects of any unobserved
frailty on prognostic factors which have been appropriately controlled.
An important concept used in survival analysis is hazard ratio (HR) which can be defined as
the ratio of the hazard rate of one set of covariates to another set of covariates in the model.
For example, the point estimate of the HR of Stage2 compared to Stage1 (i.e. the reference
category) is ĤR = eβ2 = e0.545 = 1.725; in particular, the hazard for patients in Stage2 is
1.725 times the hazard for patients in Stage1. Table 3.6 shows that applying frailty increases
the HR for most of the factors in the model. Among the factors entered in the three models,
Age, stage2, stage3, stage4, surgtype1, surgtype2, hist3 and cohort have a significant effect on
breast cancer mortality. On the other hand, only hist2 has a significant effect in the Cox PH
model and the independent Wiebull model. The Weibull scale parameter is different between
the second model and the third model. In the independent Weibull model, α is close to one
which means constant hazard (i.e. Exponential baseline hazard), while in the Gamma frailty,
α = 1.41 indicating an increasing hazard which is more realistic in human studies.
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(a) Independent (no frailty)
(b) Gamma frailty
Figure 3.2: Weibull hazards of died from breast cancer for independent and frailty models.
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Variable Cox PH Weibull Wiebull-Gamma
hazard frailty
AGE **0.030 ( 0.009 ) **0.030 ( 0.008 ) **0.037 ( 0.011 )
STAGE2 **0.545 ( 0.189 ) **0.548 ( 0.211 ) *0.613 ( 0.248 )
STAGE3 *0.728 ( 0.305 ) *0.726 ( 0.289 ) *0.933 ( 0.373 )
STAGE4 **2.152 ( 0.283 ) **2.163 ( 0.270 ) **3.722 ( 0.510 )
SURGTYPE1 **1.981 ( 0.526 ) **2.078 ( 0.416 ) **2.668 ( 0.606 )
SURGTYPE2 **1.354 ( 0.416 ) **1.387 ( 0.311 ) **1.599 ( 0.395 )
SURGTYPE3 -0.073 ( 0.356 ) -0.056 ( 0.297 ) -0.089 ( 0.337 )
SURGTYPE4 -0.253 ( 0.391 ) -0.243 ( 0.297 ) -0.363 ( 0.343 )
SURGTYPE5 -44.78 ( 181.8 ) -8.152 ( 48.73 ) -10.901 ( 181.1 )
SURGTYPE6 -0.552 ( 0.436 ) -0.549 ( 0.389 ) -0.644 ( 0.417 )
SURGTYPE7 0.499 ( 0.495 ) 0.530 ( 0.514 ) 0.543 ( 0.577 )
HIST2 *0.465 ( 0.206 ) *0.472 ( 0.207 ) 0.439 ( 0.246 )
HIST3 *-1.472( 4.690 ) *-1.471 ( 0.614 ) *-1.484 ( 0.637 )
HIST4 0.146 ( 0.238 ) 0.121 ( 0.211 ) 0.094 ( 0.267 )
COHORT **0.578 ( 0.200 ) **0.620 ( 0.192 ) **0.703 ( 0.242 )
CHEMO 0.019 ( 0.233 ) 0.043 ( 0.191 ) 0.114 ( 0.216 )
MENO 0.211 ( 0.271 ) 0.204 ( 0.284 ) 0.181 ( 0.333 )
RADIO -0.455 ( 0.328 ) -0.457 ( 0.298 ) -0.421 ( 0.326 )
SIDE 0.242 ( 0.153 ) 0.248 ( 0.151 ) 0.277 ( 0.184 )
CONSTANT **-13.700 ( 0.834 ) **-16.488 ( 1.235 )
LN(α) 0.097 ( 0.060 ) **0.343 ( 0.080 )
(FRAILTY) τ 2 *2.171 ( 0.750 )
-2 Log Likelihood 2421.70 3785.24 3764.17
Table 3.6: Results of breast cancer data: died from breast cancer with the cox
proportional hazard, Weibull hazard and Weibull-Gamma frailty. Parameters’ estimates
with their standard error in parentheses.
*.P-value < 0.05
**.P-value < 0.01
P-value for testing H0 : βi = 0 vs H1 : βi 6= 0
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Although the standard errors of the third model are higher than the other models, it is
more appropriate in making inference about the factors effect on mortality of breast cancer
and ignoring the frailty underestimate the model parameters. Using the results of the third
model, one can conclude the following remarks. As expected, as age increases breast cancer
mortality increases. There is a significant difference between the four stages of the disease in
breast cancer mortality. The hazard ratio of stage2 is e0.613 = 1.85 times as for stage1 (the
reference category). The same for stage3 and stage4, the hazard ratio of stage3 is e0.933 =
2.54 times as for stage1, and for stage4 it is e3.72 = 43.3 times as for stage1. For surgery
type, surgtype1 (None) and surgtype2 (Incision biopsy) have significantly higher hazard ratios
compared to surgtype8 (Radical mast and axillary clearance), the reference category. This
seems unexpected, but actually this is because most of these two groups occur either in stage3
or stage4 of the disease. For histology, the only significant difference is between hist3 and hist1
(reference category). Patients with hist3 (DCIS , Ductal carcinoma in situ) have a hazard
ration of e−1.48 = 0.227 times as hist1 (Ductal). Finally, The hazard ratio of mortality due to
breast cancer of Cohort with the date of primary surgery after 1990 is e0.703 = 2.02 times as
those with before 1990. Unfortunately, the likelihood ratio test cannot be applied to different
frailty distributions in Table 3.7 since they are not nested. Two criteria are usually used for
model selection among a finite set of models. The first one is AIC which stands for Akaike
Information Criterion developed by Akaike (1974). The second one is BIC which stands for
Bayesian Information Criterion by Schwarz (1978). These criteria introduce a penalty term
for the number of parameters in the model, and the model with the smallest AIC or BIC
is preferred. By both criteria, the non-parametric frailty model has the smallest values and
hence is preferable when compared to other frailty distributions. The non-parametric model
is preferable since it has the smallest standard errors for all parameters estimate.
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Frailty distribution
Variable Gamma Inverse Gaussian Log-Normal Non-parametric
AGE **0.037(0.011) **0.036(0.011) **0.041(0.015) **0.036(0.009)
STAGE2 *0.613(0.248) *0.647(0.266) **0.685(0.313) *0.530(0.221)
STAGE3 *0.933(0.373) *1.008(0.406) **1.139(0.502) **0.826(0.311)
STAGE4 **3.722(0.510) **3.340(0.490) **4.069(0.985) **3.426(0.309)
SURGTYPE1 **2.668(0.606) **2.725(0.628) **3.172(0.927) **2.307(0.463)
SURGTYPE2 **1.599(0.395) **1.694(0.440) **1.940(0.582) **1.388(0.325)
SURGTYPE3 -0.089(0.337) -0.054(0.347) -0.092(0.394) -0.141(0.309)
SURGTYPE4 -0.363(0.343) -0.355(0.359) -0.446(0.419) -0.374(0.311)
SURGTYPE5 -10.9(181.05) -7.89(38.634) -7.89(31.485) -7.889(41.46)
SURGTYPE6 -0.644(0.417) -0.657(0.437) -0.792(0.510) -0.616(0.397)
SURGTYPE7 0.543(0.577) 0.555(0.609) 0.521(0.695) 0.521(0.538)
HIST2 0.439(0.246) 0.474(0.260) 0.490(0.303) 0.403(0.218)
HIST3 *-1.484(0.637) *-1.573(0.656) **-1.740(0.745) *-1.411(0.619)
HIST4 0.094(0.267) 0.100(0.270) 0.062(0.310) 0.115(0.230)
COHORT **0.703(0.242) **0.722(0.250) **0.839(0.315) **0.609(0.205)
CHEMO 0.114(0.216) 0.098(0.227) 0.145(0.257) 0.099(0.199)
MENO 0.181(0.333) 0.201(0.342) 0.275(0.391) 0.210(0.305)
RADIO -0.421(0.326) -0.477(0.339) -0.516(0.383) -0.397(0.306)
SIDE 0.277(0.184) 0.295(0.190) *0.365(0.224) 0.239(0.162)
CONSTANT **-16.49(1.235) **-16.29(1.462) **-19.91(3.934)
LN(α) **0.343(0.080) **0.332(0.104) **0.466(0.194) **0.290(0.060)
(FRAILTY)τ 2 *2.171(0.750) 4.968(4.081) **1.998(0.487)
-2 Log Likelihood 3764.17 3770.04 3802.20 3756.78
AIC 3808.17 3814.04 3846.20 3796.78
BIC 3939.18 3945.05 3977.21 3915.88
Table 3.7: Results of breast cancer data: Died from breast cancer assuming different frailty
distributions. Parameters’ estimates with their standard error in parentheses.
*.P-value < 0.05
**.P-value < 0.01
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Number of Number of -2log-likelihood AIC BIC
Points parameters
1 23 3785.2368 3831.2 3968.2
2 25 3758.7958 3808.8 3957.7
3 27 3756.0952 3810.1 3970.9
4 29 3756.1028 3814.1 3986.8
5 31 3756.1026 3818.1 4002.7
Table 3.8: Non-parametric models with different mass points.
For the Log-Normal frailty 128 quadrature mass points were used to fit the model whereas
for the non-parametric model only five mass points were used. Table A.4 lists the estimates
of the Log-Normal frailty with different number of quadrature points. The results are very
close when using nine points or more. One important issue about the non-parametric frailty
is the number of mass points which should be used to fit the model. Since these models are
not nested the log-likelihood ratio test can not be used the number of mass points. Table
3.8 lists the values of AIC and BIC of mortality due to breast cancer with different number
of mass points. Both AIC and BIC suggest that two points as the suitable number of mass
points. The parameters estimates with three mass points are very similar to those with four
and five point points (see Table A.3).
3.7 Summary
This chapter described the main features of univariate frailty models and reviewed the
most commonly used frailty distributions. Gamma, Inverse Gaussian and the Log-Normal
distributions are intensively studied in the literature. Some software like STATA can be used
to fit both Gamma and Inverse Gaussian frailty models. The Log-Normal frailty is available
in SAS-system through the PHREG Procedure, but in this thesis a self-written Gauss code
54
Chapter 3. Frailty Models in the literature
is used. Other frailty distributions are not available in commercial software and need self-
written code in some programming languages. The simulation studies showed that the model
fits are sensitive to the choice of the frailty distribution. To overcome this problem a non-
parametric frailty model is also presented. The non-parametric frailty model was capable to
fit the model irrespective to the frailty distribution. Different models were used to analyse
the breast cancer data in which the event of interest is died from breast cancer. These models
include: Cox proportional hazard, Weibull hazard, Weibull-Gamma frailty, Weibull-Inverse
Gaussian frailty, Weibull-Log-Normal frailty and Weibull-nonparametric frailty. By applying
these modes one can conclude the following: First, ignoring the frailty underestimates the
model parameters. Second, the standard errors of parameter estimates are the smallest in
the case of non-parametric frailty. Only small numbers of mass points are needed in the
non-parametric frailty to reach the maximum likelihood estimates of the model parameters
which mean less time is required to fit the model compared to the Log-normal frailty. All
models discussed in this chapter are univariate frailty models where the main goal of adding
the frailty component is to take into account the unobserved risk factors. In many studies,
individual are clustered in subgroups or the individual could face more than one failure type.
The next chapter discusses these types of studies using multivariate frailty models.
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Multivariate frailty in competing risks
models
4.1 Introduction
Multivariate frailty models are used when there are repeated measures or clustering.
Repeated data occur in case of longitudinal data, concerning multiple recurrences of an
event for the same individual. Clustered data occur when individuals fall into groups like
families or hospitals. The difficulties of working with this kind of data arise from the
dependence of individuals upon the social context of their groups, or of repeated measures
upon the individuals concerned. Such dependence usually arises because individuals in the
same group are related to each other or because of the recurrence of an event for the same
individual. Multivariate frailty models have been used frequently for modelling dependence
in multivariate time-to-event data (Clayton 1978, Oakes 1982, Hougaard 2000 and Yashin
et al. 1995).
As mentioned, linear mixed models are usually used to analyse repeated measures and
cluster data for one outcome (response), but when multiple outcomes are measured at each
time-point or for each cluster, a joint model is required which allows for a correlation
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structure between the different outcomes. Many authors have studied such models; for
example, Thum (1997) studied models with multivariate clustered data in the context of
hierarchical modelling, Gueorguieva (2001) used joint modelling of a continuous- and a
binary-outcome measure in a developmental toxicity study on mice. Also in a longitudinal
setting, Chakraborty et al. (2003) obtained estimates of the correlation between blood and
semen HIV-1 RNA using a joint random-effects model. Although Models in all of these
examples can be applied to any number of responses, the computational procedure of model
fitting is only feasible for a limited number of responses. A recent series of papers proposed a
model-fitting procedure that is applicable irrespective of the number of responses. Fieuws and
Verbeke (2004) used a joint model of random-effects in a bivariate setting with longitudinally
measured continuous outcomes by fitting different mixed models joined by specifying a
common distribution for their random-effects. Fieuws and Verbeke (2006a) proposed a
method that allows joint analysis of multivariate repeated measures of a relatively high
dimension. The method is based on fitting bivariate mixed models for all pairs of outcomes.
As long as each bivariate mixed model can be fitted, estimates can be obtained for the full
multivariate mixed model. Fieuws et al. (2006b) applied the pairwise modelling strategy
proposed by Fieuws and Verbeke (2006a), to obtain parameter estimates of high dimensional
LMMs for binary questionnaire data, where all possible bivariate mixed models were fitted
and where the inference that follows from pseudo-likelihood theory has been proposed as
a solution. Fieuws et al. (2007) combined the proposed methods by Fieuws and Verbeke
(2006a) and Fieuws et al. (2006b); they used the pairwise modelling of repeated measures
for continuous as well as for binary questionnaire data, so that the approach is sufficiently
flexible to allow for different types of models for the different outcomes (i.e. linear, non-linear,
and generalised linear).
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Despite the big similarity between LMMs and multivariate frailty, many methods that could
be applicable to both models, the multivariate frailty models need special treatment. The
aim of the frailty model is to take into account the presence of the correlation between the
multivariate survival times. The first extension of univariate frailty to multivariate frailty is
the shared frailty model. In shared frailty models, individuals in the same group or cluster
are assumed to share the same frailty. Thus, it accommodates the heterogeneity among
clusters rather than among individuals. Correlated frailty models are an extension of shared
frailty. In correlated frailty models, frailties are correlated and have the same set of marginal
distributions. If the frailties follow a multivariate distribution with a general correlation
structure, then it is a full multivariate frailty model.
4.2 Shared frailty models
In many studies individuals are grouped into clusters, such as families, hospitals or schools.
Similar to univariate frailty, shared frailty models are used to take into account the
heterogeneity between clusters due to exclusion of important shared covariates. In these
models, it is assumed that all individuals in the same cluster share the same frailty. It was
introduced by Clayton (1978) and extensively studied by Hougaard (2000). Many authors
have studied shared frailty models with different distributions, including Gamma. Clayton
(1978), Gill (1989), Klein (1992b), Yu (2006), inverse Gaussian, Whitmore and Lee (1991),
Henderson and Oman (1999) and Log-Normal, McGilchrist (1993), Ripatti et al. (2002),
Vaida and Xu (2000). For the Bayesian approach see, Sinha (1993), Sahu et al. (1997) and
Yin and Ibrahim (2005).
In a shared frailty model there are two main assumptions: First, the failure times are
conditionally independent given the frailties. Second, the random effect Z of the jth cluster
58
Chapter 4. Multivariate frailty in competing risks models
(j = 1, · · · , k) is assumed to be constant over time and common to all individuals in the
same cluster. The hazard function of the ith individual in the jth cluster conditional on the
random effect is given by
h(tij,xij|zj) = zjh(tij,xij) = zjh0(tij)exp(x
′
ijβ),
where zj are the frailties, assumed to be iid (identically and independently distributed) with
the density g(z, θ) and parameter vector θ. h0(tij) is the baseline hazard function, xij is the
vector of covariate of the ith individual in the jth cluster and β is the fixed effect vector. Here
the frailty term is included to take into account the heterogeneity between clusters and not
individuals. Assuming that the failure times are conditionally independent given the frailties,
the conditional joint survival function is given by
S(tij,xij|zj) =
k∏
j=1
Sj(tij,xij |zj).
The unconditional joint survival function is given by
S(tij,xij) = EZ [S(tij,xij|zj)] = EZ [exp(−zj
k∑
j=1
H0j(tij)e
x
′
ijβ)] = LZ
[
k∑
j=1
H0j(tij)e
x
′
ijβ
]
.
where LZ [.] is the Laplace transformation with respect to the frailty random variable Z and
H0j(tij) is the cumulative baseline hazard function of the j
th cluster. Thus, the unconditional
joint survival function can be expressed as the Laplace transform of the sum of the cumulative
baseline hazards with respect to the frailty distribution. The unconditional joint density
function is given by differentiation of the survival function with respect to ti1, · · · , tik
f(tij,xij) = (−1)k
k∏
j=1
h0j(tij)e
x
′
ijβL(k)Z
[
k∑
j=1
H0j(tij)e
x
′
ijβ
]
.
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Another formulation of the above procedure is through the marginal survival functions
Sj(tij,xij) = LZ [H0j(tij)ex
′
ijβ].
The unconditional joint survival function is given by
S(tij,xij) = EZ [S(tij,xij |zj)] = LZ
[
k∑
j=1
L−1Z [Sj(tij,xij)]
]
.
There are some limitations with shared frailty models as mentioned by Xue and Brookmeyer
(1996). Firstly, it forces the unobserved factors to be the same within the cluster, which
is generally not appropriate. Secondly, the dependence between survival times within the
cluster is based on marginal distributions of survival times. Thirdly, in most cases shared
frailty will only induce positive association within the cluster.
4.3 Correlated frailty models
Due to their limitations, shared frailty models can be extended to correlated frailty models,
where each cluster has its own frailty distribution. Most of the correlated frailty models
developed until now are bivariate frailty models or restricted multivariate models. Such
frailties are often constructed using independent additive components with one common
component for both frailties to create the correlation between the frailties. There exists
a need for more flexibility in modelling correlation. The difficulty in these models is that
related outcomes have different but dependent frailties. (Yashin et al. (1995), Yashin and
Iachine (1999)) introduced a correlated Gamma frailty model and discussed its identifiability
conditions. Vaida and Xu (2000) suggested a bivariate frailty model in a slightly different
setting, dos Santos et al. (1995) used a combination of a shared Log-Normal and a
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Gamma frailty model on breast cancer data. Wienke et al. (2005) compared different
bivariate correlated frailty models and possible estimation strategies. Zahl (1997) used
several correlated Gamma frailty models to model the excess hazard. Li (2002) proposed
a multivariate Gamma frailty model in a genetic situation. For different frailty distributions
see Wienke (2007, 2010a) and Duchateau and Janssen (2008). A number of authors have
used a Bayesian approach for analysis of correlated frailty models; for instant, Xue and Ding
(1999), Kheiri et al. (2005), Wienke et al. (2005) Locatelli et al. (2004, 2007), Yin (2008) and
Cai (2010).
In contrast to a shared frailty model, correlated frailty models allow different frailties between
clusters and individuals in the same cluster. The hazard function of the ith individual in the
jth cluster conditional on the random effect is given by
h(ti,xij|zij) = zijh(tij,xij) = zijh0(tij)exp(x
′
ijβj).
where zij are the frailties, assumed to be iid with a joint density g(zi1, · · · , zik, θj) with
parameter vector θj. The Laplace transformation is more complicated in this case and a
different formulation is needed. Assuming the conditional independence of failure times
given the frailty, the unconditional likelihood function is given by
L(tij,xij) =
∏
i
∫
R+
· · ·
∫
R+
∏
j
[
(zijh0j(tij)e
x
′
ijβj )dij exp(−zijH0j(tij)ex
′
ijβj )
]
×fZj(zi1, · · · , zik)dzi1 · · · dzik.
(4.3.1)
For bivariate correlated Gamma frailty, see Yashin et al. (1995), restricted high dimension
of correlated Gamma frailties, Yashin and Iachine (1999), for four dimension Gamma frailty,
Giard et al. (2002) and different correlated frailty distributions Wienke (2007, 2010a). As
mentioned, correlated frailty models are usually constructed using independent positive
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components and hence they generate a restricted positive correlation coefficient which in
many cases is not appropriate. A general class of multivariate frailty models is when
the frailties are assumed to follow a multivariate distribution with a general structure of
covariance matrix. The most frequent distribution used in multivariate frailty is the Log-
Normal distribution. Other distributions are limited in the literature. The multivariate Log-
Normal frailty models are more flexible than other distributions but numerical integration is
needed to calculate the joint survival function.
4.4 Competing risks models
In studies of survival, subjects may be at risk of failure due to more than one cause, the so-
called competing risks analysis or multiple causes of failure. The objective of such analysis
is usually to determine risk rates of failure due to one cause while taking into account the
presence of the other causes. There are two approaches in the literature to analyse competing
risks: the first emphasises cause-specific hazard functions and sub-distribution functions for a
particular kind of failure, (Prentice et al. 1978, Fine and Gray 1999, Lunn and McNeil 1995).
The second, approaches the subjects through the concept of latent failure times, where there
is an inherent failure time for each type of failure and only one such time - the smallest - is
observable, (Slud et al. (1988), Kalbfleisch and Prentice (2002)). In this thesis, the emphasis
is on the concept of latent failure time. Parametric competing risk models, in which it is
assumed that the failure times are coming from a known distribution with monotonically
increasing or decreasing baseline hazard, is widely used in practice perhaps due to its
simplicity, for example (Hougaard (2000), Lambert et al. (2004), Oskrochi and Crouchley
(2004)) perhaps due to its simplicity. In conventional survival analysis the competing risks
are usually assumed independent, Han and Hausman (1990). Semi-parametric and non-
parametric competing risks models are discussed by many authors. For instance (Gelfand
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et al. 2000, Abbring and van den Berg 2003, Hudgens et al. 2001), Jewell et al. (2003)). In
univariate survival data, there is usually the following data for the ith individual: the failure
time (Yi), the censoring variable (δi) and some covariates (xi). In multivariate survival data,
there is either have cluster or recurrence data and the following data for the ith individual
in the jth cluster is observed: the failure times (Yij), the censoring variable (δij) and some
covariates (xij). In competing risks data, the following data for the i
th individual is observed:
the failure time (time to the first failure) (Yi), the failures indicator variables (δik, k = 1, ..., K)
and some covariates (xi). See Table 4.1.
4.5 Frailty in Competing Risks Models
Random effects or frailty in competing risk models consist of two underlying distributions:
the conditional distribution of the response variables (failure times), given the random effect
depending on the explanatory variables each with a failure type specific random effect; and
the distribution of the random effect in the population (frailty distribution). In this situation,
the distribution of interest is the unconditional distribution of the response variables which
may or may not have a tractable form. Bandeen-Roche and Liang (2002) described the
association of time to multivariate failure in the presence of a competing risk. As mentioned
above frailty models in the presence of competing risks involve the conditional distribution
failure time given the frailty and the distribution of the frailty. Fahrmeir and Tutz (1994) and
Oskrochi and Davies (1997) implemented the Cholesky decomposition for multivariate frailty
models. The Cholesky decomposition decomposes the frailty variance-covariance matrix into
triangular matrices to convert the integration over a multivariate distribution to multiple
integrals over independent univariate Normal distributions.
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Univariate data
ID Yi δi xi1 · · · xip
1 Y1 δ1 x11 · · · x1p
2 Y2 δ2 x21 · · · x2p
. . . . . .
. . . . . .
. . . . . .
n Yn δn xn1 · · · xnp
Multivariate data
ID Yij cluster δij xij1 · · · xijp
1 Y11 1 δ11 x111 x11p
2 Y21 1 δ21 x211 x21p
. . . . . .
. . . . . .
. . . . . .
n1 Yn11 1 δn11 xn111 · · · xn11p
. . . . . . .
. . . . . . .
. . . . . . .
1 Y1J J δ1J x1J1 x1Jp
2 Y2J J δ2J x2J1 x2Jp
. . . . . .
. . . . . .
. . . . . .
nJ YnJJ J δnJJ xnJJ1 · · · xnJJp
Competing risk data
ID Yi δi1 · · · δiK xi1 · · · xip
1 Y1 δ11 · · · δ1K x11 · · · x1p
2 Y2 δ21 · · · δ2K x21 · · · x2p
. . . . . . . .
. . . . . . . .
. . . . . . . .
n Yn δn1 · · · δnK xn1 · · · xnp
Table 4.1: Univariate, multivariate and competing risks data presentation.
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Fine and Gray (1999) proposed a novel semi-parametric proportional hazards model for
the sub-distribution. Using the partial likelihood principle and weighting techniques, they
derived estimation and inference procedures for the finite-dimensional regression parameters
under a variety of censoring scenarios. They gave a uniformly consistent estimator for
the predicted cumulative incidence for an individual with certain covariates, confidence
intervals and bands can be obtained analytically or with an easy-to-implement simulation
technique. Fine et al. (2001) considered semi-competing risk models, in which a terminal
event censors a non-terminal event but not vice versa. The joint distribution of the events is
formulated via Gamma frailty model with marginal distributions unspecified. They showed
that the dependence between morbidity and mortality can be estimated separately from their
marginals under a Gamma frailty copula in the region of observable data. Jiang et al. (2004)
considered semi-competing risk models where mortality and morbidity may be correlated
and mortality may censor morbidity. They proposed a semi-parametric estimator for the
survival function based on a joint model for the two time-to-event variables, which utilises
the Gamma frailty specification in the region of the observable data. They extended the
methods of Fine et al. (2001) for the left truncated semi-competing risk problem, developed
an estimator for the Gamma frailty parameter under left truncation and derived a closed
form estimator for the marginal distribution of the non-terminal event. Naskar et al. (2005)
proposed a dependent competing risks model where dependency is induced through the
mixture of various failure types and a frailty component. The frailty term is modelled non-
parametrically using a Dirichlet Process (DP). They considered a semi-parametric mixture
model for analysing clustered competing risks data. Conditional on cluster-specific quantities,
the joint distribution of the failure time and event indicator can be expressed as a mixture
of the distribution of time to failure due to a certain type (or specific cause), and the failure
type distribution. They assumed that the marginal probabilities of various failure types
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(competing risks) are logistic functions of some covariates. The cluster-specific quantities are
subject to some unknown distribution that causes frailty. Lu and Tsiatis (2005) compared
two approaches for the competing risks model with missing cause of failure. Under the
assumption that the cause of death is missing at random, they compared the Goetghebeur
and Ryan (1995) partial likelihood approach with the one by Dewanji (1992). They showed
that the Dewanji partial likelihood estimator for the regression coefficients is consistent and
asymptotically Normal. While the Goetghebeur and Ryan estimator is more robust estimator
against mis-specification of proportional baseline hazards. Finkelstein and Esaulovac (2006,
2008) discussed the asymptotic behaviour of competing risks models with correlated frailty
in univariate and bivariate cases. They consider a set of absolutely continuous distributions
of a lifetime random variable.
In the next section, a review the correlated Gamma frailty and its application to competing
risks framework is given. In section 4.7, a new proposed correlated Inverse Gaussian frailty
model and its application to competing risks are presented. A general multivariate Inverse
Gaussian frailty model without any restriction on the correlation structure between the
frailties is given in section 4.8. In addition, a flexible multivariate frailty model that can
be applied whatever the original distribution of the frailty in section 4.10 is proposed. In this
model, a non-parametric multivariate frailty presented.
4.6 Correlated Gamma frailty model
In this section, a summary of the main aspects of the correlated Gamma frailty, which
has been intensively studied in the literature, is listed. Yashin et al. (1995) introduced
model of bivariate survival based on the notion of correlated individual frailty. This model
usually refereed to as the additive model since the frailty variable is constructed as the sum
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of independent variables. Many authors have studied this model and its extensions and
applications, for example see (Yashin and Iachine 1995a,b, 1999, Wienke et al. 2002, 2003,
Kheiri et al. 2005, Abbring and van den Berg 2007 and Duchateau and Janssen 2008) among
others. The procedure starts by defining a system of equations (frailty ) as the sum of
independent Gamma distributions a common variable to create the dependency and then
derive the unconditional survival function as the product of their Laplace transformation.
For the bivariate case, the results shown by Yashin et al. (1995) and Wienke (2007, 2010a)
are given.
Let Z1 =
λ0
λ1
X0+X1 and Z2 =
λ0
λ2
X0+X2, where X0, X1, X2 are independent random variables
with Gamma distribution Xi ∼ Γ(αi, λi), i = 0, 1, 2. The distribution of Z1 and Z2 is Gamma
with mean one and variance V [Zi] = 1/λi = τ
2
i , i = 1, 2, the correlation coefficient between
the two frailties is given by
ρz =
α0
(α0 + α1)(α0 + α2)
.
The unconditional survival function is
S(ti1, ti2) =
S1(ti1)
1−ρσ1
σ2 S2(ti2)
1−ρσ2
σ1(
S1(ti1)−σ
2
1 + S2(ti2)−σ
2
1 − 1
) ρ
σ1σ2
. (4.6.1)
This procedure is restricted since it can only create a positive correlation between the frailties
which may limits its applications. Moreover this correlation must satisfy the following
condition.
0 ≤ ρ ≤ min
(
τ1
τ2
,
τ2
τ1
)
.
To build the likelihood function, all partial derivatives of the bivariate survival function in
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(4.6.1) must be calculated which has the following form
L(ti1, ti2) =

S(ti1, ti2) if δi1 = 0, δi2 = 0(
− ∂
∂ti1
logS(ti1, ti2)
)
× S(ti1, ti2) if δi1 = 1, δi2 = 0(
− ∂
∂ti2
logS(ti1, ti2)
)
× S(ti1, ti2) if δi1 = 0, δi2 = 1(
∂
∂ti2∂ti1
S(ti1, ti2)
)
if δi1 = 1, δi2 = 1.
The last term of the likelihood can be written in logarithmic form
∂
∂ti2∂ti1
S(ti1, ti2) = [
∂
∂ti2∂ti1
logS(ti1, ti2) +
(
∂
∂ti1
logS(ti1, ti2)
)(
∂
∂ti2
logS(ti1, ti2)
)]
S(ti1, ti2).
Hence, The log-likelihood function can be written in terms of the bivariate survival function
as
δi1δi2 log
[
∂
∂ti2∂ti1
logS(ti1, ti2) +
(
∂
∂ti1
logS(ti1, ti2)
)(
∂
∂ti2
logS(ti1, ti2)
)]
+
∑2
j=1 δij log
(
− ∂
∂tij
logS(ti1, ti2)
)
+ log[S(ti1, ti2)].
(4.6.2)
Presenting the log-likelihood in terms of logarithm of the survival function simplifies the
calculations of the log-likelihood which is equivalent to the one given by Wienke (2007, 2010a).
The partial derivatives of the lnS(ti1, ti2) are available in Appendix B. An extensions of the
above bivariate correlated frailty are given by Yashin and Iachine (1999). They used the same
argument as the bivariate model by defining the frailties as Zj = αj(Y0 + Yj), j = 1, ..., k.
The Joint survival function has the following form
S(ti1, · · · , tik) =
(
k∑
j
Sj(tij)
−σ2j − n+ 1
)
k∏
j
Sj(tij)
1−σ2j (ρjh/σh), (4.6.3)
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where ρjh are the correlation coefficients between Zj and Zh, and σ
2
j is the variance of Zj,
i, j = 1, ..., k; j 6= k. This model is restricted since ρjh/σjσh is assumed to be constant and
does not depend on j and k and should satisfies the following constrain
ρjh
σjσh
≤ min
{
1
σj
, j = 1, ..., k
}
,
which may be too restrictive for real applications.
4.7 Correlated Inverse Gaussian frailty model
In this section, a general correlated Inverse Gaussian frailty with different variances is
proposed. Many authors have studied the univariate Inverse Gaussian frailty model.
(Hougaard 1984,Manton et al. 1986, Whitmore and Lee 1991, and Klein et al. 1992a).
Although it has a closed form of the Laplace transformation, the correlated Inverse Gaussian
frailty is rarely considered in the literature since it doesn’t have the reproductivity property
(i.e. the summation of Inverse Gaussian is not an Inverse Gaussian). Kheiri et al. (2007)
suggested a Bayesian analysis of a correlated Inverse Gaussian frailty with common variance.
Wienke et al. (2010b) extended the compound Poisson frailty model to a bivariate model
where the correlated Gamma frailty model and the correlated inverse Gaussian frailty model
by Kheiri et al. (2007) as special cases.
In this section, a general correlated Inverse Gaussian frailty with different variances is
proposed. Let X1, ..., Xk be independent Inverse Gaussian random variables with Xi ∼
IG(ci, c
2
i ). The mean and the variance are equal to (ci > 0). Define Y =
∑k
i=1Xi, such that
Y ∼ IG(
∑
ci, (
∑
ci)
2). To derive the formulation of the correlated Inverse Gaussian frailty,
most of researchers start with a bivariate model then say it is straightforward to generalise
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it to the multivariate model. To derive a multivariate frailty model with general variance-
covariance matrix, a trivariate model is used to get the general form of the multivariate
model. In the first step, define the following system of equations (frailties):
Z1 = a1(X1 +X2 +X4), a1 = 1/(c1 + c2 + c4)
Z2 = a2(X1 +X3 +X5), a2 = 1/(c1 + c3 + c5)
Z3 = a3(X2 +X3 +X6), a3 = 1/(c2 + c3 + c6).
(4.7.1)
It can be shown that E[Zi] = 1, V [Zi] = ai = τ
2
i , and the variance-covariance matrix of Z
is given by
Σ = Cov(Z) =

a1 a1a2c1 a1a3c2
a1a2c1 a2 a2a3c3
a1a3c2 a2a3c3 a3
 (4.7.2)
The number of variables usually needed to define k frailty variables is
(
k
2
)
+k. For covariances(
k
2
)
variables are needed and k variables for the variances. A very important assumption
here is that given frailties Zi, i = 1, 2, 3 the survival times Ti, i = 1, 2, 3 are conditionally
independent. Hence the unconditional survival function can be calculated by
S(ti1, ti2, ti3) = E[S(ti1, ti3, ti3|Z1, Z2, Z3)]
=
∏3
j=1E[Sj(tij|Zj)]
=
∏3
j=1E[exp (−ZjH0j(tij)]
= E[exp(−X1[a1H01(ti1)+a2H02(ti2)]−X2[a1H01(ti1)+a3H03(ti3)]−
X3[a2H02(ti2) + a3H03(ti3)] − X4[a1H01(ti1)] − X5[a2H02(ti2)] −
X6[a3H03(ti3)])].
Using the fact that the random variables X1, ..., X6 are independent, the unconditional
survival function is given by
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S(ti1, ti2, ti3) = L1[a1H01(ti1) + a2H02(ti2)]L2[a1H01(ti1) + a3H03(ti3)]
L3[a2H02(ti2) + a3H03(ti3)]L4[a1H01(ti1)]L5[a2H02(ti2)]L6[a3H03(ti3)].
The unconditional survival function can be expressed using the marginal survival functions
as follow
S(ti1, ti2, ti3) =
[S1(ti1)]
(1−ρ12 τ1τ2−ρ13
τ1
τ3
)
[S2(ti2)]
(1−ρ12 τ2τ1−ρ23
τ2
τ3
)
[S1(ti3)]
(1−ρ13 τ3τ1−ρ23
τ3
τ2
)
×exp
{
ρ12
τ1τ2
(
1−
[
(1− τ 21 logS1(ti1))
2
+ (1− τ 22 logS2(ti2))
2 − 1
]1/2)}
×exp
{
ρ13
τ1τ3
(
1−
[
(1− τ 21 logS1(ti1))
2
+ (1− τ 23 logS3(ti3))
2 − 1
]1/2)}
×exp
{
ρ23
τ2τ3
(
1−
[
(1− τ 22 logS2(ti2))
2
+ (1− τ 23 logS3(ti3))
2 − 1
]1/2)}
.
(4.7.3)
Since the frailties are defined by a system of non-negative random variables, the correlation
coefficients between the frailties are positive and they must satisfy the following conditions.
ρ12
τ1
τ2
+ ρ13
τ1
τ3
< 1, ρ12
τ2
τ1
+ ρ23
τ2
τ3
< 1 and ρ13
τ3
τ1
+ ρ23
τ3
τ2
< 1.
For more detail about the derivation of the unconditional survival function see appendix B.
The following argument is used to derive the likelihood function. It has different components
depending on the number of failures. Using the general form of the likelihood as in (2.5.1)
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and using the relation in (2.1.2) one can write the likelihood as
L(ti1, ti2, ti3) = 
S(ti1, ti2, ti3) if all δij = 0, j = 1, 2, 3(
− ∂
∂tij
S(ti1, ti2, ti3)
)δij
if only one of δij = 1, j = 1, 2, 3(
∂
∂tijtik
S(ti1, ti2, ti3)
)δijδik
if two of δij = 1,
(j,k)
(j 6=k) = 1, 2, 3(
− ∂3
∂ti1∂ti2∂ti3
S(ti1, ti2, ti3)
)
if all δij = 1, j = 1, 2, 3.
(4.7.4)
In the case of competing risks models the individual faces only one type of the failures which
has the minimum failure time (i.e. only one of δij = 1, j = 1, 2, 3), see Table 4.1 . Another
possibility is that the individual does not face any of the failure types which means censored
from all failure types (i.e. all δij = 0, j = 1, 2, 3). In this case only the first order of the
partial derivatives of the likelihood function is needed. Consequently, (4.7.4) reduces to
L(ti1, ti2, ti3) =
3∏
j=1
(
− ∂
∂tij
logS(ti1, ti2, ti3)
)δij
S(ti1, ti2, ti3).
This comes from the fact that
∂
∂tij
S(ti1, ti2, ti3) =
(
− ∂
∂tij
logS(ti1, ti2, ti3)
)
S(ti1, ti2, ti3).
The log-likelihood is given by
`(ti1, ti2, ti3) =
3∑
j=1
δij log
(
− ∂
∂tij
logS(ti1, ti2, ti3)
)
+ log[S(ti1, ti2, ti3)]. (4.7.5)
In the case of competing risks, only the minimum failure time is observed and tij is replaced
by the time to the first recurrence, ti = min(ti1, ti3, ti3).
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4.8 Multivariate Inverse Gaussian frailty model
4.8.1 Inverse Gaussian frailty model
In this section, a general multivariate Inverse Gaussian frailty model where the joint
distribution of the frailty vector is a multivariate Inverse Gaussian is proposed. The additive
model in the previous section has two restrictions. First, it generates a correlated frailty
model whose marginal distributions are Inverse Gaussian variables but not a multivariate
Inverse Gaussian distribution. Second, it produces restricted correlation coefficients between
frailties. In this section, these restrictions are relaxed and a multivariate Inverse Gaussian
frailty with a general correlation structure between the frailties is presented. Minami (2003)
proposed a multivariate Inverse Gaussian distribution based on the inverse relationship with
the multivariate Normal distribution. The proposed distribution has three sets of parameters
β,µ and Ω denoted by Zk×1 ∼ MIG(β,µ,Ω) define on
{
z : β
′
z > 0, z ∈ Rk
}
. The p.d.f is
given by
f(z;β,µ,Ω) = (2π)−k/2β
′
µ |Ω|−1/2 (β′z)−(k/2+1)
× exp
{
− 1
2β
′
z
(z− µ)′Ω−1(z− µ)
}
. (4.8.1)
where β,µ ∈ Rk, β′µ > 0 and Ω is a symmetric positive definite matrix of size k × k. The
mean and the covariance matrix are given by
E[Z] = µ and V [Z] = β
′
µΩ.
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The cumulant generating function (c.g.f) of the distribution is given by
ΦMI(t) = ln(E[exp(−Zt)]) = −µ
′
(t− bβ), (4.8.2)
where
b =
1
β
′
Ωβ
{
1 + β
′
Ωt−
√
(1 + β
′
Ωt)2 − β′Ωβ t′Ωt
}
.
For identifiability purpose the frailty distribution is assumed to have a mean vector of ones
µ = 1 and β = 1, Z ∼MIG(1,1,Ω). Using the result of (4.8.2) the unconditional survival
function is given by
S(t) = exp
[
−1′H0(t) +
k
1
′
Ω1
{
1 + 1
′
ΩH0(t)
−
√
(1 + 1
′
ΩH0(t))2 − 1′Ω1 H0(t)′ΩH0(t)
}]
. (4.8.3)
where H0(t) = (H01(ti1), ..., H0k(tik))
′
is the cumulative baseline hazard. This is more
flexible than the previous model with no restriction on the correlation coefficients. The
same argument as in (4.7.4) could be used to derive the likelihood function. The first order
partial derivative of the log-survival function with respect to one of the survival times say tr
is given by
∂lnS(t)
∂tr
= −1′h0r(t) +
k
1′Ω1
×
{
1
′
Ωh0r(t)−
1
′
Ωh0r(t)(1 + 1
′
ΩH0(t))− 1
′
Ω1h
′
0r(t)ΩH0(t)√
(1 + 1′ΩH0(t))2 − 1′Ω1H0(t)′ΩH0(t)
}
. (4.8.4)
where h0r(t) = (0, ..., h0r(tr), ..., 0)
′
and k is number of individuals in the cluster or number
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repeated measure of an individual. The general likelihood of the multivariate survival data
either for cluster or repeated measures involves k orders of the partial derivatives of −logS(t).
In the case of competing risks only the first order of partial derivatives with respect to
ti1, ..., tik are required. Hence the log-likelihood function of competing risk model with k
possible failures is given by
`(ti1, ..., tik) =
k∑
j=1
δij log
(
− ∂
∂tij
logS(ti1, ..., tik)
)
+ log[S(ti1, ..., tik)]. (4.8.5)
4.9 Multivariate Log-Normal frailty model
The Laplace transformation of the Log-Normal variable does not have a closed-form
expression. Hence it doesnt follow the same methodology as the Gamma or the Inverse
Gaussian distributions to derive the unconditional survival function. The likelihood could
still be maximised directly using numerical integration methods. However, The Log-Normal
frailty model gives more flexibility in the multivariate case with general variance-covariance
matrix. A number of Authors have discussed the correlated Log-Normal frailty (Xue and
Brookmeyer 1996, Ripatti and Palmgren 2000 and Pankratz et al. 2005). For the Bayesian
analysis of multivariate Log-Normal frailty models see, (Locatelli et al. 2004 and Stefanescu
and Turnbull 2006).
4.9.1 Cholesky decomposition
This section describes the use of Cholesky decomposition in analysing competing risks model
for recurrence of the breast cancer. Given a symmetric positive definite matrix Σ, the
Cholesky decomposition creates a lower triangular matrix L with strictly positive diagonal
entries such that Σ = LL
′
or equivalently crates an upper triangle matrix D such that
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Σ = D
′
D. Fahrmeir and Tutz (1994) and Oskrochi and Davies (1997) implemented the
Cholesky decomposition for multivariate frailty models. First, define a multivariate Normal
distribution of three variables such that the vector U ∼ MVN(0,Σ) is a trivariate Normal
distribution

Ui1
Ui2
Ui3
 ∼ N


0
0
0
 ,

σ21 σ12 σ13
σ21 σ
2
2 σ23
σ31 σ32 σ
2
3


Let Zi = exp(Ui), then (Z1, Z2, Z3) have a trivariate Log-Normal

Zi1
Zi2
Zi3
 ∼ LogN


µ1
µ2
µ3
 ,

τ 21 τ12 τ13
τ21 τ
2
2 τ23
τ31 τ32 τ
2
3


The mean, variance and the correlation of the frailties Zij are
µj = E[Zij] = E[exp(Uij)] = e
0.5σ2j
τ 2j = V [Zij] = e
σ2j (eσ
2
j − 1)
τjk = Cov(Zij, Zik) = e
0.5(σ21+σ
2
2)(eσ12 − 1)
The unconditional likelihood function
L(ti1, ti2, ti3) =
n∏
i
∫∫∫
R+
3∏
j
[
(zijh0j(tij)e
x
′
ijβj )dij exp(−zijH0j(tij)ex
′
ijβj )
]
×fZj(zi1, zi2, zi3)dzi1dzi2dzi3,
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or equivalently,
L(ti1, ti2, ti3) =
n∏
i
∫∫∫
R
3∏
j
[
(h0j(tij)e
x
′
ijβj+uij)dij exp(−H0j(tij)ex
′
ijβj+uij)
]
×fUj(ui1, ui2, ui3)dui1dui2dui3.
(4.9.1)
Using the Cholesky decomposition, the multivariate Normal random vector U ∼MVN(0,Σ)
can be written as U = LU∗, where U∗ ∼MVN(0, I) and L is the lower Cholesky triangle
L =

l11 0 0
l21 l22 0
l31 l32 l33

The covariance matrix of U is Σ = LIL
′
.
U =

l11 0 0
l21 l22 0
l31 l32 l33
 ×

U∗1
U∗2
U∗3
 =

l11U
∗
1
l21U
∗
1 + l22U
∗
2
l31U
∗
1 + l32U
∗
2 + l33U
∗
3
 (4.9.2)
Hence, the random variable uij in model (4.9.1) are replaced by their corresponding values
in (4.9.2). Since the joint distribution of U∗ is a multivariate standard Normal distribution,
then it can be written as the product of its marginals.
L(ti1, ti2, ti3) =
n∏
i
∫∫∫
R
3∏
j
[
(h0j(tij)e
x
′
ijβj+[LU
∗]ij)dij exp(−H0j(tij)ex
′
ijβj+[LU
∗]ij)
]
×
3∏
j
fU∗j (u
∗
ij)du
∗
i1du
∗
i2du
∗
i3.
where [LU∗]ij is the j
th row of the vector LU∗. To evaluate the triple integrals the
Gaussian quadrature is used and then replacing the vector of the standard Normal variable
(u∗i1, u
∗
i2, u
∗
i3)
′
by quadrature mass points (y∗i1, y
∗
i2, y
∗
i3)
′
with quadrature weights (w∗i1, w
∗
i2, w
∗
i3)
′
,
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see section (3.3.3). The unconditional likelihood is given by
L =
n∏
i
(∑
m3
∑
m2
∑
m1
[
3∏
j
(
h0j(tij)e
x
′
ijβj+[Ly
∗]j
)dij
exp
(
−H0j(tij)ex
′
ijβj+[Ly
∗]j
)]
w∗i1w
∗
i2w
∗
i3
)
.
(4.9.3)
where m1,m2 and m3 are the number of quadrature points of y
∗
i1, y
∗
i2 and y
∗
i3 respectively. The
likelihood function in (4.8.3) contains nested loops which may increase the time needed to
obtain the optimal solution of the model. Most software used to get the maximum likelihood
estimates are matrix oriented and working with matrices is much faster than loops. For
example, Gauss software has an element by element product procedure which can be used
to replace the loop by a vector. The summation in (4.8.3) is over the quadrature points and
the total number of iterations needed to get a single outcome is m1 × m2 × m3. One can
transform the loops into vectors by creating the following vectors
v1 = 1m2m3×1 ⊗ y∗1 ω1 = 1m2m3×1 ⊗w∗1
v2 = 1m3×1 ⊗ (y∗2 ⊗ 1m1×1) ω2 = 1m3×1 ⊗ (w∗2 ⊗ 1m1×1)
v3 = y
∗
3 ⊗ 1m1m2×1 ω3 = w∗3 ⊗ 1m1m2×1,
where ⊗ is the Kronecker product. This procedure showed a significant decrease in time
to reach the optimal solution of the model (i.e. the maximum likelihood estimators of the
model parameters). Converting the nested loops to vectors decreases the time needed to
fit the model by 50%. For the breast cancer data, fitting the model with five quadrature
points took ten days while using vectors only five days are required to fit the model. Further
reduction in time is by using the proposed non-parametric frailty model given in the next
section which decreases the time needed to fit the model by more than 80% of the nested
loops. Around two days are needed to fit the model of the breast cancer data using the
purposed non-parametric frailty.
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4.9.2 Weibull competing risks with Log-Normal frailty model
Assume that the failure times of the ith individual of jth failure (risk) have Weibull distribution
(Tij ∼ Weib(λj, αj)), i = 1, .., n,j = 1, .., k. The baseline hazards are hij(ti) = αjt
αj−1
i , where
ti = min
j
(tij). The likelihood of the trivariate competing risks model is given by
L =
n∏
i
(∑
m3
∑
m2
∑
m1
[
3∏
j
(
αjt
αj−1
i e
x
′
ijβj+[Ly
∗]j
)dij
exp
(
−tαji e
x
′
ijβj+[Ly
∗]j
)]
w∗i1w
∗
i2w
∗
i3
)
.
4.10 Competing risks with non-parametric frailty
model
In the previous chapter, it was shown that the model estimates are not robust against
the mis-specifying of the frailty distribution. In multivariate frailty models, the choice of
the frailty distribution is crucial to obtain correct estimates of the dependence structure
(Duchateau and Janssen, 2008). This section makes use of the results of the previous section
of Cholesky decomposition and the non-parametric frailty in section (3.3.4). The frailty
variable is assumed to follow some distribution say g(z) with a variance-covariance matrix
Σ = QIQ
′
where Q is lower triangle of the Cholesky decomposition.
Z =

q11 0 0
q21 q22 0
q31 q32 q33
 ×

Z∗1
Z∗2
Z∗3
 =

q11Z
∗
1
q21Z
∗
1 + q22Z
∗
2
q31Z
∗
1 + q32Z
∗
2 + q33Z
∗
3

Z = QZ∗ where Z∗ has some p.d.f, g∗(z∗) and the variance-covariance matrix is the identity
matrix I. There are two differences between this model and the Log-Normal model. First,
the identity matrix of the variance-covariance of Z∗ does not necessary imply independence
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and hence the joint density can not be written as the product of the marginal distributions.
Second, the diagonal of the variance-covariance matrix of Z will be absorbed in the non-
parametric representation and the frailty variable QZ∗ will be replaced by the quadrature
mass points.
L(ti1, ti2, ti3) =
n∏
i
∫∫∫
R
3∏
j
[
(h0j(tij)e
x
′
ijβj+[QZ
∗]j)dij exp(−H0j(tij)ex
′
ijβj+[QZ
∗]j)
]
×fZ∗j (z
∗
i1, z
∗
i2, z
∗
i3)dz
∗
i1dz
∗
i2dz
∗
i3

q11Z
∗
1
q21Z
∗
1 + q22Z
∗
2
q31Z
∗
1 + q32Z
∗
2 + q33Z
∗
3
 =

γ1
r21γ1 + γ2
r31γ1 + r32γ2 + γ3
 = γ.
Hence, the likelihood function is given by
L =
n∏
i
(∑
m3
∑
m2
∑
m1
[
3∏
j
(
αjt
αj−1
i e
x
′
ijβj+[γ]ij
)dij
exp
(
−tαji e
x
′
ijβj+[γ]ij
)]
πi1πi2πi3
)
.
where [γ]ij is the j
th row of the vector γ and (γ1, .., γ3, πi1, ..., πi3) are also vector of the
quadrature points and weights respectively. The terms (qij, i = j) are absorbed in the non-
parametric representation and (qij, i 6= j) are replaced by rij. The relation between (qij, i 6= j)
and rij can be found algebraically. For example, r21 = (q21/q11)(γ1 − β10). Note that rij are
not the correlation coefficients between the frailties, but they were added to the model to
account for the association between frailties. In non-parametric analysis, the main interest
is to fit the regression coefficients not these associations. Here the quadrature mass points
and their corresponding weights are unknown and need to be estimated. In this model,
there are two assumptions. First, the marginal distributions of the frailty are identical and
can be estimated by the same vector of quadrature mass points, γ1 = γ2 = γ3 and same
weights, πi1 = πi2 = πi3. For example, if three quadrature points are used, then the number
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of parameters needed to approximate the integrations is six parameters, three mass points
and three weights.
Second, using the Cholesky decomposition generates independence between the frailties. But
these two assumptions can be relaxed. First, one can assume different mass points and
different weights but independent marginal. In this case the total number of parameters
needed to approximate the integrations is eighteen parameters, nine mass points and nine
weights. Second, if the Cholesky decomposition does not generate independence between
the frailties, the weights at each pair of mass point cannot be written as the product of the
corresponding weights. In this case each combination of three points need a weight. The
number of parameters needed is nine mass points and one twenty-seven weights. Fortunately,
simulations showed that if there is no restriction on these parameters, the total number of
parameters needed to get acceptable result decreases.
4.11 Multivariate simulations
This is to test the performance of the above proposed models through simulated data.
Four simulation studies are conducted. First, a bivariate competing risks model with two
failure times following a Weibull distribution with same shape parameter α and different
scale parameters λ. The bivariate frailty is assumed to follow Inverse Gaussian distribution.
Second, same as the first data but the frailty is assumed to follow Log-Normal distribution
fitted using Cholesky decomposition. Third, an extension of the previous data by adding
a third failure type, a competing risks model with multivariate frailty. Fourth, a bivariate
competing risks model is generated with a Weibull baseline hazard and three different frailty
distributions, Log-Normal, Gamma, and Inverse Gaussian and fitted by non-parametric
frailty.
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4.11.1 Bivariate Inverse Gaussian frailty of competing risks model
This is to check the proposed bivariate correlated Inverse Gaussian frailty model given in
section 4.7. A bivariate competing risks model with two failure times following a Weibull
distribution is generated, T1 ∼ Weib(λ1, α) and T2 ∼ Weib(λ2, α). Censoring times are
assumed to be independent and follow a Weibull distribution C ∼ Weib(θ, α). The frailties
Zij are assumed to follow a correlated bivariate Inverse Gaussian distribution with mean
one and variance τ 2i generated using the argument given in section 4.7. The failure times
were generated as Tij = (− log(uij)/λij)1/α, where λij = Zij exp(x
′
iβj) and uij ∼ Uni(0, 1),
j = 1, 2. Two different sets of parameters were used to check the model estimation. Three
different types of explanatory variables were generated, Xi1 is a continuous random variable
from Uniform distribution, Xi2 is a dichotomous, and Xi3 is a qualitative variable with three
categories which was converted to two dummy variable Xi3,1 and Xi3,2. See section 3.5. The
regression model is constructed using the following predictors,
x
′
iβ1 = β10 + xi1β11 + xi2β12 + xi3,1β13 + xi3,2β14.
x
′
iβ2 = β20 + xi1β21 + xi2β22 + xi3,1β23 + xi3,2β24.
The censoring times were generated as Ci = (− log(ui)/θ)1/α, where ui ∼ Uni(0, 1) and
finally the survival times are Yi = min(Ti1, Ti2, Ci). Table 4.2 shows the simulated data of
two sets of parameters. The censoring rate is set to 20% and failure rate to 40% for each of
the two failure types to get a representative sample of each group. For each set of parameters,
500 data sets were generated each with sample sizes of 1000 and 5000. Using sample size
of 1000 instead of 500 like other simulation is due to the difficulty of getting the maximum
likelihood estimation of the Inverse Gaussian distribution. Different values of α, τ 2, ρ, and
different regression coefficients were used. The simulated data showed high levels of accuracy
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in retrieving the true values of model parameters with small standard errors particularly
when large sample size is used. The estimation method was capable to accommodate both
weak and strong correlation between frailties with small and large variances. The parameters
used in the first data set are, τ 21 = 0.8, τ
2
2 = 1.25, ρ = 0.3 and in the second data set are,
τ 21 = τ
2
2 = 1, ρ = 0.8.
Parameter True values
Sample size
True values
Sample size
1000 5000 1000 5000
Mean Mean Mean Mean
(S.e) (S.e) (S.e) (S.e)
α1 0.5 0.510 0.501 1.0 1.028 1.003
(0.057) (0.021) (0.112) (0.041)
α2 0.5 0.507 0.501 1.0 1.030 1.001
(0.059) (0.022) (0.128) (0.049)
τ 21 0.8 1.317 0.838 1.0 1.710 1.045
(1.611) (0.330) (1.895) (0.350)
τ 22 1.25 1.929 1.311 1.0 2.017 1.080
(2.046) (0.449) (2.084) (0.494)
ρ 0.3 0.197 0.294 0.8 0.690 0.815
(0.689) (0.273) (0.511) (0.186)
β10 -4.0 -4.027 -4.003 -2.0 -1.978 -2.002
(0.272) (0.116) (0.237) (0.089)
β11 9.0 9.201 9.013 6.0 6.214 6.019
(1.023) (0.383) (0.698) (0.251)
β12 3.0 3.050 3.007 4.0 4.101 4.010
(0.400) (0.150) (0.460) (0.179)
β13 2.0 2.053 2.003 2.0 2.066 2.005
(0.258) (0.102) (0.247) (0.093)
β14 1.0 0.987 0.998 -1.0 -1.015 -1.004
(0.339) (0.143) (0.198) (0.085)
β20 -3.0 -2.977 -3.006 -1.0 -0.895 -0.991
(0.201) (0.087) (0.320) (0.111)
β21 7.0 7.077 7.015 2.0 1.999 1.988
(0.888) (0.348) (0.668) (0.262)
β22 4.0 4.071 4.013 5.0 5.165 5.008
(0.477) (0.185) (0.595) (0.234)
β23 1.0 0.996 1.003 1.0 1.020 1.003
(0.218) (0.091) (0.261) (0.109)
β24 3.0 3.069 3.011 -2.0 -2.063 -2.004
(0.386) (0.142) (0.338) (0.138)
Table 4.2: Bivariate Inverse Gaussian frailty model with Weibull baseline hazard and two sets of
covariates simulated data, 500 data sets each with sample sizes of 1000 and 5000.
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4.11.2 Bivariate Log-Normal frailty of competing risks model
In this section, the accuracy of Cholesky decomposition in estimating the bivariate frailty
models discussed in section 4.9 is checked. Similar to the previous section, a bivariate
competing risks model with two failure times following a Weibull distribution is generated.
The log of frailty distributions associated with each failure are assumed to be Normal with
mean zero and variance σ2i , Wi ∼ N(0, σ2i ), i = 1, 2. For each failure type, only two types
of explanatory variables were generated, Xi1 is a continuous random variable from Uniform
distribution Xi1 ∼ Uni(0, 1), and Xi2 is a dichotomous variable generated as follows
Xi2 =
{
1 if ui < 0.3
0 if ui ≥ 0.3
where ui ∼ Uni(0, 1). The regression model was constructed using the following predictors,
x
′
iβ1 = β10 + xi1β11 + xi2β12, and x
′
iβ2 = β20 + xi1β21 + xi2β22.
The failure times were generated as Tij = (− log(uij)/λij)1/α, where λij = exp(x
′
iβj + Wj)
and uij ∼ Uni(0, 1), j = 1, 2. The log of the frailty distributions associated with each failure
are assumed to be Normal with mean zero and variance σ2i . W ∼ BV N(0,Σ) is a bivariate
Normal distribution
(
W1
W2
)
∼ N
((
0
0
)
,
(
σ21 ρσ1σ2
ρσ1σ2 σ
2
2
))
.
The censoring times were generated as Ci = (− log(ui3)/θ)1/α, where ui3 ∼ Uni(0, 1) and
finally the survival times are Yi = min(Ti1, Ti2, Ci). Table 4.3 shows the simulated data of
two sets of parameters with censoring rate of 20%. A Gaussian quadrature integration with 32
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quadrature points was used to integrate out the frailty, codes are in appendix C. For each set
of parameters, 600 data sets each with sample sizes of 500 and 5000 are simulated. Different
values of α, σ2, ρ, and different regression coefficients are used. The simulated data showed
high levels of accuracy in retrieving the true values of model parameters using Cholesky
decomposition. In first data set, the parameter used are σ21 = σ
2
2 = 1, ρ = 0.3 and in the
second data set the parameters used are, σ21 = 0.7, σ
2
2 = 1.2, ρ = 0.8. The frailty variances
have bigger standard errors than other parameters in the model.
Parameter True values
Sample size
True values
Sample size
500 5000 500 5000
Mean Mean Mean Mean
(S.e) (S.e) (S.e) (S.e)
α1 1 1.088 1.010 0.5 0.527 0.501
(0.265) (0.051) (0.130) (0.023)
α2 1 1.069 1.007 0.5 0.610 0.506
(0.203) (0.047) (0.218) (0.029)
σ21 1 1.799 1.072 0.7 0.905 0.710
(2.506) (0.354) (0.618) (0.127)
σ22 1 1.668 1.058 1.2 1.738 1.236
(1.917) (0.326) (1.016) (0.164)
ρ 0.3 0.137 0.274 0.8 0.488 0.772
(0.926) (0.281) (0.567) (0.250)
β10 -3 -3.224 -3.027 -0.2 -0.318 -0.205
(0.738) (0.161) (0.303) (0.090)
β11 1 1.038 1.009 0.5 0.476 0.486
(0.454) (0.120) (0.393) (0.101)
β12 2 2.145 2.013 1 1.050 0.997
(0.613) (0.134) (0.341) (0.077)
β20 -4 -4.305 -4.030 0.2 0.201 0.202
(0.878) (0.216) (0.348) (0.076)
β21 2 2.154 2.019 0.7 0.907 0.701
(0.555) (0.138) (0.542) (0.113)
β22 3 3.230 3.024 1 1.223 1.017
(0.681) (0.156) (0.527) (0.086)
Table 4.3: Bivariate Log-Normal frailty model with Weibull baseline hazard and two sets of
covariates simulated data, 600 data sets each with sample sizes of 500 and 5000.
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4.11.3 Multivariate Log-Normal frailty of competing risks model
This section extends the pervious data by adding another failure time to have a trivariate
frailty model. The purpose of this addition is to test the performance of the Choleskey
decomposition of the Log-Normal frailty model in high dimensions. Three competing risks
with failure times, T1, T2, and T3 following the Weibull distribution are generated. Similar to
bivariate simulations, for each failure type two types of explanatory variables were generated,
Xi1 is a continuous random variable and Xi2 is a dichotomous variable. The log of the frailty
distributions associated with each failure are assumed to be Normal with mean zero and
variance σ2i . W ∼MVN(0,Σ) is a multivariate Normal distribution

W1
W2
W3
 ∼ N


0
0
0
 ,

σ21 ρ12σ1σ2 ρ13σ1σ3
ρ12σ1σ2 σ
2
2 ρ23σ2σ3
ρ13σ1σ3 ρ23σ2σ3 σ
2
3


Table 4.4 shows the simulated data of three dimensions competing risks. The failure and
censoring times are generated at censoring rate of 20%. Gaussian quadrature integration
with 8 quadrature points was used to integrate out the frailty. 500 data sets each with
sample sizes of 1000 and 5000 are simulated. Because of high dimensionality of the model a
sample size of 1000 is used instead of 500. These simulations used the following parameters:
σ21 = 1.25, σ
2
2 = 0.8, σ
2
3 = 1.75, and the following correlations: ρ12 = −0.7, ρ13 = −0.1, ρ23 =
0.25. In conclusion, the estimation method using the Cholesky decomposition can be used in
all situations of positive and negative correlation between the log of frailties and with small
and large variances. The standard errors of parameters estimates in case of sample size 5000
are smaller than those for 1000.
86
Chapter 4. Multivariate frailty in competing risks models
Parameter True values
Sample size
1000 5000
Mean(S.e) Mean(S.e)
β10 -4.0 -4.260 ( 0.596 ) -3.992 ( 0.266 )
β11 3.0 3.199 ( 0.541 ) 2.990 ( 0.219 )
β12 -1.0 -1.034 ( 0.426 ) -1.000 ( 0.189 )
α1 0.5 0.531 ( 0.078 ) 0.501 ( 0.030 )
β20 -3.0 -3.049 ( 0.377 ) -3.011 ( 0.128 )
β21 -2.0 -2.095 ( 0.409 ) -2.006 ( 0.148 )
β22 5.0 5.164 ( 0.706 ) 5.024 ( 0.206 )
α2 0.5 0.521 ( 0.074 ) 0.503 ( 0.023 )
β30 -2.0 -2.141 ( 0.366 ) -2.008 ( 0.133 )
β31 1.0 1.095 ( 0.355 ) 1.005 ( 0.141 )
β32 -2.0 -2.111 ( 0.595 ) -2.015 ( 0.253 )
α3 0.50 0.539 ( 0.095 ) 0.503 ( 0.029 )
σ21 1.25 1.754 ( 1.098 ) 1.275 ( 0.418 )
σ22 0.80 1.038 ( 0.875 ) 0.835 ( 0.196 )
σ23 1.75 2.536 ( 1.741 ) 1.846 ( 0.513 )
ρ12 -0.70 -0.647 ( 0.333 ) -0.706 ( 0.216 )
ρ13 -0.10 -0.086 ( 0.455 ) -0.092 ( 0.248 )
ρ23 0.25 0.247 ( 0.385 ) 0.258 ( 0.200 )
Table 4.4: Trivariate Log-Normal frailty model with Weibull baseline hazard and two covariates
simulated data, 500 data sets each with sample sizes of 1000 and 5000.
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4.11.4 Bivariate non-parametric frailty of competing risks model
This section tests the ability of the non-parametric frailty model proposed in section 4.10 in
capturing the model fits whatever the original frailty distribution. The simulation procedure
is similar to section 4.11.2 with different frailty distributions and there were fitted non-
parametrically. Assuming Weibull baseline hazard, the failure times were generated as
Tij = (− log(uij)/λij)1/α, where λij = Zj exp(x
′
iβj) and uij ∼ Uni(0, 1), j = 1, 2 with
censoring rate of 20%. The distribution of frailties Zj are assumed to be either Log-Normal,
Gamma, or Inverse Gaussian. Table 4.5 shows the simulated data of 500 data sets each
with sample sizes of 500 and 5000 of Log-Normal, Gamma and Inverse Gaussian frailty
with two covariates fitted non-parametrically. The constant terms were absorbed in the
non-parametric representation. The component r was included in the model to capture the
association between frailties. The variances and the correlation used in these simulations
are τ 21 = 0.8, τ
2
2 = 1.25, ρ = 0.3. Only three mass points of the quadrature integration and
three corresponding weights were used for each frailty distribution and it was enough to
fit the models adequately whatever the original distribution. These mass points and their
weight are represented by γij and πij, (i = 1, 2; j = 1, 2, 3) respectively. To increase the
flexibility of the non-parametric frailty model, the mass points of each frailty distribution
are assumed to be different (i.e. γ1j and γ2j, j = 1, 2, 3 are different). The same applies for
their corresponding weights. The standard errors are almost the same whatever the original
frailty distribution.
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Parameter True values
Log-Normal Gamma Inverse Gaussian
500 5000 500 5000 500 5000
Mean Mean Mean Mean Mean Mean
(S.e) (S.e) (S.e) (S.e) (S.e) (S.e)
β11 9 9.327 8.936 9.259 8.750 9.434 9.032
( 1.468 ) ( 0.441 ) ( 1.375 ) ( 0.478 ) ( 1.531 ) ( 0.470 )
β12 3 3.136 3.010 3.142 2.932 3.193 3.031
( 0.574 ) ( 0.186 ) ( 0.521 ) ( 0.189 ) ( 0.619 ) ( 0.188 )
α1 0.5 0.520 0.498 0.518 0.487 0.527 0.503
( 0.080 ) ( 0.026 ) ( 0.076 ) ( 0.027 ) ( 0.086 ) ( 0.027 )
β21 7 7.600 6.975 7.958 7.128 7.761 7.098
( 1.770 ) ( 0.450 ) ( 2.032 ) ( 0.539 ) ( 1.784 ) ( 0.511 )
β22 4 4.327 3.957 4.475 4.056 4.423 4.032
( 0.971 ) ( 0.243 ) ( 1.104 ) ( 0.296 ) ( 0.975 ) ( 0.270 )
α2 0.5 0.542 0.496 0.565 0.508 0.555 0.505
( 0.123 ) ( 0.030 ) ( 0.140 ) ( 0.036 ) ( 0.122 ) ( 0.034 )
r 1.032 0.584 1.078 0.585 0.964 0.516
( 2.014 ) ( 0.403 ) ( 1.542 ) ( 0.317 ) ( 1.402 ) ( 0.494 )
γ11 -4.531 -4.149 -5.798 -5.215 -4.582 -4.767
( 6.269 ) ( 1.423 ) ( 7.983 ) ( 2.130 ) ( 1.893 ) ( 5.957 )
γ12 -4.283 -4.218 -5.392 -5.180 -4.427 -4.551
( 3.863 ) ( 2.114 ) ( 6.445 ) ( 2.251 ) ( 1.608 ) ( 3.592 )
γ13 -4.330 -4.333 -4.972 -5.122 -4.597 -4.686
( 4.610 ) ( 1.759 ) ( 2.203 ) ( 1.874 ) ( 2.209 ) ( 3.961 )
γ21 0.009 -0.805 -0.059 -1.252 -0.064 -1.109
( 6.559 ) ( 2.338 ) ( 6.084 ) ( 3.125 ) ( 5.122 ) ( 2.348 )
γ22 0.263 -0.695 -0.074 -1.470 0.198 -1.114
( 6.658 ) ( 2.411 ) ( 5.673 ) ( 2.743 ) ( 5.332 ) ( 2.585 )
γ23 0.264 -0.904 -0.210 -1.545 -0.215 -1.196
( 7.680 ) ( 2.464 ) ( 5.989 ) ( 2.588 ) ( 5.941 ) ( 2.392 )
π11 0.333 0.330 0.322 0.321 0.359 0.350
( 0.218 ) ( 0.207 ) ( 0.242 ) ( 0.234 ) ( 0.223 ) ( 0.204 )
π12 0.348 0.338 0.342 0.336 0.320 0.309
( 0.209 ) ( 0.212 ) ( 0.239 ) ( 0.239 ) ( 0.207 ) ( 0.195 )
π13 0.319 0.332 0.336 0.343 0.322 0.341
( 0.215 ) ( 0.220 ) ( 0.237 ) ( 0.235 ) ( 0.204 ) ( 0.199 )
π21 0.335 0.342 0.321 0.318 0.356 0.323
( 0.245 ) ( 0.225 ) ( 0.259 ) ( 0.225 ) ( 0.252 ) ( 0.228 )
π22 0.338 0.318 0.350 0.334 0.321 0.336
( 0.255 ) ( 0.217 ) ( 0.264 ) ( 0.214 ) ( 0.255 ) ( 0.223 )
π23 0.327 0.340 0.330 0.348 0.323 0.341
( 0.246 ) ( 0.219 ) ( 0.253 ) ( 0.215 ) ( 0.249 ) ( 0.232 )
Table 4.5: Log-Normal, Gamma and Inverse Gaussian frailty model with Weibull baseline hazard
and two covariates simulated data fitted non-parametrically, 500 data sets each with sample sizes
of 500 and 5000.
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4.12 Results on breast cancer recurrence data
In this section, the proposed multivariate competing risks frailty models is applied on the
breast cancer data discussed in previous chapters. This includes the Weibull hazard models
with multivariate Log-Normal frailty using Cholesky decomposition and the multivariate
non-parametric frailty along with the univariate models. The following tables summarise
the regression analysis for each model of the competing risks assuming Weibull hazard with
four different frailty models. First, the independent Log-Normal frailty model. Second, a
multivariate Log-Normal frailty model. Third, an independent non-parametric frailty model.
Fourth, a multivariate non-parametric frailty model. The discussion of the results is based
on the last model since it doesn’t assume a specific frailty distribution and it has the lowest
standard errors of the parameters estimates. In chapter six discusses the advantages and
disadvantages of these models.
4.12.1 Analysis and conclusions
Through Table 4.6 to Table 4.10, the emphasis is on the results of the multivariate non-
parametric frailty models since they have the smallest standard errors. Table 4.6 displays
the multivariate non-parametric frailty model of local recurrence. It shows that there is no
significant effect of age on the hazard of local recurrence, but the direction of the relation was
as expected, i.e. young patients have a higher chance of local recurrence. Patients in stage2
and stage3 of the disease have higher hazard than patients in stage1 (reference category).
There is no difference in the hazard of local recurrence between patients in stage4 and stage1
due to the fact that none of stage4 patients has local recurrence, see appendix A Table A.1.
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LOCAL RECURRENCE
Frailty distribution
Variable Univarite Multivariate Univarite Multivariate
Log-Normal Log-Normal non-parametric non-parametric
AGE -0.017(0.012)
∗
-0.026(0.011) -0.016(0.010) -0.017(0.010)
STAGE2
∗∗
0.808(0.288)
∗∗
0.827(0.246)
∗∗
0.664(0.227)
∗∗
0.758(0.242)
STAGE3
∗
0.935(0.409)
∗∗
1.196(0.368)
∗
0.726(0.317)
∗
0.758(0.343)
STAGE4 -10.895(52.30) -13.818(425.2) -11.720(98.65) -11.760(88.21)
SURGTYPE1
∗∗
3.314(0.738)
∗∗
3.044(0.703)
∗∗
3.088(0.605)
∗∗
2.888(0.618)
SURGTYPE2
∗∗
3.604(0.511)
∗∗
3.936(0.471)
∗∗
3.201(0.368)
∗∗
3.327(0.378)
SURGTYPE3
∗∗
1.457(0.344)
∗∗
1.616(0.393)
∗∗
1.322(0.287)
∗∗
1.355(0.286)
SURGTYPE4 0.280(0.358) 0.374(0.392) 0.226(0.307) 0.286(0.310)
SURGTYPE5 0.353(0.876) 0.712(0.777) 0.231(0.771) 0.469(0.799)
SURGTYPE6 -0.019(0.507) -0.094(0.462) 0.043(0.418) -0.032(0.416)
SURGTYPE7 0.275(0.878) 0.458(0.776) 0.313(0.767) 0.338(0.772)
HIST2 -0.416(0.330) -0.482(0.283) -0.404(0.275) -0.391(0.278)
HIST3 -0.469(0.379)
∗
-0.885(0.395) -0.459(0.317) -0.570(0.315)
HIST4
∗
-0.655(0.321)
∗
-0.654(0.273)
∗
-0.702(0.280)
∗
-0.651(0.276)
COHORT 0.125(0.237) 0.026(0.414) 0.154(0.199) 0.053(0.212)
CHEMO 0.280(0.237) 0.304(0.205) 0.234(0.197) 0.277(0.198)
MENO 0.258(0.323) 0.170(0.278) 0.237(0.270) 0.218(0.275)
RADIO
∗∗
-1.196(0.317)
∗∗
-1.132(0.289)
∗∗
-1.099(0.272)
∗∗
-1.061(0.273)
SIDE -0.053(0.195) 0.012(0.400) -0.066(0.164) -0.043(0.186)
LN(α) 0.084(0.116) 0.142(0.098) -0.069(0.068) 0.009(0.100)
CONSTANT
∗∗
-11.913(1.590)
∗∗
-11.159(1.255)
-2 Log Likelihood 3628.10 3628.52
Table 4.6: Results of breast cancer data: local recurrence. Parameters’ estimates with their
standard error in parentheses.
*.P-value < 0.05
**.P-value < 0.01
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The hazard of local recurrence for the first three surgery types no surgery, incision biopsy
and excision biopsy is significantly (P-value < 0.01) higher than hazard of radical mastectomy
and axillary clearance (reference category). The hazard of the other four types of surgery
has no significant difference from the radical mastectomy and axillary clearance. Patients
with ductal histology (reference category) have a higher but not significant hazard of
local recurrence than lobular and dcis (ductal carcinoma in situ), while it is significantly
higher than other histology. Patients with radiotherapy have a significantly lower hazard
of local recurrence than those without. Other variables such as date of primary surgery,
chemotherapy, menopausal status, and side of the body affected have no significant effect
on the hazard of local recurrence. The log of the shape parameter of Weibull, Ln(α) is not
significantly different from zero, which means local recurrence has a constant hazard.
Table 4.7 displays the multivariate non-parametric frailty model of regional recurrence. The
results show that there is a significant inverse effect of age on the hazard of region recurrence.
Similar to local recurrence, patients in stage2 and stage3 of the disease have a higher hazard
of regional recurrence than patients in stage1. There is no difference in the hazard of local
recurrence between patients in stage4 and stage1 due to the fact that only few patients with
regional recurrence are in stage4. The hazard of regional recurrence for the first five surgery
types no surgery, incision biopsy, excision biopsy, simple mastectomy and radical mastectomy
is significantly higher than hazard of radical mastectomy and axillary clearance. The hazard
of wide local excision and axillary clearance, and surgery after neo adjuvant chemotherapy
has no significant difference from the radical mastectomy and axillary clearance. The hazard
recurrence ductal histology is significantly higher than all other histology types especially Dcis
(ductal carcinoma in situ) which has a much lower hazard than ductal histology. Patients
with primary surgery before 1990 have a significantly lower hazard of regional recurrence
than those after 1990.
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REGIONAL RECURRENCE
Frailty distribution
Variable Univarite Multivariate Univarite Multivariate
Log-Normal Log-Normal non-parametric non-parametric
AGE -0.023(0.012)
∗∗
-0.140(0.023)
∗∗
-0.047(0.012)
∗
-0.023(0.009)
STAGE2
∗∗
1.318(0.282)
∗∗
4.344(0.554)
∗∗
2.065(0.342)
∗∗
1.213(0.220)
STAGE3
∗∗
2.086(0.382)
∗∗
7.042(0.812)
∗∗
2.959(0.413)
∗∗
1.732(0.288)
STAGE4 0.796(0.513)
∗∗
2.327(0.589) 0.846(0.590) 0.604(0.423)
SURGTYPE1
∗∗
3.183(0.820)
∗∗
6.115(0.876)
∗∗
4.220(0.935)
∗∗
2.491(0.590)
SURGTYPE2
∗∗
3.604(0.604)
∗∗
11.029(1.129)
∗∗
5.205(0.532)
∗∗
2.910(0.410)
SURGTYPE3
∗∗
2.278(0.421)
∗∗
5.813(0.696)
∗∗
3.065(0.427)
∗∗
1.756(0.309)
SURGTYPE4
∗∗
1.437(0.383)
∗∗
3.127(0.545)
∗∗
1.837(0.402)
∗∗
1.185(0.281)
SURGTYPE5
∗∗
2.738(0.651)
∗∗
6.799(0.880)
∗∗
3.873(0.669)
∗∗
2.204(0.571)
SURGTYPE6 -0.870(0.633)
∗∗
-3.196(0.789) -1.121(0.651) -0.923(0.497)
SURGTYPE7 1.277(0.854)
∗∗
2.969(0.836) 0.752(0.883) 0.870(0.612)
HIST2
∗∗
-1.518(0.400)
∗∗
-3.537(0.756)
∗∗
-1.621(0.413)
∗∗
-1.136(0.318)
HIST3
∗∗
-4.151(0.894)
∗∗
-11.138(1.355)
∗∗
-5.077(0.881)
∗∗
-3.413(0.744)
HIST4
∗
-0.755(0.306)
∗∗
-1.620(0.355)
∗∗
-1.361(0.363)
∗∗
-0.707(0.239)
COHORT
∗∗
-0.731(0.271)
∗∗
-1.559(0.308)
∗
-0.644(0.271)
∗∗
-0.572(0.190)
CHEMO -0.332(0.268) 0.438(0.324) -0.304(0.318) -0.016(0.239)
MENO 0.529(0.341) 0.003(0.710) 0.063(0.378) 0.236(0.258)
RADIO -0.507(0.326)
∗∗
-1.071(0.338)
∗
-0.809(0.390) -0.347(0.226)
SIDE 0.211(0.205)
∗
0.819(0.326) 0.125(0.231) 0.151(0.154)
LN(α)
∗
0.200(0.088)
∗∗
1.295(0.094)
∗∗
0.511(0.047) 0.063(0.073)
CONSTANT
∗∗
-12.995(1.321)
∗∗
-31.481(3.384)
-2 Log Likelihood 5248.06 5227.96
Table 4.7: Results of breast cancer data: regional recurrence. Parameters’ estimates with their
standard error in parentheses.
*.P-value < 0.05
**.P-value < 0.01
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Other variables such as chemotherapy, menopausal status, radiotherapy, and side of the
body affected have no significant effect on the hazard of regional recurrence. Similar to
local recurrence, the log of the shape parameter of Weibull for regional recurrence is not
significantly different from zero, which means regional recurrence has constant hazard.
Table 4.8 displays the multivariate non-parametric frailty model of metastasis. Similar to
regional recurrence, there is a significant inverse effect of age on the hazard of metastasis.
As patients move from one stage to another of the disease, the hazard of metastasis increases
significantly. The hazard ratios of metastasis of stage2, stage3, and stage4 compared to stage1
are 4.95, 11.81, and 65.24, respectively. The hazard of metastasis of surgeries, incision
biopsy and radical mastectomy is significantly higher than hazard of radical mastectomy
and axillary clearance, meanwhile the hazard is significantly lower for excision biopsy and
wide local excision and axillary clearance than hazard of radical mastectomy and axillary
clearance. There is no significant difference between the metastasis hazard of ductal and
lobular histology. While the hazard is significantly lower for ductal than the other two
histology types, Dcis (ductal carcinoma in situ) and other. The hazard ratios of Dcis and
other compared to Ductal are 0.019 and 0.51 respectively. Patients with primary surgery
after 1990 have significantly lower hazard of metastasis than those before 1990. Namely,
the hazard ratio of cohort surgery after 1990 is about half of cohort surgery before 1990.
The hazard of metastasis of patients with any neo or adjuvant chemotherapy is significantly
2.28 higher than those without. Patients who are post menopausal have significantly lower
metastasis hazard than pre menopausal. The hazard of metastasis of patients with any
adjuvant radiotherapy is significantly 1.92 higher than those without. The side of the body
affected has no significant effect on the hazard of metastasis. In contrast to local and regional
recurrence the log of the shape parameter of Weibull for metastasis is significantly more than
zero, which means the hazard of metastasis increases by time.
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METASTASIS
Frailty distribution
Variable Univarite Multivariate Univarite Multivariate
Log-Normal Log-Normal non-parametric non-parametric
AGE
∗∗
-0.054(0.010)
∗∗
-0.201(0.026)
∗∗
-0.062(0.010)
∗∗
-0.061(0.010)
STAGE2
∗∗
1.185(0.189)
∗∗
5.182(0.586)
∗∗
1.508(0.197)
∗∗
1.599(0.225)
STAGE3
∗∗
2.008(0.321)
∗∗
8.917(0.971)
∗∗
2.537(0.293)
∗∗
2.469(0.339)
STAGE4
∗∗
3.885(0.527)
∗∗
13.404(1.340)
∗∗
4.486(0.350)
∗∗
4.178(0.468)
SURGTYPE1 -1.370(0.933)
∗
-2.887(1.357) -0.883(1.084) -0.916(1.188)
SURGTYPE2 0.737(0.388)
∗∗
4.642(0.983)
∗
0.904(0.423)
∗∗
1.135(0.390)
SURGTYPE3
∗∗
-0.735(0.280)
∗∗
-1.328(0.492)
∗∗
-0.961(0.300)
∗
-0.783(0.318)
SURGTYPE4 -0.126(0.239)
∗
0.994(0.428) -0.145(0.258) -0.085(0.264)
SURGTYPE5 0.451(0.405) 0.496(0.720)
∗∗
1.365(0.467)
∗
1.235(0.511)
SURGTYPE6
∗∗
-1.137(0.302)
∗∗
-4.171(0.797)
∗∗
-1.368(0.316)
∗∗
-1.453(0.337)
SURGTYPE7 -0.881(0.483)
∗∗
-2.125(0.613) -0.839(0.486) -0.775(0.486)
HIST2 -0.218(0.220) -0.576(0.420) -0.171(0.215) -0.209(0.226)
HIST3
∗∗
-3.279(0.824)
∗∗
-12.354(1.668)
∗∗
-3.875(0.802)
∗∗
-3.990(0.816)
HIST4 -0.418(0.228)
∗∗
-2.011(0.729)
∗
-0.588(0.267)
∗∗
-0.672(0.261)
COHORT
∗∗
-0.512(0.178)
∗∗
-1.122(0.327)
∗∗
-0.650(0.214)
∗∗
-0.668(0.209)
CHEMO
∗∗
0.780(0.173)
∗∗
2.711(0.394)
∗∗
0.930(0.183)
∗∗
0.825(0.195)
MENO
∗
-0.545(0.235)
∗∗
-2.047(0.579)
∗
-0.574(0.253)
∗
-0.562(0.253)
RADIO
∗∗
0.753(0.229)
∗∗
1.684(0.388)
∗∗
0.684(0.208)
∗∗
0.652(0.210)
SIDE 0.006(0.129) 0.615(0.321) 0.069(0.156) 0.090(0.161)
LN(α)
∗∗
0.228(0.077)
∗∗
1.585(0.102)
∗∗
0.421(0.037)
∗∗
0.465(0.074)
CONSTANT
∗∗
-9.294(0.920)
∗∗
-35.571(4.180)
-2 Log Likelihood 8808.40 8769.62
Table 4.8: Results of breast cancer data: metastasis. Parameters’ estimates with their standard
error in parentheses.
*.P-value < 0.05
**.P-value < 0.01
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Table 4.9 displays the multivariate non-parametric frailty model of died from breast cancer.
In contrast with the pervious recurrences, there is a significant proportional effect of age
on the hazard of died from breast cancer. There is no significant difference between died
from breast cancer hazard of stage2 and stage3, and stage1 of the disease. While the hazard
of stage4 is significantly 70 times higher than stage1, the hazard of died from breast for
patients with surgery, none and incision biopsy is significantly higher than hazard of radical
mastectomy and axillary clearance, meanwhile there is no significant difference between
other surgeries and radical mastectomy and axillary clearance. The hazard ratio of died
from breast cancer is significant 0.25 times lower for ductal than Dcis (ductal carcinoma in
situ). There is no significant difference between the hazards of ductal and the other two
types of histology. Patients with primary surgery after 1990 have significantly 2.12 times
higher hazard ratio of dying due breast than those of surgery before 1990. Other variables
such as chemotherapy, menopausal status, radiotherapy, and side of the body affected
have no significant effect on the hazard of died from breast cancer. Similar to metastasis
the Log of the shape parameter of Weibull for died from breast cancer is significantly
more than zero, which means the hazard of died from breast cancer increases by time.
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DIED FROM BREAST CANCER
Frailty distribution
Variable Univarite Multivariate Univarite Multivariate
Log-Normal Log-Normal non-parametric non-parametric
AGE
∗∗
0.059(0.014)
∗∗
0.114(0.023)
∗∗
0.036(0.009)
∗∗
0.040(0.012)
STAGE2
∗∗
0.939(0.344)
∗∗
1.899(0.411)
∗
0.530(0.221) 0.525(0.284)
STAGE3
∗∗
1.568(0.467)
∗∗
2.246(0.524)
∗∗
0.826(0.311) 0.848(0.438)
STAGE4
∗∗
5.511(0.680)
∗∗
12.139(1.346)
∗∗
3.426(0.309)
∗∗
4.245(0.533)
SURGTYPE1
∗∗
3.889(0.626)
∗∗
9.334(1.135)
∗∗
2.307(0.463)
∗∗
2.881(0.788)
SURGTYPE2
∗∗
2.910(0.535)
∗∗
2.760(0.490)
∗∗
1.388(0.325)
∗∗
1.566(0.508)
SURGTYPE3 -0.393(0.480) -0.491(0.495) -0.141(0.309) -0.262(0.369)
SURGTYPE4 -0.328(0.449) -0.098(0.702) -0.374(0.311) -0.503(0.371)
SURGTYPE5 -12.646(216.3) -17.414(49.29) -7.889(41.46) -8.092(44.35)
SURGTYPE6
∗
-1.119(0.556)
∗∗
-2.760(0.662) -0.616(0.397) -0.722(0.446)
SURGTYPE7 0.867(0.665)
∗∗
-3.226(0.879) 0.521(0.538) 0.463(0.617)
HIST2
∗
0.712(0.299) 0.563(0.345) 0.403(0.218) 0.471(0.293)
HIST3
∗
-1.733(0.847)
∗∗
-5.591(0.970)
∗
-1.411(0.619)
∗
-1.375(0.662)
HIST4 0.313(0.317)
∗∗
-1.037(0.356) 0.115(0.230) 0.122(0.279)
COHORT
∗∗
0.962(0.293)
∗∗
2.267(0.394)
∗∗
0.609(0.205)
∗∗
0.753(0.260)
CHEMO 0.104(0.274)
∗∗
1.220(0.422) 0.099(0.199) 0.157(0.233)
MENO 0.747(0.428) 0.050(0.721) 0.210(0.305) 0.206(0.369)
RADIO -0.210(0.466) -1.040(0.533) -0.397(0.306) -0.335(0.343)
SIDE
∗
0.537(0.224)
∗∗
0.705(0.234) 0.239(0.162) 0.238(0.220)
LN(α)
∗∗
0.715(0.106)
∗∗
1.369(0.117)
∗∗
0.290(0.060)
∗∗
0.377(0.119)
CONSTANT
∗∗
-25.928(2.782)
∗∗
-52.334(6.182)
-2 Log Likelihood 3801.12 3758.80
Table 4.9: Results of breast cancer data: died from breast cancer. Parameters’ estimates with
their standard error in parentheses.
*.P-value < 0.05
**.P-value < 0.01
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Table 4.10 displays the multivariate non-parametric frailty model of died from other causes.
Similar to died from breast cancer, there is a significant proportional effect of age on the
hazard of died from other causes. The hazard ratio of stage2 is significantly 1.69 times higher
than stage1. Whilst there is no significant difference between died from other causes hazard
of stage3 and stage4, and stage1 of the disease. The hazard of died from other causes for
patients with surgery, none, incision biopsy, and excision biopsy is significantly higher than
hazard of radical mastectomy and axillary clearance. In the meantime, there is no significant
difference between other surgeries and radical mastectomy and axillary clearance. There
is no significant difference between the hazard of ductal and all other types of histology.
The hazard ratio of died from other causes of patients with any adjuvant radiotherapy is
significantly 0.38 lower than those without. Other variables such as cohort, chemotherapy,
menopausal status, and side of the body affected have no significant effect on the hazard of
died from other causes. Similar to local recurrence the log of the shape parameter of Weibull
is not significantly different from zero, which means died from other causes has constant
hazard.
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DIED FROM OTHER CAUSES
Frailty distribution
Variable Univarite Multivariate Univarite Multivariate
Log-Normal Log-Normal non-parametric non-parametric
AGE
∗∗
0.086(0.012)
∗∗
0.086(0.015)
∗∗
0.086(0.012)
∗∗
0.083(0.012)
STAGE2 0.350(0.232) 0.381(0.259) 0.346(0.232)
∗
0.527(0.267)
STAGE3 0.401(0.326) 0.405(0.362) 0.399(0.326) 0.509(0.357)
STAGE4 -1.202(1.029) -1.683(1.076) -1.204(1.029) -1.526(1.070)
SURGTYPE1
∗
1.293(0.576) 1.315(0.886)
∗
1.295(0.574)
∗
1.317(0.597)
SURGTYPE2
∗
1.050(0.459) 1.335(0.802)
∗
1.050(0.457)
∗∗
1.289(0.487)
SURGTYPE3
∗∗
0.841(0.319)
∗
0.897(0.348)
∗∗
0.843(0.319)
∗∗
0.943(0.337)
SURGTYPE4 0.489(0.325) 0.502(0.391) 0.489(0.325) 0.594(0.343)
SURGTYPE5 1.025(0.754) 1.154(0.802) 1.088(0.754) 1.326(0.798)
SURGTYPE6 0.415(0.461) 0.449(0.487) 0.415(0.461) 0.418(0.470)
SURGTYPE7 0.303(1.040) 0.432(1.066) 0.301(1.040) 0.393(1.061)
HIST2 0.102(0.266) 0.117(0.282) 0.099(0.266) 0.089(0.276)
HIST3 -0.448(0.441) -0.476(0.482) -0.453(0.441) -0.557(0.454)
HIST4 -0.143(0.279) -0.132(0.289) -0.146(0.278) -0.133(0.283)
COHORT -0.282(0.228) -0.298(0.235) -0.280(0.228) -0.352(0.234)
CHEMO 0.015(0.209) -0.017(0.751) 0.013(0.204) 0.032(0.214)
MENO 0.394(0.453) 0.419(0.482) 0.392(0.453) 0.357(0.458)
RADIO
∗∗
-0.944(0.353)
∗
-0.979(0.412)
∗∗
-0.947(0.352)
∗∗
-0.977(0.358)
SIDE -0.097(0.179) -0.080(0.195) -0.098(0.178) -0.070(0.187)
LN(α) 0.063(0.076) 0.084(0.087) 0.062(0.076) 0.125(0.089)
CONSTANT
∗∗
-16.831(1.118)
∗∗
-17.209(1.235)
-2 Log Likelihood 2747.36 2746.92
Table 4.10: Results of breast cancer data: died from other causes. Parameters’ estimates with
their standard error in parentheses.
*.P-value < 0.05
**.P-value < 0.01
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4.12.2 Merging failure types
Dimensionality in multivariate analysis is a very important issue. Removing one failure type
from a competing risks model could minimise the model fitting time remarkably. One would
be interested in testing for merge some of failure types
H0 : h0j(tij)e
x
′
ijβj = h0k(tik)e
x
′
ikβk
j 6= k
H1 : h0j(tij)e
x
′
ijβj 6= h0k(tik)ex
′
ikβk
.
For example, can local and regional recurrence be merged? To answer these types of questions,
the chi-square distribution is used with degrees of freedom equivalent to the difference in
number of parameters between the full (before merging) and reduced models (after merging).
Table 4.11 lists the deviance of testing merging between each pair of competing risks. Since
all deviance values are very large and by using the chi-square distribution with 30 degrees of
freedom, the null hypothesis is rejected and none of the competing risks pairs can be merged.
Local Regional Metastasis
Died from
breast cancer
Local
Regional 463.9
Metastasis 506.1 771.9
Died from breast cancer 332.9 365.7 546.0
Died from other causes 293.6 300.4 301.3 295.0
Table 4.11: Deviances of testing for merging competing risks.
4.12.3 Interpretation of the frailties
Using the Cholesky decomposition of the multivariate Log-Normal frailty, the lower triangle
of the variance-covariance matrix of the random effects is given by
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LR RR MT DB DO

LR l11 0 0 0 0
RR l12 l22 0 0 0
MT l13 l23 l33 0 0
DB l14 l24 l34 l44 0
DO l15 l25 l35 l45 l55
=
LR RR MT DB DO

1.377 0 0 0 0
6.001 3.653 0 0 0
4.491 2.396 6.511 0 0
−6.358 3.688 0.095 0.0004 0
0.431 −0.456 −0.033 −0.0001 0
and hence, the variance-covariance matrix of the random effects is Σ = LL
′
LR RR MT DB DO

LR σ21 σ12 σ13 σ14 σ15
RR σ12 σ
2
2 σ23 σ24 σ25
MT σ13 σ23 σ
2
3 σ34 σ35
DB σ14 σ24 σ34 σ
2
4 σ45
DO σ15 σ25 σ35 σ45 σ
2
5
=
LR RR MT DB DO

1.90 8.26 6.18 −8.76 0.59
8.26 49.36 35.70 −24.68 0.92
6.18 35.70 68.30 −19.10 0.63
−8.76 −24.68 −19.10 54.03 −4.43
0.59 0.92 0.63 −4.43 0.39
The variance of the frailty distribution is very small in case of died from other causes, σ25 =
0.39 which is an indicator of no important risks factors are omitted from the model. Whilst,
the variances of other frailty are very big especially for regional recurrence, metastasis and
died from breast cancer with σ22 = 49.36, σ
2
3 = 68.3 and σ
2
4 = 54.03 respectively. This means
that there are many important risks factor are not included in the model. Although, the
interpretation of the nature of frailty in multivariate competing risks models is not straight
forward and more complex than in univariate cases, still one can get a clear idea about the
way they are correlated. In multivariate cases, it is frequently encountered with more than
one omitted risk factor. This causes the interpretation of the nature of frailty to be more
complex than a univariate cases. The above variance-covariance matrix suggests that
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• the frailty of time to local recurrence (LR) is positively correlated with the frailty
of time to regional recurrence (RR), metastasis (MT), and died from other causes
(DO). The correlation coefficients are 0.85, 0.54, and 0.68 respectively. It is negatively
correlated with the frailty of time to died from breast cancer (DB) (ρ = -0.87);
• the frailty of regional recurrence is positively correlated with the frailty of time to
metastasis (ρ = 0.62), but it is negatively associated with frailty of time to died from
breast cancer (ρ = -0.48). It is weakly correlated to died from other causes;
• the frailty of metastasis is weakly correlated with frailty of time to died from breast
cancer (ρ = 0.31), but it is not correlated with the frailty of time to died from other
causes (ρ = 0.12); and
• the frailty of died from breast cancer is negatively and highly correlated with frailty of
time to died from other causes (ρ = -0.96)
Using the multivariate non-parametric frailty the association coefficients are:
LR RR MT DB DO

LR
RR r12
MT r13 r23
DB r14 r24 r34
DO r15 r25 r35 r45
=
LR RR MT DB DO

1.15
1.07 0.07
−1.46 0.02 0.64
0.50 0.01 −0.15 0.01
The diagonal of the association matrix was absorbed in the non-parametric representation
of the model and merged with the constant part βj0. As mentioned before, this is not a
correlation matrix, and it was included in the model to account for the association between
competing risks frailties. As a summary conclusions, died from breast cancer is informative
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(highly correlated) for both local and regional recurrence while died from other causes is
informative for local recurrence only. It seems that the nature of frailty for local recurrence
(non-aggressive cancer), which definitely exists, is highly and positively correlated with other
frailties except died from breast cancer, which is negatively correlated. With regard to the
time of regional recurrence (aggressive cancer), the frailty was related to the susceptibility
of patients to more aggressive types of breast cancer (metastasis). On the other hand, died
from breast cancer is negatively associated with all other frailties, especially the frailty of
died from other causes. None of these competing risks can be merged with another and it
seems that each failure type has its own characteristics and different risk factors.
4.12.4 Clinical results
The following points summarise the effect of the risk factors on the hazard of each type of
outcome.
• Age of patient. Young patients have higher chance of local, regional and metastasis
recurrence than old patients, whereas they have lower hazard of ”died from breast
cancer” than old patients.
• Stage of the disease. Patients in stage2 and stage3 have significantly higher hazard
of local and regional than patient in stage1. The hazard of metastasis of stage1 is
significantly lower than the other three stages. Only patients in stage4 have significantly
higher hazard of ”died from breast cancer” than stage1.
• Surgery type. Patients without surgery or with incision biopsy surgery have higher
hazard of all recurrence than patients with radical mastectomy and axillary clearance
except metastasis no difference. Patients with excision biopsy surgery have higher
hazard of local and regional recurrence than patients with radical mastectomy and
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axillary clearance and lower hazard for metastasis no difference for ”died from breast
cancer”.
• Histology. There is more chance for patients with ductal than patients with Other
histology for local recurrence and higher hazard of regional than all other three types
of histology. The hazard of metastasis for patients with ductal is the same for lobular
but higher than the other two types. The hazard of metastasis for patients with ductal
is higher than dcis (ductal carcinoma in situ) but the same for the other two types.
• Cohort. Patients with primary surgery before 1990 have the same change of local
recurrence as those after 1990 but they have lower hazard of regional recurrence and
metastasis. However, the hazard of ”died from breast cancer” is higher for patients
with primary surgery before 1990 than after 1990.
• Chemotherapy. Patients with chemotherapy have higher hazard of metastasis than
patients without. There is no significant effect of chemotherapy on the hazard of local,
regional and ”died from breast cancer”.
• Menopausal status. Patients pre-menopausal have lower hazard of metastasis than
patients post-menopausal. There is no significant effect of menopausal status on the
hazard of local, regional and ”died from breast cancer”.
• Radiotherapy. Patients with radiotherapy have lower hazard of local recurrence than
patients without. There is no significant effect of radiotherapy on the hazard of regional,
metastasis and ”died from breast cancer”.
• Side of the body affected. There is no significant effect of the side of body with
cancer (right or left) on the hazard of all types of outcome (competing risks).
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4.13 Summary
In this chapter, different types of frailty models are discussed, shared frailty, correlated frailty
and multivariate frailty. Most of the existent models are correlated frailty models rather
than multivariate model. One of the limitations of the correlated frailty model is that they
have restricted correlation coefficients between frailties; e.g. Correlated Gamma and Inverse
Gaussian frailty discussed in sections 4.6 and 4.7. Whilst the multivariate frailty models
have unrestricted correlations, but they have the limitation that the marginal likelihood
function does not have a closed form and numerical integration is needed to get the maximum
likelihood estimator; e.g. Log-Normal frailty discussed in section 4.9. The interpretation of
the frailty is not straight forward in multivariate frailty models. A competing risks model
with multivariate frailty is introduced and employed in the analysis of the time to the first
recurrence of breast cancer. The analysis was carried out by a Cholesky decomposition
of multivariate Log-Normal frailty and by a non-parametric multivariate frailty. The non-
parametric frailty model is much less time consuming in fitting the data with the smallest
standard errors of parameters estimates. The simulations showed that only a few numbers of
mass points are needed to fit the data using non-parametric frailty compared to multivariate
Log-normal where at least eight points are needed to get acceptable results. In the analysis
of competing risks models, including frailty is important to take into account the potential
relation between different failure types. Ignoring this fact and employing the commonly used
estimation procedures underestimate the parameters of interest and could lead to inaccurate
inference about relevant risk factors. Another way to overcome the problem of mis-specifying
the frailty distribution is breaking the frailty distribution in sub-distribution the so-called
finite mixtures. in the next chapter, several simulation studies of mixture of different frailly
distribution are conducted.
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Frailty and finite mixture
5.1 Introduction
In previous chapters, it was shown that the choice of the frailty distribution is crucial for
making valid inferences. Fitting the model using a non-parametric frailty is one way to
overcome this problem. In this chapter, a different prospective is used to solve the problem.
The model is fitted by breaking the frailty distribution into a finite number of components,
the so-called finite mixture. Mixture models are usually used to model data that come from a
heterogeneous population. Using a mixture of frailty distributions increases the flexibility of
modelling the unobserved heterogeneity, especially if the frailty distribution is not unimodal.
The finite mixture models of a parametric frailty distribution can be viewed as a semi-
parametric models, as they can be written in terms of J components of a specific distribution.
In general, a random variable T with a probability density function f(t) can be decomposed
into a sum of J class probability density functions. Let fj(t) denote the j
th class probability
density function. The finite mixture model with J-component has the following general form
f(t|θ1, · · · , θJ ; π1, · · · , πJ−1) =
J∑
j=1
πjfj(t|θj),
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where πj represents the probability that the realisation t is coming from the j
th component.
Furthermore, these probabilities must satisfy the following constraints
0 < πj < 1 and
J∑
j=1
πj = 1.
The mean and the variance of the finite mixture are
µ = E[T ] =
J∑
j=1
πjµj σ
2 = V [T ] =
J∑
j=1
πj(µ
2
j + σ
2
j )− µ2 (5.1.1)
For more information see (Everitt and Hand, 1981) and (Frhwirth-Schnatter, 2006).
5.2 Frailty as a finite mixture
Finite mixture models with and without covariates are extensively studied in the literature.
Most of the published work has concentrated on mixtures of normal distribution, with less
emphasis on non-normal mixtures. Recently, many studies have factored the random effects
into a wide variety of regression models. For example, Hall and Wang (2005) considered a
finite mixtures of generalized linear mixed effect models. van Duijn and Bockenholt (1995)
presented mixture models for the analysis of repeated count data. Olsen and Schafer (2001)
considered regression models with mixed effects for clustered continuous data. A Finite
mixture of bivariate Poisson regression models in the presence of random effect was considered
by BermDez and Karlis (2012).
In this chapter, a simulation study of finite mixture of frailty models is conducted where the
frailty distribution is constructed as a mixture of distributions especially for those with
a closed-form of the unconditional hazard such as Gamma and Inverse Gaussian. The
purpose of these simulations is to assess the performance of finite mixture of frailty models.
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Ravishanker and Dey (2000) considered a multivariate survival data using finite mixtures
of positive stable frailty distributions. Hanagal (2008) gave two types of mixture models
for survival data with frailty. In the frailty model, the general form of the unconditional
likelihood function is
L(ti, δi|xi) =
∫
R+
(zh0(ti)e
x
′
iβ)δie−zH0(ti)e
x
′
iβf(z, τ)dz,
where h0(ti) is the baseline hazard, xi is the vector of covariates of the i
th subject, β is a
p× 1 fixed effect vector and f(z, τ) is the p.d.f of the frailty distribution. Assuming that the
frailty distribution can be written as a sum of J class probability density functions, then
f(z, τ) =
J∑
j=1
πjfj(z, τj),
where, 0 < πj < 1, j = 1, · · · , J and
∑J
j=1 πj = 1. The unconditional likelihood function can
be written as
L(ti, δi|xi) =
∫
R
(−zh0(ti)ex
′
iβ)δie−zH0(ti)e
x
′
iβ
J∑
j=1
πjfj(z, τj)dz,
consequently,
L(ti, δi|xi) =
J∑
j=1
πj
∫
R
(−zh0(ti)ex
′
iβ)δie−zH0(ti)e
x
′
iβfj(z, τj)dz (5.2.1)
The set of parameters need to be estimated is θ = (β1, ..., βp, τ
2
1 , ..., τ
2
J , π1, ..., πJ−1)
′
, which
can be estimated either by EM-algorithm or by direct the maximisation of likelihood function.
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5.2.1 Finite mixture of Gamma frailty model
Assuming the survival times follow the Weibull distribution T ∼ Weib(α, λ), and the jth
class of the frailty distribution is a Gamma distribution with a unit mean and variance τ 2j ,
fj ∼ Γ(1/τ 2j , τ 2j ), the frailty distribution can be written as
f(z, τ 2) =
J∑
j=1
πjΓ(1/τ
2
j , τ
2
j ).
The unconditional (marginal) likelihood function has a close-form and given by
L(ti, δi|xi) =
J∑
j=1
πj
(
αt
α−1
i e
x
′
iβ
1 + τ
2
j t
α
i e
x
′
iβ
)δi
[1 + τ
2
j t
α
i e
x
′
iβ]
−(1
/
τ
2
j )
= (αt
α−1
ex
′
iβ)δi
J∑
j=1
πi(1 + τ
2
j t
α
i e
x
′
iβ)
−(δi+( 1τj )). (5.2.2)
5.2.2 Finite mixture of Inverse Gaussian frailty model
In this section, a Weibull regression model with a finite mixture of Inverse Gaussian frailty
is proposed. Assuming the survival times follow the Weibull distribution, T ∼ Weib(α, λ),
and jth class of the frailty distribution is an Inverse Gaussian distribution with a unit mean
and variance τ 2j , fj ∼ IG(1, 1/τ 2j ), the frailty distribution can be written as
f(z, τ 2) =
J∑
j=1
πjIG(1, 1/τ
2
j ).
The unconditional likelihood function has a close-form and given by
L(ti, δi|xi) =
J∑
j=1
πj
(
αtα−1i e
x
′
iβ
(1 + 2τ 2j t
α
i e
x
′
iβ)1/2
)δi
exp
(
1
τj
(1− (1 + 2τ 2j tαi ex
′
iβ)1/2)
)
. (5.2.3)
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5.2.3 Finite mixture of Log-Normal frailty model
Assuming the survival times follow the Weibull distribution and jth class of the frailty
distribution is a Log-Normal random variable with mean µ and variance τ 2j , the frailty
distribution can be written as
f(z, τ 2) =
J∑
j=1
πjLogN(1/τ
2
j , τ
2
j ).
In this case the unconditional likelihood function does not have a closed-form, but using the
results of section 3.4.4, it can be expressed as
L(ti, δi,xi) =
J∑
j=1
πj
∫
R
(αtα−1i e
x
′
iβ+τjy
√
2)δi exp(tαi e
x
′
iβ+τjy
√
2)
1√
π
e−y
2
dy.
≈
J∑
j=1
K∑
k=1
πjπ
∗
k(αt
α−1
i e
x
′
iβ+τy
∗
k)δi exp(tαi e
x
′
iβ+τy
∗
k). (5.2.4)
where y∗k and π
∗
k are the zeros of Hermite polynomials and their corresponding weight factors
respectively while πj is the mixing probability.
5.3 Finite mixture of correlated Inverse Gaussian
frailty model
In this section, a mixture of correlated Inverse Gaussian frailty model is proposed based on the
results reported in section 4.7. Assuming the survival times follow the Weibull distribution
and jth class of the frailty distribution is a correlated Inverse Gaussian distribution with
a unit mean vector and variance-covariance matrix Σj, similar to the one given in 4.7.2,
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fj ∼ BIG(1,Σj), the frailty distribution can be written as
f(z,Σ) =
J∑
j=1
πjBIG(1,Σj).
In general, the mean and the variance of multivariate mixtures are given by
E[Z] = µ =
J∑
j=1
πjµj, V [Z] =
J∑
j=1
πjΣj +
J∑
j=1
πj(µj − µ)(µj − µ)
′
(5.3.1)
For the mixture in 5.3.1, the variance reduces to
V [Z] =
J∑
j=1
πjΣj
In the bivariate case, the unconditional log-likelihood function is given by
`(ti1, ti2) =
J∑
j=1
πj
{
δi1δi2 log
[
∂
∂ti2∂ti1
logSj(ti1, ti2) +
(
∂
∂ti1
logSj(ti1, ti2)
)(
∂
∂ti2
logSj(ti1, ti2)
)]
+
2∑
j=1
δij log
(
− ∂
∂tij
logSj(ti1, ti2)
)
+ log[Sj(ti1, ti2)]
}
.
(5.3.2)
where,
Sj(ti1, ti2) =
[S1(ti1)]
(1−ρj
τ1j
τ2j
)
[S2(ti2)]
(1−ρj
τ2j
τ1j
)
×exp
{
ρj
τ1jτ2j
(
1−
[(
1− τ 21j logS1(ti1)
)2
+
(
1− τ 22j logS2(ti2)
)2 − 1]1/2)}
In case of competing risks, either the individual faces one of the failures (i.e. only one of
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δij = 1, j = 1, 2) or censored (i.e. both δij = 0, j = 1, 2). In constructing the likelihood
function only the first order of the partial derivatives is needed. Hence the log-likelihood in
5.3.2 reduces to
`(ti1, ti2) =
J∑
j=1
2∑
k=1
πjδik log
(
− ∂
∂tik
logSj(ti1, ti2)
)
+ log[Sj(ti1, tij)]. (5.3.3)
5.4 Simulations
This section examines the performance of a frailty mixture with different distribution in
both univariate and bivariate data. In univariate data, three mixtures are tested, Gamma,
Inverse Gaussian, and Log-Normal distributions. In bivariate frailty, only a mixture of the
correlated Inverse Gaussian frailty proposed in section 4.7 is examined. In each study, data
are generated using Weibull baseline hazard and four different frailty distributions, namely,
the Log-Normal, Gamma, Inverse Gaussian and an arbitrary distribution. These models are
fitted using mixtures of Gamma, Inverse Gaussian, and Log-Normal frailty distributions.
Simulations from the frailty distributions were conducted in the same manner as described
in the previous chapters. The arbitrary distribution is generated from a discrete random
variable, say Y with an expected value equals to one using the following steps. First, generate
a random numbers from a Uniform distribution U ∼ Uni(0, 1). Second, cut the range (0, 1)
into different segments with different lengths (probabilities). Third, if the generated number
from is within the first segment return some value of Y and if it within the second segment
return another value Y , and so forth. The returned values and the length of segments are
set so that the expect value of the random variable Y is equal to one.
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P
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Log-Normal Gamma Inverse Gaussian Arbitrary
Sample size Sample size Sample size Sample size
500 5000 500 5000 500 5000 500 5000
Mean Mean Mean Mean Mean Mean Mean Mean
(S.e) (S.e) (S.e) (S.e) (S.e) (S.e) (S.e) (S.e)
β0 -4 -3.933 -3.919 -4.049 -4.008 -3.909 -3.878 -3.907 -3.879
(0.259) (0.085) (0.308) (0.094) (0.258) (0.079) (0.282) (0.089)
β1 1 0.943 0.943 1.024 0.999 0.909 0.917 0.949 0.937
(0.246) (0.078) (0.304) (0.094) (0.241) (0.073) (0.273) (0.083)
β2 -2 -1.887 -1.877 -2.006 -2.004 -1.857 -1.839 -1.885 -1.865
(0.201) (0.060) (0.241) (0.078) (0.191) (0.061) (0.224) (0.066)
β3 4 3.77 3.758 4.037 4.010 3.715 3.678 3.753 3.727
(0.305) (0.094) (0.378) (0.110) (0.292) (0.091) (0.337) (0.102)
β4 2 1.879 1.878 2.016 2.008 1.877 1.838 1.879 1.862
(0.216) (0.073) (0.279) (0.086) (0.216) (0.070) (0.249) (0.081)
α 1 0.945 0.940 1.009 1.002 0.931 0.921 0.942 0.934
(0.068) (0.020) (0.082) (0.024) (0.065) (0.019) (0.072) (0.022)
τ 2 1 0.364 0.377 0.993 1.004 0.337 0.334 0.662 0.661
(0.147) (0.043) (0.238) (0.068) (0.137) (0.043) (0.188) (0.053)
Table 5.1: Log-Normal, Gamma, Inverse Gaussian and arbitrary frailty models with Weibull
baseline hazard and four covariates simulated data estimated by Gamma frailty, 500 data sets each
with sample sizes of 500 and 5000.
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P
ar
am
et
er
T
ru
e
va
lu
es Log-Normal Gamma Inverse Gaussian Arbitrary
Sample size Sample size Sample size Sample size
500 5000 500 5000 500 5000 500 5000
Mean Mean Mean Mean Mean Mean Mean Mean
(S.e) (S.e) (S.e) (S.e) (S.e) (S.e) (S.e) (S.e)
β0 4 -3.929 -3.909 -4.016 -3.988 -3.893 -3.880 -3.889 -3.876
(0.254) (0.085) (0.305) (0.091) (0.254) (0.082) (0.288) (0.085)
β1 1 0.931 0.935 0.996 0.994 0.917 0.922 0.927 0.932
(0.233) (0.077) (0.291) (0.090) (0.243) (0.072) (0.275) (0.084)
β2 -2 -1.879 -1.874 -1.981 -1.990 -1.832 -1.841 -1.873 -1.860
(0.191) (0.060) (0.246) (0.075) (0.194) (0.063) (0.226) (0.068)
β3 4 3.758 3.746 3.983 3.976 3.681 3.678 3.740 3.723
(0.293) (0.094) (0.365) (0.114) (0.294) (0.096) (0.337) (0.099)
β4 2 1.880 1.875 1.978 1.990 1.851 1.835 1.874 1.858
(0.214) (0.072) (0.281) (0.090) (0.216) (0.071) (0.247) (0.078)
α 1 0.941 0.938 0.992 0.995 0.924 0.921 0.939 0.933
(0.064) (0.020) (0.081) (0.026) (0.066) (0.021) (0.072) (0.021)
τ 2 1 0.382 0.372 0.937 0.981 0.322 0.335 0.655 0.659
(0.319) (0.044) (0.238) (0.076) (0.147) (0.045) (0.181) (0.053)
τ 21 0.682 0.372 0.644 0.767 0.231 0.287 0.479 0.586
(7.542) (0.044) (0.500) (0.691) (0.167) (0.107) (0.241) (0.124)
τ 22 1.957 0.372 0.667 0.731 0.229 0.287 0.473 0.586
(31.033) (0.044) (0.535) (0.450) (0.239) (0.103) (0.243) (0.127)
τ 23 1.855 0.372 0.676 0.768 0.238 0.289 0.480 0.584
(36.809) (0.044) (0.502) (0.510) (0.174) (0.108) (0.239) (0.125)
τ 24 0.964 0.372 0.721 0.740 0.258 0.289 0.471 0.588
(15.666) (0.044) (0.846) (0.536) (0.412) (0.104) (0.240) (0.129)
τ 25 1.240 0.373 0.672 0.734 0.238 0.286 0.486 0.589
(16.411) (0.048) (0.604) (0.393) (0.341) (0.107) (0.249) (0.127)
π1 0.190 0.199 0.190 0.185 0.188 0.192 0.187 0.187
(0.112) (0.035) (0.283) (0.280) (0.257) (0.191) (0.243) (0.187)
π2 0.200 0.198 0.208 0.208 0.185 0.202 0.196 0.199
(0.133) (0.032) (0.293) (0.299) (0.245) (0.210) (0.248) (0.199)
π3 0.197 0.200 0.199 0.223 0.208 0.210 0.210 0.194
(0.135) (0.028) (0.296) (0.323) (0.273) (0.209) (0.273) (0.198)
π4 0.200 0.201 0.213 0.186 0.230 0.207 0.193 0.212
(0.132) (0.033) (0.297) (0.289) (0.282) (0.213) (0.246) (0.208)
π5 0.213 0.202 0.189 0.199 0.190 0.190 0.214 0.208
(0.148) (0.041) (0.284) (0.289) (0.252) (0.183) (0.272) (0.213)
Table 5.2: Log-Normal, Gamma, Inverse Gaussian and arbitrary frailty models with Weibull
baseline hazard and four covariates simulated data estimated by mixture of Gamma frailty, 500
data sets each with sample sizes of 500 and 5000.
114
Chapter 5. Frailty and finite mixture
P
ar
am
et
er
T
ru
e
va
lu
es
Log-Normal Gamma Inverse Gaussian Arbitrary
Sample size Sample size Sample size Sample size
500 5000 500 5000 500 5000 500 5000
Mean Mean Mean Mean Mean Mean Mean Mean
(S.e) (S.e) (S.e) (S.e) (S.e) (S.e) (S.e) (S.e)
β0 4 -4.040 -3.999 -3.587 -3.563 -4.070 -4.010 -3.843 -3.814
(0.304) (0.092) (0.233) (0.076) (0.318) (0.099) (0.258) (0.078)
β1 1 1.056 1.007 0.890 0.883 1.073 1.007 0.998 0.978
(0.295) (0.088) (0.282) (0.086) (0.312) (0.086) (0.291) (0.090)
β2 -2 -2.079 -2.016 -1.797 -1.771 -2.122 -2.013 -1.991 -1.963
(0.301) (0.086) (0.213) (0.064) (0.353) (0.094) (0.221) (0.067)
β3 4 4.172 4.029 3.564 3.517 4.240 4.025 3.964 3.900
(0.553) (0.146) (0.266) (0.081) (0.622) (0.168) (0.300) (0.088)
β4 2 2.087 2.012 1.803 1.778 2.116 2.011 1.982 1.946
(0.333) (0.093) (0.218) (0.069) (0.360) (0.102) (0.246) (0.077)
α 1 1.046 1.008 0.911 0.897 1.061 1.006 1.000 1.001
(0.134) (0.034) (0.054) (0.016) (0.149) (0.041) (0.068) (0.478)
τ 2 1 2.160 1.059 1.851 1.715 2.327 1.068 2.346 1.995
(4.000) (0.289) (0.487) (0.113) (3.186) (0.334) (1.305) (0.232)
Table 5.3: Log-Normal, Gamma, Inverse Gaussian and arbitrary frailty models with Weibull
baseline hazard and four covariates simulated data estimated by Inverse Gaussian frailty, 500 data
sets each with sample sizes of 500 and 5000.
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Sample size Sample size Sample size Sample size
500 5000 500 5000 500 5000 500 5000
Mean Mean Mean Mean Mean Mean Mean Mean
(S.e) (S.e) (S.e) (S.e) (S.e) (S.e) (S.e) (S.e)
β0 4 -4.050 -4.008 -3.958 -3.971 -4.030 -4.004 -3.995 -3.976
(0.312) (0.095) (0.319) (0.100) (0.332) (0.099) (0.299) (0.094)
β1 1 1.022 1.005 1.052 1.056 1.030 1.004 1.069 1.043
(0.286) (0.080) (0.330) (0.105) (0.300) (0.086) (0.332) (0.100)
β2 -2 -2.057 -2.001 -2.110 -2.110 -2.064 -2.004 -2.103 -2.082
(0.317) (0.091) (0.319) (0.102) (0.360) (0.108) (0.302) (0.112)
β3 4 4.133 4.005 4.194 4.221 4.111 4.008 4.210 4.162
(0.580) (0.157) (0.529) (0.184) (0.644) (0.192) (0.497) (0.192)
β4 2 2.062 2.003 2.111 2.107 2.064 2.002 2.109 2.078
(0.327) (0.099) (0.348) (0.113) (0.371) (0.114) (0.335) (0.118)
α 1 1.034 1.001 1.049 1.055 1.032 1.002 1.054 1.041
(0.137) (0.037) (0.120) (0.044) (0.155) (0.045) (0.117) (0.046)
τ 2 1 1.846 1.020 2.878 1.952 2.062 1.063 4.302 1.989
(2.664) (0.300) (2.636) (0.614) (3.139) (0.516) (4.155) (0.546)
τ 21 2.488 1.025 52.384 120.800 2.388 0.754 6.494 4.342
(3.347) (1.335) (76.120) (165.430) (3.554) (1.136) (7.048) (2.604)
τ 22 0.421 0.398 1.706 17.318 0.407 0.214 0.606 0.575
(1.892) (2.966) (3.520) (78.278) (1.557) (0.311) (2.937) (1.208)
τ 23 0.098 0.034 0.870 0.995 0.079 0.033 0.126 0.094
(0.453) (0.031) (4.357) (2.233) (0.118) (0.028) (0.164) (0.078)
τ 24 0.063 0.017 0.257 0.407 0.083 0.014 0.098 0.054
(0.220) (0.042) (1.661) (1.513) (0.479) (0.020) (0.465) (0.070)
τ 25 0.175 0.906 0.747 24.502 0.187 0.497 0.247 0.464
(0.957) (3.019) (5.499) (72.074) (1.633) (1.131) (1.204) (1.195)
π1 0.600 0.505 0.295 0.149 0.649 0.522 0.602 0.568
(0.335) (0.385) (0.217) (0.191) (0.356) (0.457) (0.231) (0.200)
π2 0.153 0.195 0.366 0.357 0.163 0.123 0.150 0.225
(0.282) (0.313) (0.329) (0.271) (0.291) (0.298) (0.232) (0.216)
π3 0.026 0.009 0.111 0.198 0.021 0.004 0.025 0.032
(0.099) (0.035) (0.229) (0.259) (0.084) (0.018) (0.095) (0.082)
π4 0.046 0.025 0.040 0.090 0.042 0.007 0.033 0.033
(0.115) (0.072) (0.132) (0.168) (0.118) (0.024) (0.098) (0.090)
π5 0.175 0.266 0.189 0.206 0.125 0.344 0.190 0.141
(0.234) (0.355) (0.229) (0.243) (0.212) (0.439) (0.210) (0.217)
Table 5.4: Log-Normal, Gamma, Inverse Gaussian and arbitrary frailty models with Weibull
baseline hazard and four covariates simulated data estimated by mixture of Inverse Gaussian frailty,
500 data sets each with sample sizes of 500 and 5000.
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Sample size Sample size Sample size Sample size
500 5000 500 5000 500 5000 500 5000
Mean Mean Mean Mean Mean Mean Mean Mean
(S.e) (S.e) (S.e) (S.e) (S.e) (S.e) (S.e) (S.e)
β0 4 -4.030 -3.986 -4.015 -3.988 -4.016 -3.903 -4.024 -3.965
(0.317) (0.094) (0.360) (0.100) (0.308) (0.108) (0.279) (0.080)
β1 1 1.004 0.987 1.151 1.068 1.002 0.983 1.035 0.996
(0.276) (0.080) (0.475) (0.104) (0.273) (0.081) (0.280) (0.081)
β2 -2 -2.015 -1.989 -2.266 -2.128 -1.992 -1.973 -2.050 -1.991
(0.286) (0.084) (0.568) (0.106) (0.321) (0.075) (0.235) (0.071)
β3 4 4.048 3.975 4.545 4.258 3.997 3.937 4.103 3.984
(0.514) (0.140) (1.120) (0.181) (0.537) (0.136) (0.366) (0.111)
β4 2 2.015 1.986 2.263 2.131 1.989 1.965 2.053 1.994
(0.316) (0.089) (0.601) (0.116) (0.325) (0.087) (0.283) (0.080)
α 1 1.010 0.994 1.135 1.065 0.999 0.985 1.025 0.996
(0.120) (0.033) (0.269) (0.043) (0.127) (0.031) (0.085) (0.025)
τ 2 1 0.771 0.805 1.292 1.213 0.759 0.795 0.810 0.758
(0.284) (0.081) (0.525) (0.108) (0.299) (0.072) (0.227) (0.080)
τ 21 0.643 0.688 1.017 1.047 0.605 0.502 0.633 0.615
(0.448) (0.274) (0.808) (0.647) (0.403) (0.233) (0.524) (0.412)
τ 22 0.663 0.684 0.964 1.097 0.602 0.498 0.673 0.597
(0.389) (0.290) (0.811) (0.650) (0.297) (0.218) (0.826) (0.415)
τ 23 0.658 0.656 0.985 1.091 0.608 0.496 0.606 0.635
(0.633) (0.198) (0.803) (0.611) (0.369) (0.219) (0.508) (0.427)
τ 24 0.636 0.692 1.059 1.082 0.628 0.513 0.609 0.589
(0.595) (0.340) (0.957) (0.646) (0.444) (0.228) (0.480) (0.402)
τ 25 0.608 0.667 1.033 1.092 0.629 0.516 0.603 0.600
(0.367) (0.215) (0.852) (0.622) (0.443) (0.218) (0.468) (0.394)
π1 0.203 0.203 0.212 0.205 0.182 0.177 0.179 0.205
(0.250) (0.260) (0.243) (0.198) (0.235) (0.331) (0.224) (0.229)
π2 0.207 0.209 0.190 0.186 0.192 0.199 0.198 0.214
(0.252) (0.261) (0.231) (0.186) (0.252) (0.358) (0.223) (0.231)
π3 0.199 0.187 0.205 0.196 0.191 0.189 0.209 0.212
(0.259) (0.233) (0.246) (0.187) (0.251) (0.343) (0.228) (0.227)
π4 0.196 0.210 0.192 0.203 0.220 0.220 0.204 0.185
(0.244) (0.259) (0.230) (0.193) (0.276) (0.372) (0.235) (0.227)
π5 0.195 0.190 0.201 0.210 0.215 0.215 0.211 0.183
(0.248) (0.256) (0.230) (0.207) (0.270) (0.369) (0.228) (0.223)
Table 5.5: Log-Normal, Gamma, Inverse Gaussian and arbitrary frailty model with Weibull
baseline hazard and four covariates simulated data estimated by mixture of Log-Normal frailty,
500 data sets each with sample sizes of 500 and 5000.
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Parameter True values
Log-Normal Gamma Inverse Gaussian
500 5000 500 5000 500 5000
Mean Mean Mean Mean Mean Mean
(S.e) (S.e) (S.e) (S.e) (S.e) (S.e)
β10 -4 -4.041 -3.984 -4.080 -4.042 -3.995 -3.984
(0.354) (0.343) (0.423) (0.123) (0.371) (0.110)
β11 9 9.603 9.098 9.917 9.164 9.541 9.070
(1.730) (0.504) (1.631) (0.378) (1.853) (0.487)
β12 3 3.176 3.041 3.255 2.967 3.197 3.041
(0.624) (0.231) (0.601) (0.167) (0.674) (0.191)
α1 0.5 0.530 0.500 0.550 0.500 0.530 0.510
(0.100) (0.030) (0.090) (0.020) (0.140) (0.030)
β20 -3 -2.948 -2.977 -2.864 -2.882 -2.937 -2.993
(0.314) (0.332) (0.360) (0.098) (0.370) (0.086)
β21 7 7.412 7.099 7.645 7.117 7.470 7.081
(1.394) (0.430) (1.330) (0.366) (1.675) (0.423)
β22 4 4.246 4.049 4.452 4.176 4.275 4.024
(0.767) (0.279) (0.781) (0.188) (0.909) (0.232)
α2 0.5 0.530 0.500 0.550 0.520 0.530 0.500
(0.090) (0.040) (0.090) (0.020) (0.150) (0.030)
τ 21 0.8 6.04 1.010 20.61 2.950 6.35 0.740
(14.64) (0.670) (68.01) (1.330) (14.75) (0.840)
τ 22 1.25 7.16 1.610 37.78 8.600 8.44 1.580
(13.42) (0.880) (80.79) (3.410) (17.11) (0.980)
ρ 0.3 0.540 0.490 0.570 0.650 0.550 0.520
(0.340) (0.280) (0.330) (0.230) (0.320) (0.290)
Table 5.6: Bivariate Log-Normal, Gamma and Inverse Gaussian frailty model with Weibull baseline
hazard and two covariates simulated data fitted by mixture of bivariate Inverse Gaussian, 500 data
sets each with sample sizes of 500 and 5000.
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The above tables describe four simulation studies of finite frailty mixtures. The simulated
data is generated with four different frailty distributions, Log-Normal, Gamma, Inverse
Gaussian and an arbitrary distribution. In the first study, data was fitted by Gamma frailty
and mixture of Gamma, results are shown in tables 5.1 and 5.2 respectively. Neither the
Gamma frailty model nor its mixture was able to capture the model estimates even with
five Gamma mixtures except when the original frailty distribution is Gamma. In the second
study, the simulated data was fitted by Inverse Gaussian and mixture of Inverse Gaussian
distribution. The results are shown in tables 5.3 and 5.4 respectively. Similar to Gamma
distribution, the Inverse Gaussian frailty was not able to capture the model estimates, while
its mixture managed to fit all of the four frailty models. Only the frailty variance, τ 2 is
not close to its true value since it is the mixing parameter. The mixing variances and
their corresponding weights are represented by τ 2i and πi, (i = 1, . . . , 5) respectively. In
the third study, the simulated data was fitted by the Log-Normal and the mixture of Log-
Normal distributions. The results of Log-Normal frailty are in Table 3.2 in chapter three,
while the results of its mixture are presented in in Table 5.5. The Log-Normal mixture
model displays similarity to the Inverse Gaussian mixture with respect to capturing the
estimates of the four frailty models. These results confirm the conclusions drawn from the
previous chapters. Because of quadrature integration in a Log-normal mixture, the Inverse
Gaussian mixture is preferable since it is less time consuming. The last study of simulation
is the correlated bivariate Inverse Gaussian frailty mixture. The results are summarized in
Table 5.6. Obviously, the bivariate Inverse Gaussian mixture is capable of capturing the
parameter estimates of other frailty models except the frailty variances since they are the
mixing parameters. Only three mixtures are capable to fit the model, the mixing variances
and their corresponding weights are not presented since they are not of the main interest.
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5.5 Summary
The main goal of this chapter was to check the performance of finite mixture of frailty models
through simulation studies. In the univariate frailty, three finite mixtures are considered,
Gamma, Inverse Gaussian and Log-Normal. The Gamma mixture was not able to capture
the model parameters except when the original frailty distribution is Gamma. Both Inverse
Gaussian and Log-Normal finite mixture were capable to fit the model parameters whatever
is the original frailty distribution. However, the inverse Gaussian mixture is preferable since
it does not involve numerical integrations. In the bivariate frailty, only the Inverse Gaussian
mixture is considered. Using only three mixtures, it managed to fit the model parameters
very well except the frailty variances and the correlation coefficient and overestimates them
which expected since it they are analytically different from the true parameters, see formulae
5.3.1.
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Conclusions
6.1 Introduction
The present thesis discussed a variation of univariate, bivariate and multivariate frailty
models in the presence of competing risks. There are two sources of variability in survival
data, variability due to observable covariates and variability caused by unknown risk factors
which usually is uncontrollable. Estimating the individual hazard rate without taking into
account the unobserved heterogeneity will underestimate the hazard function. Competing
risks frailty models consist of two underlying distributions: baseline hazard distribution and
the random effect distribution. The main emphasis in this thesis is on the frailty distribution
rather than the baseline hazard distribution which is assumed to have a Weibull distribution.
6.2 Concluding Remarks
The simulations showed that the right specification of the frailty distribution is crucial
for making valid model inferences. There are four proposed frailty models in this thesis.
First, a novel non-parametric multivariate frailty model with competing risks which showed
a significant decrease in time to model by more than 80%. A model that can accommodate
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all multivariate frailty models irrespective of the original frailty distribution. Second, a
correlated Inverse Gaussian frailty model, but with restrictions on correlation coefficients.
Third, a multivariate Inverse Gaussian frailty model without any restrictions. Fourth, a
finite mixture of frailty models especially for those with a close-form of unconditional survival
function. One should distinguish between correlated and multivariate models. In correlated
models, the marginal distributions are known while the joint distribution is constructed by
the sum of marginals. In multivariate models, both the marginals and joint distribution are
well defined. Most of the published research in the area of frailty is for correlated models
rather than multivariate models. This is what makes the multivariate Log-Normal and the
proposed non-parametric frailty models more flexible in modelling frailty.
There are two advantages of the proposed non-parametric multivariate frailty over the Log-
Normal frailty. First, it is a distribution free model which does not depends on the original
distribution of the frailty. Second, it is much less time consuming compared with the Log-
Normal distribution, even when more parameters are added to the model (the quadrature
points and their corresponding weights). By estimating the quadrature points and their
weights from the model it minimises the number of iterations of the model fit. Latent
approach of competing risks is not a full multivariate survival data in the sense that only the
minimum failure time is observed, i.e. there is only one dependent variable. The multivariate
settings come from the inclusion of the indicator variable of each failure in the model. One
of the limitations of correlated frailty models is that they may be not flexible enough in
modelling data that are negatively correlated. Another limitation is that in frailty models,
the likelihood function is usually expressed in terms of all partial derivatives of the survival
function. Hence, generalisation from the bivariate to the multivariate is not straightforward.
On the other hand, this could be an advantage of competing risks model over the multivariate
survival data since only the first order of the partial derivative is needed to fit the model.
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The simulation studies of the non-parametric frailty for univariate and multivariate showed
that a small number of quadrature points (around three) is needed to fit the model well. To
test the applicability of the proposed models, a real data set of breast cancer was used. It
is a complicated data set in which around three thousand patients of breast cancer and five
competing risks are included in the model. Both Log-Normal and non-parametric frailty were
tried for the data. In the Log-Normal frailty model with five quadrature points a vector with
(55 = 3125) points is needed to get a single iteration (number of quadrature to the power of
number of competing risks).
From an estimation point of view, one important issue in competing risks with frailty model is
the initial values of the model parameters to start with. The following procedure is suggested
to minimise the fitting time of the model. First, start with individual failure time without
frailty and use them as starting values for individual failure with frailty. Second, aggregate
these results as starting values of the multivariate model. Third, for the Log-Normal frailty it
is better to start with two quadrature points and then use them as starting values for higher
number of quadrature points.
6.3 Limitations and future research
Despite their similarity with linear mixed models, frailty models need special treatment.
There is a need for additional developments in methods of frailty models analysis especially
in multivariate case. One of the limitations of the multivariate Log-Normal frailty is the
numerical integration that is needed to fit the model. The time it needs to fit the model
depends on the number of quadrature points for the numerical integration and the dimension
of the multivariate (number of failure times) which creates nested loops in the estimation
process. Converting loops into vectors decreased the time of model fit tremendously, but still
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it is a time consuming process. For future research, one may work on relaxing the assumptions
used in frailty models such as constant frailty across individuals and the proportionality
of hazard to suit practical applications. Throughout this thesis, it was assumed that the
baseline hazard is following the Weibull distribution (i.e. parametric baseline hazard). A
further research could be more general models where both the baseline hazard and the frailty
are distribution free, i.e. a full non-parametric model.
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Data
A.1 Variables in the model
The variables included in the regression analysis of breast cancer data are as follow:
AGE a continuous variable represents the age of patient in years
STAGE a categorical variable with four level. Stage of the disease which is known as
Manchester stage as given in page 43. The code for dummy variables used is as follows
STAGE1 0 0 0
STAGE2 1 0 0
STAGE3 0 1 0
STAGE4 0 0 1
SURGTYPE a categorical variable of surgery type with with eight levels: the code for
dummy variables used is as follows
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None 1 0 0 0 0 0 0
Incision biopsy 0 1 0 0 0 0 0
Excision biopsy 0 0 1 0 0 0 0
Simple mastectomy 0 0 0 1 0 0 0
Radical mastectomy 0 0 0 0 1 0 0
Wide local excision and axillary clearance 0 0 0 0 0 1 0
Surgery after neo adjuvant chemotherapy 0 0 0 0 0 0 1
Radical mastectomy and axillary clearance 0 0 0 0 0 0 0
HIST a categorical variable of histology status with four levels: the code for dummy
variables used is as follows
Ductal 0 0 0
Lobular 1 0 0
Dcis (Ductal Carcinoma In Situ) 0 1 0
Other 0 0 1
COHORT a categorical variable of date of primary surgery with two levels:
(0)Before 1990 (1)After 1990
CHEMO a categorical variable of any neo or adjuvant chemotherapy with two levels:
(0)No (1)Yes
MENO a categorical variable of menopausal status with two levels:
(0)PRE (1)Post
RADIO a categorical variable of any adjuvant radiotherapy with two levels:
(0)No (1)Yes
SIDE a categorical variable of side of the body affected with two levels:
(0)Right (1) Left
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A.2 Variables by risks
Local Regional Metastasis Died from Died from
recurrence recurrence breast cancer other causes
Variable N % N % N % N % N %
STAGE
1 110 65.1 147 56.3 232 51.4 91 49.2 87 68
2 33 19.5 56 21.5 124 27.5 34 18.4 27 21.1
3 26 15.4 46 17.6 46 10.2 19 10.3 13 10.2
4 0 0 12 4.6 49 10.9 41 22.2 1 0.8
SURGERY
1 6 3.6 8 3.1 2 0.4 19 10.3 8 6.3
2 32 18.9 40 15.3 47 10.4 47 25.4 12 9.4
3 56 33.1 91 34.9 75 16.6 25 13.5 42 32.8
4 25 14.8 75 28.7 111 24.6 20 10.8 33 25.8
5 2 1.2 8 3.1 13 2.9 0 0 2 1.6
6 10 5.9 6 2.3 55 12.2 13 7 8 6.3
7 2 1.2 4 1.5 10 2.2 5 2.7 1 0.8
8 36 21.3 29 11.1 138 30.6 56 30.3 22 17.2
HIST
1 105 62.1 202 77.4 342 75.8 93 50.3 76 59.4
2 18 10.7 15 5.7 55 12.2 32 17.3 18 14.1
3 19 11.2 2 0.8 2 0.4 3 1.6 7 5.5
4 27 16 42 16.1 52 11.5 57 30.8 27 21.1
COHORT 1 81 47.9 183 70.1 238 52.8 76 41.1 80 62.5
2 88 52.1 78 29.9 213 47.2 109 58.9 48 37.5
CHEMO 1 100 59.2 175 67 202 44.8 118 63.8 66 51.6
2 69 40.8 86 33 249 55.2 67 36.2 62 48.4
MENO 1 113 66.9 159 60.9 282 62.5 159 85.9 120 93.8
2 56 33.1 102 39.1 169 37.5 26 14.1 8 6.3
RADIO 1 134 79.3 171 65.5 265 58.8 155 83.8 113 88.3
2 35 20.7 90 34.5 186 41.2 30 16.2 15 11.7
SIDE 1 84 49.7 119 45.6 216 47.9 80 43.2 62 48.4
2 85 50.3 142 54.4 235 52.1 105 56.8 66 51.6
Age
Mean ± SD 58.0 ± 14.3 56.0 ± 14.6 53.9 ± 12.8 65.8 ± 14.0 71.6 ± 11.9
Table A.1: Independent variables by recurrence type.
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A.3 Data analysis without frailty
Frailure type
Variable Local Regional Metastasis Died from Died from
recurrence recurrence breast cancer other causes
AGE -0.012(0.01) -0.012(0.01) -0.038(0.01) 0.03(0.01) 0.086(0.01)
STAGE2 0.533(0.21) 0.772(0.17) 0.844(0.12) 0.548(0.21) 0.346(0.23)
STAGE3 0.565(0.29) 1.373(0.22) 1.291(0.18) 0.725(0.29) 0.399(0.33)
STAGE4 -10.89(70.7) 0.521(0.35) 2.664(0.23) 2.163(0.27) -1.204(1.03)
SURGTYPE1 2.894(0.56) 2.148(0.49) -0.904(0.75) 2.077(0.42) 1.296(0.59)
SURGTYPE2 2.92(0.34) 2.177(0.32) 0.472(0.25) 1.385(0.31) 1.051(0.47)
SURGTYPE3 1.23(0.27) 1.522(0.26) -0.552(0.19) -0.055(0.3) 0.844(0.32)
SURGTYPE4 0.198(0.3) 1.084(0.25) -0.08(0.16) -0.242(0.3) 0.489(0.33)
SURGTYPE5 0.212(0.73) 1.565(0.41) 0.387(0.3) -7.886(42.66) 1.088(0.75)
SURGTYPE6 -0.001(0.4) -0.851(0.48) -0.805(0.2) -0.551(0.39) 0.417(0.46)
SURGTYPE7 0.273(0.75) 0.725(0.55) -0.636(0.35) 0.53(0.51) 0.306(1.04)
HIST2 0.603(0.25) 0.564(0.2) 0.319(0.16) -0.121(0.21) 0.148(0.28)
HIST3 0.273(0.33) -0.471(0.31) 0.151(0.2) 0.351(0.26) 0.248(0.34)
HIST4 0.182(0.37) -2.496(0.74) -2.405(0.73) -1.592(0.63) -0.307(0.49)
COHORT 0.123(0.18) -0.35(0.16) -0.316(0.12) 0.621(0.19) -0.28(0.23)
CHEMO 0.252(0.19) -0.115(0.15) 0.501(0.11) 0.042(0.19) 0.012(0.24)
MENO 0.27(0.26) 0.354(0.21) -0.386(0.16) 0.204(0.28) 0.392(0.45)
RADIO -1.026(0.26) -0.297(0.18) 0.516(0.14) -0.458(0.3) -0.95(0.35)
SIDE -0.046(0.16) 0.108(0.13) 0.005(0.09) 0.248(0.15) -0.098(0.18)
LN(α) -0.131(0.07) -0.253(0.05) -0.103(0.04) 0.097(0.06) 0.062(0.08)
CONSTANT -9.87(0.85) -8.87(0.67) -6.918(0.53) -13.578(0.85) -16.966(1.14)
-2 Log Likelihood 3628.52 5227.95 8769.63 3758.80 2746.91
Table A.2: Weibull baseline hazard model without frailty for all failure types.
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A.4 Non-parametric frailty
The parameters estimates of breast cancer data using non-parametric frailty using different
number of mass points.
Number of mass points
Variable One Two Three Four Five
AGE 0.030(0.008) 0.036(0.009) 0.047(0.014) 0.048(0.014) 0.048(0.014)
STAGE2 0.548(0.211) 0.530(0.221) 0.623(0.288) 0.626(0.290) 0.626(0.290)
STAGE3 0.726(0.289) 0.826(0.311) 1.124(0.407) 1.138(0.408) 1.138(0.408)
STAGE4 2.163(0.270) 3.427(0.321) 4.132(0.542) 4.168(0.539) 4.168(0.539)
SURGTYPE1 2.077(0.416) 2.307(0.464) 2.706(0.597) 2.719(0.599) 2.720(0.598)
SURGTYPE2 1.385(0.311) 1.388(0.326) 1.674(0.441) 1.684(0.443) 1.684(0.443)
SURGTYPE3 -0.055(0.296) -0.141(0.309) -0.201(0.394) -0.207(0.397) -0.207(0.397)
SURGTYPE4 -0.242(0.297) -0.374(0.311) -0.638(0.448) -0.653(0.451) -0.654(0.451)
SURGTYPE5 -17.873(5136) -9.769(106.3) -15.252(1151) -12.646(339) -12.646(335)
SURGTYPE6 -0.550(0.389) -0.616(0.397) -0.886(0.532) -0.905(0.536) -0.905(0.536)
SURGTYPE7 0.531(0.514) 0.521(0.538) 0.434(0.735) 0.424(0.744) 0.424(0.744)
HIST2 0.472(0.207) 0.403(0.219) 0.391(0.286) 0.387(0.289) 0.387(0.289)
HIST3 -1.471(0.613) -1.411(0.619) -1.713(0.708) -1.726(0.709) -1.726(0.709)
HIST4 0.121(0.210) 0.115(0.230) 0.059(0.280) 0.055(0.283) 0.055(0.283)
COHORT 0.621(0.192) 0.609(0.206) 0.711(0.251) 0.718(0.252) 0.718(0.252)
CHEMO 0.042(0.193) 0.099(0.199) 0.137(0.260) 0.142(0.263) 0.142(0.263)
MENO 0.204(0.285) 0.210(0.306) 0.329(0.390) 0.343(0.394) 0.343(0.394)
RADIO -0.459(0.297) -0.397(0.306) -0.512(0.376) -0.514(0.378) -0.514(0.378)
SIDE 0.248(0.151) 0.239(0.163) 0.269(0.198) 0.270(0.199) 0.270(0.199)
LN(α) 0.097(0.060) 0.290(0.063) 0.508(0.132) 0.519(0.130) 0.519(0.130)
-2 Log Likelihood 3785.2368 3758.7958 3756.0952 3756.1028 3756.1026
Table A.3: Breast cancer Weibull hazard with non-parametric frailty using different number of
mass points.
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A.5 Log-Normal frailty
Table A.4: Breast cancer Weibull hazard with Log-normal frailty using different number of mass
points.
Number of mass points
Variable 3 points 4 points 5 points 6 points
AGE 0.036(0.012) 0.046(0.017) 0.059(0.014) 0.042(0.013)
STAGE2 0.637(0.267) 0.649(0.312) 0.939(0.344) 0.694(0.333)
STAGE3 1.139(0.417) 1.047(0.393) 1.569(0.467) 1.140(0.429)
STAGE4 3.771(0.531) 3.764(0.524) 5.512(0.679) 4.034(0.576)
SURGTYPE1 3.006(0.617) 2.887(0.724) 3.888(0.626) 3.208(0.797)
SURGTYPE2 1.928(0.509) 1.704(0.435) 2.909(0.535) 2.150(0.566)
SURGTYPE3 -0.088(0.356) -0.177(0.411) -0.393(0.479) -0.057(0.427)
SURGTYPE4 -0.392(0.363) -0.611(0.477) -0.326(0.448) -0.411(0.426)
SURGTYPE5 -7.890(38.45) -7.89(30.89) -7.898(20.46) -7.89(28.26)
SURGTYPE6 -0.698(0.431) -0.895(0.534) -1.118(0.555) -0.865(0.519)
SURGTYPE7 0.524(0.589) 0.415(0.748) 0.869(0.665) 0.531(0.712)
HIST2 0.475(0.263) 0.404(0.300) 0.711(0.299) 0.490(0.321)
HIST3 -1.531(0.645) -1.762(0.699) -1.732(0.847) -1.842(0.751)
HIST4 0.149(0.273) 0.004(0.298) 0.313(0.317) 0.049(0.307)
COHORT 0.756(0.248) 0.740(0.253) 0.963(0.293) 0.833(0.293)
CHEMO 0.115(0.226) 0.161(0.263) 0.104(0.274) 0.168(0.288)
MENO 0.230(0.350) 0.379(0.443) 0.748(0.428) 0.273(0.403)
RADIO -0.450(0.338) -0.552(0.379) -0.210(0.465) -0.534(0.408)
SIDE 0.394(0.192) 0.301(0.208) 0.537(0.224) 0.327(0.220)
CONSTANT -18.189(1.824) -19.87(2.765) -25.93(2.781) -20.96(2.628)
LN(α) 0.386(0.098) 0.461(0.127) 0.714(0.106) 0.523(0.132)
LN(τ 2) 0.452(0.177) 0.678(0.209) 1.043(0.124) 0.813(0.209)
-2 Log Likelihood 3805.78 3799.3574 3801.1342 3799.3808
Continued on next page
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Continued from previous page
Number of mass points
Variable 7 points 8 points 9 points 16 points
AGE 0.041(0.017) 0.050(0.016) 0.039(0.013) 0.039(0.013)
STAGE2 0.703(0.326) 0.713(0.383) 0.673(0.308) 0.663(0.293)
STAGE3 1.154(0.874) 1.290(0.474) 1.038(0.440) 1.088(0.476)
STAGE4 4.455(1.883) 4.759(0.656) 4.014(0.999) 3.876(0.760)
SURGTYPE1 3.308(0.894) 4.177(1.282) 3.240(0.916) 2.999(0.764)
SURGTYPE2 1.757(0.478) 2.935(0.805) 1.848(0.524) 1.875(0.519)
SURGTYPE3 -0.109(0.400) -0.096(0.522) -0.073(0.385) -0.085(0.382)
SURGTYPE4 -0.524(0.520) -0.194(0.514) -0.419(0.408) -0.416(0.396)
SURGTYPE5 -7.892(30.265) -7.902(20.196) -7.891(32.579) -7.890(33.451)
SURGTYPE6 -0.835(0.546) -1.201(0.678) -0.772(0.504) -0.754(0.479)
SURGTYPE7 0.498(0.700) 0.686(0.708) 0.532(0.690) 0.514(0.667)
HIST2 0.512(0.349) 0.791(0.478) 0.487(0.287) 0.474(0.288)
HIST3 -1.766(0.791) -2.112(0.962) -1.716(0.737) -1.694(0.709)
HIST4 0.032(0.324) 0.098(0.351) 0.030(0.316) 0.066(0.299)
COHORT 0.886(0.466) 1.130(0.457) 0.815(0.310) 0.811(0.295)
CHEMO 0.152(0.254) 0.230(0.319) 0.160(0.262) 0.135(0.247)
MENO 0.208(0.377) 0.451(0.489) 0.234(0.376) 0.255(0.373)
RADIO -0.543(0.411) -0.385(0.464) -0.506(0.375) -0.507(0.371)
SIDE 0.410(0.319) 0.399(0.281) 0.344(0.214) 0.351(0.212)
CONSTANT -20.095(5.502) -25.80(3.834) -19.32(3.269) -19.10(2.839)
LN(α) 0.479(0.259) 0.720(0.162) 0.442(0.176) 0.426(0.148)
LN(τ 2) 0.711(0.483) 1.124(0.215) 0.639(0.333) 0.614(0.281)
-2 Log Likelihood 3802.828 3799.447 3802.376 3802.405
Continued on next page
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Number of mass points
Variable 32 points 64 points 128 points
AGE 0.042(0.015) 0.041(0.015) 0.041(0.015)
STAGE2 0.691(0.319) 0.685(0.313) 0.685(0.313)
STAGE3 1.154(0.514) 1.139(0.502) 1.139(0.502)
STAGE4 4.123(1.068) 4.070(0.986) 4.069(0.985)
SURGTYPE1 3.225(1.013) 3.174(0.928) 3.172(0.927)
SURGTYPE2 1.960(0.608) 1.941(0.582) 1.940(0.582)
SURGTYPE3 -0.092(0.398) -0.092(0.395) -0.092(0.394)
SURGTYPE4 -0.451(0.425) -0.445(0.419) -0.446(0.419)
SURGTYPE5 -7.891(30.966) -7.891(31.484) -7.891(31.485)
SURGTYPE6 -0.802(0.520) -0.791(0.510) -0.792(0.510)
SURGTYPE7 0.524(0.700) 0.522(0.695) 0.521(0.695)
HIST2 0.495(0.308) 0.489(0.303) 0.490(0.303)
HIST3 -1.755(0.760) -1.741(0.745) -1.740(0.745)
HIST4 0.062(0.315) 0.062(0.314) 0.062(0.310)
COHORT 0.850(0.327) 0.839(0.315) 0.839(0.315)
CHEMO 0.148(0.261) 0.145(0.258) 0.145(0.257)
MENO 0.278(0.395) 0.274(0.391) 0.275(0.391)
RADIO -0.519(0.388) -0.516(0.383) -0.516(0.383)
SIDE 0.369(0.228) 0.364(0.224) 0.365(0.224)
CONSTANT -20.14(4.320) -19.92(3.940) -19.91(3.934)
LN(α) 0.477(0.211) 0.466(0.194) 0.466(0.194)
LN(τ 2) 0.712(0.376) 0.693(0.352) 0.692(0.352)
-2 Log Likelihood 3802.189 3802.201 3802.202
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Correlated frailty
B.1 Correlated Gamma frailty
The logarithm of bivariate survival function of the correlated frailty model and its partial
derivatives
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)
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∂2
∂t1∂t2
lnS(t1, t2) =
(
ρ
τ1τ2
)(
τ 21 f1(t1)S1(t1)
−τ21−1
)(
τ 22 f2(t2)S2(t2)
−τ22−1
)
×
(
S1(t1)
−τ21 + S2(t2)
−τ22 − 1
)−2
B.2 Correlated Inverse Gaussian frailty
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Appendix C
Gauss code
The software used to analysis the breast cancer data and in conducting the simulations are
”Gauss” and ”R”. STATA was used only to check the codes written in Gauss and R for
univariate frailty models. In multivariate case only Gauss program was used to fit the model.
The optimisation procedure in Gauss showed robustness in reaching the maximum likelihood
estimates, while the optimisation procedure in R was sensitive to the parameters’ initial
values. The list below is a sample of Gauss code used in the thesis.
GAUSS is commercial statistical software. GAUSS is a matrix programming language for
mathematics and statistics developed by Aptech Systems. Its primary purpose is the solution
of numerical problems in statistics, econometrics, time-series, optimization and 2D- and 3D-
visualization.
R is a free software programming language and a software environment for statistical
computing and graphics. The R language is widely used among statisticians and data miners
for developing statistical software and data analysis.
STATA is commercial statistical software developed by StataCorp. Its capabilities include
data management, statistical analysis, graphics and simulations
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Listing C.1: Gauss code of univariate simulation of Log-Normal frailty
1 /* Simulation of Univariate survival time assuming weibull(alpha ,lambda) for failure times@
2 and weibull(alpha ,theta) for survival times */
3 new;
4 output file = Univariate_Simulation5000.out reset;
5 for ii(1 ,600 ,1);
6 n=5000;
7 const=ones(n,1);
8 alpha =1;
9 sigma =1;
10 b0=-4;
11 b1=1;
12 b2=-2;
13 b3=4;
14 b4=2;
15 x1=rndu(n,1);
16 u1=rndu(n,1);
17 x2=(u1 . <0.3);
18 u2=rndu(n,1);
19 x31=(u2 . <0.4);
20 x32 =(0.4 .<= u2).*(u2 . <0.6);
21 z=sigma*rndn(n, 1);
22 xb=b0+b1*x1+b2*x2+b3*x31+b4*x32;
23 lamb=exp(xb+z);
24 u3=rndu(n,1);
25 lifetimes =(-ln(u3)./ lamb )^(1/ alpha);
26 theta = 0.01;
27 u4=rndu(n,1);
28 censtimes =(-ln(u4)/theta )^(1/ alpha);
29 aa=lifetimes~censtimes;
30 stime = minc(aa ’);
31 status= (censtimes .> lifetimes );
32 y=stime~const~x1~x2~x31~x32~status;
33 let varname = time const x1 x2 x31 x32 status;
34 call dstat(0,y);
35 call dstat(0,z);
36 b_ =cols(y);
37 u={
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38 -10.07742267422950 , -9.06439921070241 , -8.21972876538224 , -7.46075575412152 , -6.75593083054070 ,
39 -6.08896430907698 , -5.45003327362342 , -4.83260461324449 , -4.23202110999540 , -3.64478124988082 ,
40 -3.06813516901312 , -2.49984041518739 , -1.93800490592571 , -1.38098019927214 , -0.82728490377977 ,
41 -0.27554641923028 ,0.27554641923028 ,0.82728490377977 ,1.38098019927214 ,1.93800490592571 ,
42 2.49984041518739 ,3.06813516901312 ,3.64478124988082 ,4.23202110999540 ,4.83260461324449 ,
43 5.45003327362342 ,6.08896430907698 ,6.75593083054070 ,7.46075575412152 ,8.21972876538224 ,
44 9.06439921070241 ,10.07742267422950
45 };
46 w={
47 4.124607489018270E -23 ,5.208449591960860E -19 ,6.755290223670070E -16 ,2.378064855777800E-13,
48 3.347501239801200E -11 ,2.312518412074240E -09 ,8.881290713105870E -08 ,2.059622103953430E-06,
49 3.055980306089630E -05 ,3.025570258170630E -04 ,2.062051051307880E -03 ,9.903461702320580E-03,
50 3.410984772609200E -02 ,8.534480827208050E -02 ,1.565389937575980E -01 ,2.117055698804790E-01,
51 2.117055698804790E -01 ,1.565389937575980E -01 ,8.534480827208050E -02 ,3.410984772609200E-02,
52 9.903461702320580E -03 ,2.062051051307880E -03 ,3.025570258170630E -04 ,3.055980306089630E-05,
53 2.059622103953430E -06 ,8.881290713105870E -08 ,2.312518412074240E -09 ,3.347501239801200E-11,
54 2.378064855777800E -13 ,6.755290223670070E -16 ,5.208449591960860E -19 ,4.124607489018270E-23
55 };
56
57 proc lwei(be,y);
58 local llikl ,I;
59 llikl=zeros(n,1);
60 I=zeros(n,1);
61 I=sumr(
62 exp( y[.,b_].*
63 (be[b_ -1,1]+y[.,2:b_ -1]* be[1:b_ -2,1] + u’*exp(be[b_ ,1])+( exp(be[b_ -1 ,1]) -1).* ln(y[. ,1]))
64 - (Exp(y[.,2:b_ -1] * be[1:b_ -2,1] + u’*exp(be[b_ ,1]) ).* (y[. ,1]^( exp(be[b_ -1 ,1]))))
65 ).*w’ );
66
67 llikl=ln(I + (I.==0.0).*1e-15);
68 retp(llikl);
69 endp;
70
71 library maxlik;
72 #include maxlik.ext;
73 start ={1,1,1,1,1,1,1};
74 maxset;
75 __title = "Simulation of Weibull with random effect using cholesky decomposition ";
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76 __output = 1000;
77
78 {x0 ,f,g,cov ,ret}= maxlik(y,0,&lwei ,start);
79 call maxprt(x0,f,g,cov ,ret);
80 print "log -likelihood =" f*n;
81 endfor;
82 output off;
83 end;
Listing C.2: Gauss code of multivariate simulation of Log-Normal frailty
1 /* Simulation of Biivariate survival time assuming weibull(alpha ,lambda1) for failure times
2 of type1 ,weibull(alpha ,lambda2) for failure times of type2 and weibull(alpha ,theta)
3 for survival times */
4 new;
5 output file = Bivariate_Simulation700.csv reset;
6 mm=700;
7 p_est=zeros(mm ,11);
8 strr=zeros(mm ,11);
9 for ii(1,mm ,1);
10 print ii;
11 n=500;
12 const=ones(n,1);
13 alpha =0.5;
14 sigma1 =0.7;
15 sigma2 =1.2;
16 rho =0.8;
17
18 b10 =-0.2;
19 b11 =0.5;
20 b12 =1;
21
22 b20 =0.2;
23 b21 =0.7;
24 b22 =1;
25
26 x11= rndu(n,1);
27 unif1=rndu(n,1);
28 x12=(unif1 . <0.3);
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29 sigma=sigma1 ^2~rho*sigma1*sigma2|rho*sigma1*sigma2~ sigma2 ^2;
30 sigma;
31 z=rndmn ((0~0)’,sigma ,n);
32 vcx(z);
33
34 xb1=b10+b11*x11+b12*x12;
35 xb2=b20+b21*x11+b22*x12;
36
37 unif3=rndu(n,1);
38 unif4=rndu(n,1);
39
40 lamb1=exp(xb1+z[. ,1]);
41 lifetimes1 =(-ln(unif3 )./ lamb1 )^(1/ alpha);
42
43 lamb2=exp(xb2+z[. ,2]);
44 lifetimes2 =(-ln(unif4 )./ lamb2 )^(1/ alpha);
45
46 theta = 0.3;
47 unif5=rndu(n,1);
48 censtimes =(-ln(unif5)/theta )^(1/ alpha );
49
50 aa=lifetimes1~lifetimes2~censtimes;
51 stime = minc(aa ’);
52 status1 = (lifetimes1 .< censtimes ).*( lifetimes1 .< lifetimes2) ;
53 status2 = (lifetimes2 .< censtimes ).*( lifetimes2 .< lifetimes1) ;
54 cens =( status1 .==0).*( status2 .==0);
55
56 y=stime~const~x11~x12~status1~status2;
57 pr=cols(y);
58 b_ =pr -1;
59
60 u={
61 -10.07742267422950 , -9.06439921070241 , -8.21972876538224 , -7.46075575412152 , -6.75593083054070 ,
62 -6.08896430907698 , -5.45003327362342 , -4.83260461324449 , -4.23202110999540 , -3.64478124988082 ,
63 -3.06813516901312 , -2.49984041518739 , -1.93800490592571 , -1.38098019927214 , -0.82728490377977 ,
64 -0.27554641923028 ,0.27554641923028 ,0.82728490377977 ,1.38098019927214 ,1.93800490592571 ,
65 2.49984041518739 ,3.06813516901312 ,3.64478124988082 ,4.23202110999540 ,4.83260461324449 ,
66 5.45003327362342 ,6.08896430907698 ,6.75593083054070 ,7.46075575412152 ,8.21972876538224 ,
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67 9.06439921070241 ,10.07742267422950
68 };
69 w={
70 4.124607489018270E -23 ,5.208449591960860E -19 ,6.755290223670070E -16 ,2.378064855777800E-13,
71 3.347501239801200E -11 ,2.312518412074240E -09 ,8.881290713105870E -08 ,2.059622103953430E-06,
72 3.055980306089630E -05 ,3.025570258170630E -04 ,2.062051051307880E -03 ,9.903461702320580E-03,
73 3.410984772609200E -02 ,8.534480827208050E -02 ,1.565389937575980E -01 ,2.117055698804790E-01,
74 2.117055698804790E -01 ,1.565389937575980E -01 ,8.534480827208050E -02 ,3.410984772609200E-02,
75 9.903461702320580E -03 ,2.062051051307880E -03 ,3.025570258170630E -04 ,3.055980306089630E-05,
76 2.059622103953430E -06 ,8.881290713105870E -08 ,2.312518412074240E -09 ,3.347501239801200E-11,
77 2.378064855777800E -13 ,6.755290223670070E -16 ,5.208449591960860E -19 ,4.124607489018270E-23
78 };
79 e=ones(rows(u),1);
80 u2=u.*.e;
81 u1=e.*.u;
82 w2=w.*.e;
83 w1=e.*.w;
84
85 proc lwei(be,y);
86 local llikl ,I;
87 llikl=zeros(n,1);
88 I=zeros(n,1);
89 I=sumr(
90 exp(
91 y[.,b_].*(be[b_ -1,1] +y[.,2:b_ -1]* be[1:b_ -2,1] + u1 ’*be[b_ ,1]+ u2 ’*be[2*b_+1,1]
92 +(exp(be[b_ -1 ,1]) -1).* ln(y[. ,1]))
93 -(Exp(y[.,2:b_ -1]*be[1:b_ -2,1]+u1 ’*be[b_ ,1]+u2 ’*be[2*b_+1,1] ).*(y[. ,1]^( exp(be[b_ -1 ,1]))))
94 +
95 y[.,b_ +1].* (be[2*b_ -1,1] + y[.,2:b_ -1]* be[b_+1:2*b_ -2,1] + u2 ’*be[2*b_ ,1]
96 +(exp(be[2*b_ -1 ,1]) -1).* ln(y[. ,1]))
97 -(Exp(y[.,2:b_ -1]* be[b_ +1:2*b_ -2,1] + u2 ’*be[2*b_ ,1] ).* (y[. ,1]^( exp(be[2*b_ -1 ,1]))))
98
99 )
100 .*w1 ’.*w2’ );
101
102 llikl=ln(I + (I.==0.0).*1e-15);
103 retp(llikl);
104 endp;
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105
106 library maxlik;
107 #include maxlik.ext;
108 start ={1,1,1,1,1,1,1,1,1,1,1};
109 maxset;
110 __title = "Bivariate Simulation of Weibull with random effect ";
111 __output = 1000;
112 {x0 ,f,g,cov ,ret}= maxlik(y,0,&lwei ,start);
113 call maxprt(x0,f,g,cov ,ret);
114 print "log -likelihood =" f*n;
115 p_est[ii ,.]=x0 ’;
116 if rows(cov) == 11;
117 strr[ii ,.]= sqrt(diag(cov))’;
118 endif;
119 endfor;
120 output off;
121 output file = Parameters_Bivariate_Simulation700.out reset;
122 format /m1 8,4;
123 outwidth 132;
124 print p_est;;
125 print strr;
126 output off;
127 end;
142
Bibliography
Aalen, O. O. (1988), ‘Heterogeneity in survival analysis’, Statistics in Medicine. 7, 1121–1137.
Aalen, O. O. (1992), ‘Modelling heterogeneity in survival analysis by the compound poisson
distribution’, Annals of Applied Probability 4, 951 – 972.
Abbring, J. H. and van den Berg, G. J. (2003), ‘The identifiability of the mixed proportional
hazards competing risks model’, Royal Statistical Society, Series B 65(3), 701 – 710.
Abbring, J. H. and van den Berg, G. J. (2007), ‘The unobserved heterogeneity distribution
in duration analysis’, Biometrika 94(1), 87–99.
Aitkin, M. (1999), ‘A general maximum likelihood analysis of variance components in
generalized linear models’, Biometrics 55(1), 117–128.
Aitkin, M., Francis, B., Hinde, J. and Darnell, R. (2009), Statistical Modelling in R, Oxford
statistical science series, Oxford University Press, Oxford.
Akaike, H. (1974), ‘A new look at the statistical model identification’, IEEE Transactions on
Automatic Control 19, 716723.
Anderson, J. E. and Louis, T. A. (1995), ‘Survival analysis using a scale change random
effects model’, Journal of the American Statistical Association 90, 669 – 679.
Balakrishnan, N. and Peng, Y. W. (2006), ‘Generalized gamma frailty model’, Statistics in
Medicine 25(16), 2797–2816.
Bandeen-Roche, K. and Liang, K. Y. (2002), ‘Modelling multivariate failure time associations
in the presence of a competing risk’, Biometrika 89(2), 299 – 314.
143
BIBLIOGRAPHY
Beamonte, E. and Bermdez, J. D. (2003), ‘A bayesian semiparametric analysis for additive
hazard models with censored observations’, TEST 12(2), 347 – 363.
BermDez, L. and Karlis, D. (2012), ‘A finite mixture of bivariate poisson regression models
with an application to insurance ratemaking’, Computational Statistics and Data Analysis
56(12), 3988–3999.
Bock, R. and Aitkin, M. (1981), ‘Marginal maximum likelihood estimation of item
parameters: Application of an em algorithm’, Psychometrika 46(4), 443–459.
Cai, B. (2010), ‘Bayesian semiparametric frailty selection in multivariate event time data’,
Biometrical Journal 52(2), 171–185.
Cai, J. and Zeng, D. (2011), ‘Additive mixed effect model for clustered failure time data’,
Biometrics 67(4), 1340–1351.
Casella, G. and Berger, R. (2002), Statistical inference, Thomson Learning.
Chakraborty, H., Helms, R. W., Sen, P. K. and Cohen, M. S. (2003), ‘Estimating correlation
by using a general linear mixed model: evaluation of the relationship between the
concentration of hiv-1 rna in blood and semen’, Statistics in Medicine 22, 1457 – 1464.
Chang, S. H. (2004), ‘Estimating marginal effects in accelerated failure time models for serial
sojourn times among repeated events’, Lifetime Data Analysis 10, 175 – 190.
Chen, D. G. and Lio, Y. L. (2008), ‘Comparative studies on frailties in survival analysis’,
Communications in Statistics-Simulation and Computation 37(8), 1631–1646.
Clayton, D. G. (1978), ‘A model for association in bivariate life tables and its application
in epidemiological studies of familial tendency in chronic disease incidence’, Biometrika
65, 141 – 151.
Clayton, D. G. (1988), ‘The analysis of event history data - a review of progress and
outstanding problems’, Statistics in Medicine 7(8), 819–841.
144
BIBLIOGRAPHY
Clayton, D. G. and Cuzick, J. (1985), ‘Multivariate generalizations of the proportional
hazards model (with discussion)’, Journal of the Royal Statistical Society, Series A
148(2), 82 – 117.
Congdon, P. (1995), ‘Modelling frailty in area mortality’, Statistics in Medicine 14, 1859
–1874.
Cox, D. R. (1972), ‘Regression models and life-tables’, Journal of the Royal Statistical Society.
Series B (Methodological). 34(2), 187–220.
Cox, D. R. and Oakes, D. V. (1984), Analysis of Survival Data, Chapman and Hall, London.
Crowder, M. (1985), ‘A distributional model for repeated failure time measurements’, Royal
Statistical Society, Series B 47, 447 – 452.
David, I., Lorino, T. and Sanaa, M. (2007), ‘Bayesian versus frequentist approach of the frailty
cox model, application to calf gastroenteritis’, Communications in Statistics - Simulation
and Computation 36(6), 1309–1320.
Davies, R. B. (1993), ‘Nonparametric control for residual heterogeneity in modelling recurrent
behaviour’, Computational Statistics and Data Analysis 16(2), 143–160.
Davies, R. B. and Crouchley, R. (1984), ‘Calibrating longitudinal models of residential-
mobility and migration - an assessment of a non-parametric marginal likelihood approach’,
Regional Science and Urban Economics 14(2), 231–247.
Dewanji, A. (1992), ‘A note on a test for competing risks with missing failure type’,
Biometrika 79(4), 855–857.
dos Santos, D. M., Davies, R. B. and Francis, B. (1995), ‘Nonparametric hazard versus
nonparametric frailty distribution in modelling recurrence of breast cancer’, Journal of
Statistical Planning and Inference 47, 111 – 127.
Duchateau, L. and Janssen, P. (2008), The Frailty Model, Springer.
145
BIBLIOGRAPHY
Economou, P. and Caroni, C. (2005), ‘Graphical tests for the assumption of gamma and
inverse gaussian frailty distributions’, Lifetime Data Anal 11(4), 565–82.
Elbers, C. and Ridder, G. (1982), ‘True and spurious duration dependence - the identifiability
of the proportional hazard model’, Review of Economic Studies 49(3), 403–409.
Everitt, B. and Hand, D. (1981), Finite Mixture Distributions, Chapman and Hall.
Fahrmeir, L. and Tutz, G. (1994), Multivariate Statistical Modelling based on Generalised
Linear Models, Springer-Verlag, New York.
Fieuws, S. and Verbeke, G. (2004), ‘Joint modelling of multivariate longitudinal profiles:
pitfalls of the random-effects approach’, Statistics in Medecine 23, 3093 – 3104.
Fieuws, S. and Verbeke, G. (2006a), ‘Pairwise fitting of mixed models for the joint modeling
of multivariate longitudinal profiles’, Biometrics 62, 424 – 431.
Fieuws, S., Verbeke, G., Boen, F. and Delecluse, C. (2006b), ‘High dimensional multivariate
mixed models for binary questionnaire data’, Journal of the Royal Statistical Society: Series
C (Applied Statistics) 55(4), 449 – 460.
Fieuws, S., Verbeke, G. and Molenberghs, G. (2007), ‘Random-effects models for multivariate
repeated measures’, Statistical Methods in Medical Research 16, 387 – 397.
Fine, J. P. and Gray, R. J. (1999), ‘A proportional hazards model for the subdistribution of
a competing risk’, Journal of the American Statistical Association 944, 496 – 509.
Fine, J. P., Jiang, H. and Chappell, R. (2001), ‘On semi-competing risks data’, Biometrika
88(4), 907 – 919.
Finkelstein, M. and Esaulovac, V. (2006), ‘Asymptotic behavior of a general class of mixture
failure rates’, The Advances in Applied Probability 38(1), 244 – 262.
Finkelstein, M. and Esaulovac, V. (2008), ‘On asymptotic failure rates in bivariate frailty
competing risks models’, Statistics and Probability Letters 78, 1174 – 1180.
146
BIBLIOGRAPHY
Frhwirth-Schnatter, S. (2006), Finite Mixture and Markov Switching Models, Springer Science
+ Business Media, LLC.
Gelfand, A. E., Ghosh, S. K., Christiansen, C., Soumerai, S. B. and McLaughlin, T. J.
(2000), ‘Proportional hazards models: a latent competing risk approach’, Applied statistics
49(3), 385 – 397.
Giard, N., Lichtenstein, P. and Yashin, A. I. (2002), ‘A multistate model for the genetic
analysis of the ageing process’, Statistics in Medicine 21(17), 2511–26.
Gill, R. D. (1989), ‘Non-parametric and semi-parametric maximum-likelihood estimators and
the von mises method .1’, Scandinavian Journal of Statistics 16(2), 97–128.
Goetghebeur, E. and Ryan, L. (1995), ‘Analysis of competing risks survival data when some
failure types are missing’, Biometrika 82(4), 821–833.
Gueorguieva, R. (2001), ‘A multivariate generalized linear mixed model for joint modelling
of clustered outcomes in the exponential family’, Statistical Modelling 1(3), 177 – 193.
Gustafson, P. (1997), ‘Large hierarchical baysian analysis of multivariate survival data’,
Biometrics 53, 230 – 242.
Hall, D. B. and Wang, L. (2005), ‘Two-component mixtures of generalized linear mixed effects
models for cluster correlated data’, Statistical Modelling 5(1), 21–37.
Han, A. and Hausman, J. A. (1990), ‘Flexible parametric estimation of duration and
competing risk models’, Journal of Applied Econometrics 5, 1 – 28.
Hanagal, D. D. (2008), ‘Frailty regression models in mixture distributions’, Journal of
Statistical Planning and Inference 138(8), 2462–2468.
Heckman, J. J. and Singer, B. (1982a), The identification problem in econometric models for
duration data, Cambridge University Press, Cambridge, pp. 39–77.
Heckman, J. J. and Singer, B. (1984), ‘A method for minimising the impact of distributional
assumptions in econometric models for duration data’, Econometrica 52, 271 – 320.
147
BIBLIOGRAPHY
Heckman, J. J. and Singer, B. (1985), ‘Social science duration analysis in longitudinal analysis
of labor market data’, Cambridge University Press pp. 39 – 110.
Henderson, R. and Oman, P. (1999), ‘Effect of frailty on marginal regression estimates in
survival analysis’, Journal of the Royal Statistical Society Series B-Statistical Methodology
61, 367–379. Part 2.
Hougaard, P. (1984), ‘Life table methods for heterogeneous populations’, Biometrika 71, 75
– 83.
Hougaard, P. (1986a), ‘Survival models for heterogeneous populations derived from stable
distributions’, Biometrika 73, 387 – 396.
Hougaard, P. (1986b), ‘A class of multivariate failure time distributions’, Biometrika 73, 671
– 678.
Hougaard, P. (1995), ‘Frailty models for survival data’, Lifetime Data Analysis 1, 255 – 273.
Hougaard, P. (2000), Analysis of Multivariate Survival Data, Springer, New York.
Hsu, Y. W. (2000), ‘On the bock-aitkin procedure - from an em algorithm perspective’,
Psychometrika 65(4), 547–549.
Huang, X. and Wolfe, R. A. (2002), ‘A frailty model for informative censoring’, Biometrics
58, 510 – 520.
Hudgens, M. G., Satten, G. A. and Longini, J. I. M. (2001), ‘Nonparametric maximum
likelihood estimation for competing risks survival data subject to interval censoring and
truncation’, Biometrics 57, 74 – 80.
Jeong, J. H. and Oakes, D. (2005), ‘Effects of different hazard ratios on asymptotic
relative efficiency of estimates from cox’s model’, Communications in Statistics-Theory
and Methods 34(2), 429–448.
Jewell, N. P., Laan, M. V. D. and Henneman, T. (2003), ‘Nonparametric estimation from
current status data with competing risks’, Biometrika 90(1), 183 – 197.
148
BIBLIOGRAPHY
Jiang, H., Fine, J. and Chappell, R. J. (2004), ‘Semiparametric methods for semi-competing
risks problem with censoring and truncation’, Harvard University Biostatistics Working
Paper Series. Working Paper 15 .
Jonker, M. A., Bhulai, S., Boomsma, D. I., Ligthart, R. S. L., Posthuma, D. and Vaart, A.
W. V. D. (2009), ‘Gamma frailty model for linkage analysis with application to interval-
censored migraine data’, Biostatistics 10(1), 187–200.
Kalbfleisch, J. D. and Prentice, R. L. (2002), The statistical analysis of failure time data,
second edn, Wiley-Interscience.
Kaplan, E. L. and Meier, P. (1958), ‘Nonparametric estimation from incomplete observations’,
Journal of the American Statistical Association 53, 457 – 481.
Keiding, N., Andersen, P. and Klein, J. (1997), ‘The role of frailty models and accelerated
failure time models in describing heterogeneity due to omitted covariates’, Statistics in
Medicine 16, 215 – 224.
Kheiri, S., Kimber, A. and Meshkani, M. R. (2007), ‘Bayesian analysis of an inverse gaussian
correlated frailty model’, Computational Statistics and Data Analysis 51(11), 5317–5326.
Kheiri, S., Meshkani, M. R. and Faghihzadeh, S. (2005), ‘A correlated frailty model for
analysing risk factors in bilateral corneal graft rejection for keratoconus: a bayesian
approach’, Statistics in Medicine 24(17), 2681–2693.
Klein, J. P. (1992b), ‘Semiparametric estimation of random effects using the cox model based
on the em algorithm’, Biometrics 48, 795806.
Klein, J. P. and Moeschberger, M. L. (1997), Survival analysis - techniques for censored and
truncated data, Springer, New York.
Klein, J. P., Moeschberger, M., Li, Y. H. and Wang, S. T. (1992a), Estimating random effects
in the Framingham Heart Study, Kluwer Academic Publishers, pp. 99 – 120.
Klein, J. P., Pelz, C. and Zhang, M. J. (1999), ‘Random effects for censored data by a
multivariate normal regression model’, Biometrics 55, 497 – 506.
149
BIBLIOGRAPHY
Korsgaard, I. R. and Andersen, A. H. (1998), ‘The additive genetic gamma frailty model’,
Scandinavian Journal of Statistics 25, 255 – 269.
Kundu, D. (2004), ‘Parameter estimation for partially complete time and type of failure
data’, Biometrical Journal 46(2), 165–179.
Laird, N. (1978), ‘Nonparametric maximum likelihood estimation of a mixing distribution’,
Journal of the American Statistical Association 73(364), 805–811.
Lam, K. F. and Kuk, A. Y. C. (1997), ‘A marginal likelihood approach to estimation in
frailty models’, Journal of the American Statistical Association 92(439), 985–990.
Lambert, P. and Collett, C., eds (2002), Shared frailty accelerated failure time models for
clustered survival data, International Biometric Society, Freiburg, Germany.
Lambert, P., Collett, D., Kimber, A. and Johnson, R. (2004), ‘Parametric accelerated
failure time models with random effects and an application to kidney transplant survival’,
Statistics in Medicine 23(20), 3177 – 3192.
Lancaster, T. and Nickell, S. (1980), ‘The analysis of re-employment probabilities for the
unemployed’, Journal of the Royal Statistical Society. Series A 143(2), 141–165.
Lawless, J. F. (1982), Statistical models and methods for lifetime data, Wiley and Sons, New
York.
Lee, E. and Wang, J. (2003), Statistical Methods for Survival Data Analysis, J. Wiley.
Li, H. (2002), ‘An additive genetic gamma frailty model for linkage analysis of diseases with
variable age of onset using nuclear families’, Life time Data Analysi 8, 315 – 334.
Li, Y. and Lin, X. (2000), ‘Covariate measurement errors in frailty model for clustered survival
data’, Biometrics 87, 849866.
Lillard, L. A. (1993), ‘Simultaneous equations for hazards: marriage duration and fertility
timing’, Journal of Econometrics 56, 189 – 217.
150
BIBLIOGRAPHY
Lillard, L. A., Brian, M. J. and Waite, M. J. (1995), ‘Premarital cohabitation and subsequent
marital dissolution: a matter of self-selection?’, Demography 32, 437 – 457.
Lin, D. Y. and Ying, Z. L. (1994), ‘Semiparametric analysis of the additive risk model’,
Biometrika 81(61 - 71).
Lin, D. Y. and Ying, Z. L. (1995), ‘Semiparametric analysis of general additive-multiplicative
hazard models for counting process’, Annals of Statistics 23, 1712 – 1734.
Locatelli, I., Lichtenstein, P. and Yashin, A. I. (2004), ‘The heritability of breast cancer: A
bayesian correlated frailty model applied to swedish twins data’, Twin Research 7(2), 182–
191.
Locatelli, I., Rosina, A., Lichtenstein, P. and Yashin, A. I. (2007), ‘A correlated frailty
model with long-term survivors for estimating the heritability of breast cancer’, Statistics
in Medicine 26(20), 3722–3734.
Lu, K. and Tsiatis, A. A. (2005), ‘Comparison between two partial likelihood approaches for
the competing risks model with missing cause of failure’, Lifetime Data Analysis 11, 29 –
40.
Lunn, M. and McNeil, D. (1995), ‘Applying cox regression to competing risks’, Biometrics
51(2), 524 – 532.
Manda, S. O. M. (2011), ‘A nonparametric frailty model for clustered survival data’,
Communications in Statistics-Theory and Methods 40(5), 863–875.
Manton, K., Stallard, E. and Vaupel, J. (1986), ‘Alternative models for heterogeneity of
mortality risks among the aged’, Journal of the American Statistical Association 81, 635
– 644.
McCulloch, C. E. and Searle, S. R. (2001), Generalized, Linear, and Mixed Models, Wiley-
Interscience, New York.
McGilchrist, C. A. (1993), ‘Reml estimation for survival models with frailty’, Biometrics
49, 221 – 225.
151
BIBLIOGRAPHY
McGilchrist, C. A. and Aisbett, C. W. (1991), ‘Regression with frailty in survival analysis’,
Biometrics 47, 461 – 466.
McLachlan, G. J. and Krishnan, T. (2008), The EM Algorithm and Extensions, Wiley series
in probability and statistics, New Jersey.
Miller, R. G. (1981), Survival analysis, John Wiley and Sons, New York.
Minami, M. (2003), ‘A multivariate extension of inverse gaussian distribution derived from
inverse relationship’, Communications in Statistics-Theory and Methods 32(12), 2285–
2304.
Molenberghs, G. and Verbeke, G. (2011), ‘On the weibull-gamma frailty model, its infinite
moments, and its connection to generalized log-logistic, logistic, cauchy, and extreme-value
distributions’, Journal of Statistical Planning and Inference 141(2), 861–868.
Muller, K. E. and Stewart, P. W. (2006), Linear Model Theory Univariate, Multivariate, and
Mixed Models, John Wiley and Sons, Hoboken, New Jersey.
Naskar, M. (2008), ‘Semiparametric analysis of clustered survival data under nonparametric
frailty’, Statistica Neerlandica 62(2), 155–172.
Naskar, M., Das, K. and Ibrahim, J. G. (2005), ‘A semiparametric mixture model for
analyzing clustered competing risks data’, Biometrics 61, 729 – 737.
Oakes, D. (1982), ‘A concordance test for independence in the presence of censoring’,
Biometrics 38, 451 – 455.
Olsen, M. K. and Schafer, J. L. (2001), ‘A two-part random effects model for semicontinuous
longitudinal data’, Journal of the American Statistical Association 96(454), 730–745.
Oskrochi, G. R. and Crouchley, R. (2004), Modelling breast cancer data with informative
dropout, in ‘Proceedings of the 19th International Workshop on Statistical Modelling’,
Firenze University Press, Florence, Italy.
152
BIBLIOGRAPHY
Oskrochi, G. R. and Davies, R. B. (1997), ‘An em-type algorithm for multivariate mixture
models’, Statistics and Computing 7(2), 145 – 151.
Pan, W. (2001), ‘Using frailties in the accelerated failure time model’, Lifetime Data Analysis
7, 55 – 64.
Pankratz, V. S., de Andrade, M. and Therneau, T. M. (2005), ‘Random-effects cox
proportional hazards model: General variance components methods for time-to-event
data’, Genetic Epidemiology 28(2), 97–109.
Peng, Y. W. and Zhang, J. J. (2008), ‘Estimation method of the semiparametric mixture
cure gamma frailty model’, Statistics in Medicine 27(25), 5177–5194.
Pennell, M. L. and Dunson, D. B. (2006), ‘Bayesian semiparametric dynamic frailty models
for multiple event time data’, Biometrics 62(4), 1044–1052.
Perperoglou, A., van Houwelingen, H. C. and Henderson, R. (2006), ‘A relaxation of the
gamma frailty (burr) model’, Statistics in Medicine 25(24), 4253–4266.
Peterson, J. (1998), ‘An additive frailty model for correlated life times’, Biometrics 54(646 -
661).
Pipper, C. B. and Martinussen, T. (2004), ‘An estimating equation for parametric shared
frailty models with marginal additive hazards’, Royal Statistical Society. Series B
66(1), 207 – 220.
Prentice, R. L., Kalbfleisch, J. D., Peterson, J. A. V., Flournoy, N., Farewell, V. T. and
Breslow, N. E. (1978), ‘The analysis of failure times in the presence of competing risks’,
Biometrics 34(4), 541 – 554.
Price, D. L. and Manatunga, A. K. (2001), ‘Modelling survival data with a cured fraction
using frailty models’, Statistics in Medicine 20, 1515 – 1527.
Ravishanker, N. and Dey, D. (2000), ‘Multivariate survival models with a mixture of positive
stable frailties’, Methodology and Computing in Applied Probability 2(3), 293–308.
153
BIBLIOGRAPHY
Richardson, S. and Green, P. J. (1997), ‘On bayesian analysis of mixtures with an unknown
number of components (with discussion)’, Journal of the Royal Statistical Society, Series
B 59, 731 – 792.
Ripatti, S., Larsen, K. and Palmgren, J. (2002), ‘Maximum likelihood inference for
multivariate frailty models using an automated mcem algorithm’, Lifetime Data Analysis
8, 349 – 360.
Ripatti, S. and Palmgren, J. (2000), ‘Estimation of multivariate frailty models using penalised
partial likelihood’, Biometrics 56, 1016 – 1022.
Sahu, S. K., Dey, D. K., Aslanidou, H. and Sinha, D. (1997), ‘A weibull regression model
with gamma frailties for multivariate survival data’, Lifetime Data Anal 3(2), 123–37.
Sastry, N. (1997), ‘A nested frailty model for survival data, with an application to the study of
child survival in northeast brazil’, Journal of the American Statistical Association 92, 426
– 435.
Scallan, A. J. (1987), ‘A glim model for repeated measurements’, GL1M Newsletter 15, 10 –
22.
Schwarz, G. E. (1978), ‘Estimating the dimension of a model’, Annals of Statistics 6, 461464.
Shih, J. H. and Louis, T. A. (1995), ‘Assessing gamma frailty models for clustered failure
time data’, Lifetime Data Analysis 1, 205 – 220.
Sinha, D. (1993), ‘Semiparametric bayesian-analysis of multiple event time data’, Journal of
the American Statistical Association 88(423), 979–983.
Slud, E. V., Byar, D. P., Schatzkin, A., Prentice, R. and Kalbfleisch, J. (1988), ‘Dependent
competing risks and the latent-failure model’, Biometrics 44(4), 1203 – 1205.
Stefanescu, C. and Turnbull, B. W. (2006), ‘Multivariate frailty models for exchangeable
survival data with covariates’, Technometrics 48(3), 411–417.
154
BIBLIOGRAPHY
Thum, Y. M. (1997), ‘Hierarchical linear models for multivariate outcomes’, Journal of
Educational and Behavioral Statistics 22(1), 77 – 108.
Vaida, F. and Xu, R. (2000), ‘Proportional hazards models with random effects’, Statistics
in Medicine 19(24), 3309 – 3324.
van Duijn, M. A. J. and Bockenholt, U. (1995), ‘Mixture models for the analysis of
repeated count data’, Journal of the Royal Statistical Society. Series C (Applied Statistics)
44(4), 473 – 485.
Vaupel, J. W. (1990), ‘Relative risks: frailty model of life history data’, Theoretical Population
Biology 37, 220 – 234.
Vaupel, J. W., Manton, K. G. and Stallard, E. (1979), ‘The impact of heterogeneity in
individual frailty on the dynamics of mortality’, Demography 16, 439 – 454.
Vaupel, J. W. and Yashin, A. I. (1985), ‘The deviant dynamics of death in heterogeneous
populations’, Sociological Methodology 15, 179 – 211.
Verbeke, G. and Molenberghs, G. (2000), Linear Mixed Models for longitudinal data, Springer,
New York.
Weibull, W. (1939), ‘A statistical theory of the strength of material’, Proc. Roy. Swedish
Inst. Eng. Res. 151(1).
West, B. T., Welch, K. B., Galecki, A. T. and Gillespie, B. W. (2007), Linear Mixed Models:
A Practical Guide Using Statistical Software, Chapman and Hall/CRC, New York.
Whitmore, G. A. and Lee, M. L. T. (1991), ‘A multivariate survival distribution generated
by an inverse gaussian mixture of exponentials’, Technometrics 33, 39 – 50.
Wienke, A. (2007), Frailty Models in Survival Analysis, PhD thesis, Martin-Luther-Universit
at Halle-Wittenberg.
Wienke, A. (2010a), Frailty Models in Survival Analysis, Chapman and Hall/CRC, New York.
155
BIBLIOGRAPHY
Wienke, A., Arbeev, K. G., Locatelli, I. and Yashin, A. I. (2005), ‘A comparison of different
bivariate correlated frailty models and estimation strategies’, Mathematical Biosciences
198(1), 1–13.
Wienke, A., Christensen, K., Skytthe, A. and Yashin, A. (2002), ‘Genetic analysis of cause
of death in a mixture model of bivariate lifetime data’, Statistical Modelling 2(2), 89–102.
Wienke, A., Lichtenstein, P. and Yashin, A. I. (2003), ‘A bivariate frailty model with a cure
fraction for modeling familial correlations in diseases’, Biometrics 59(4), 1178–1183.
Wienke, A., Ripatti, S., Palmgren, J. and Yashin, A. (2010b), ‘A bivariate survival model
with compound poisson frailty’, Statistics in Medicine 29(2), 275–283.
Xu, L. and Zhang, J. (2009), ‘An alternative estimation for the accelerated failure time
mixture cure model’, Communication in Statistics 38, 1980 – 1990.
Xu, L. and Zhang, J. (2010), ‘Em-like algorithm for the semiparametric accelerated failure
time gamma frailty model’, Computational Statistics and Data Analysis 54, 1467 – 1474.
Xue, X. and Brookmeyer, R. (1996), ‘Bivariate frailty model for the analysis of multivariate
survival time’, Lifetime Data Analysis 2(3), 277 – 290.
Xue, X. and Ding, Y. (1999), ‘Assessing heterogeneity and correlation of paired failure times
with the bivariate frailty model’, Statistics in Medicine 18(8), 907–918.
Yashin, A. I. and Iachine, I. (1999), ‘Dependent hazards in multivariate survival problems’,
Journal of Multivariate Analysis 71, 241 – 261.
Yashin, A. I. and Iachine, I. A. (1995a), ‘Genetic-analysis of durations - correlated frailty
model applied to survival of danish twins’, Genetic Epidemiology 12(5), 529–538.
Yashin, A. I. and Iachine, I. A. (1995b), ‘Survival of related individuals: an extension of some
fundamental results of heterogeneity analysis’, Mathematical population studies 5(4), 321–
377.
156
BIBLIOGRAPHY
Yashin, A. I., Vaupel, J. W. and Iachine, I. A. (1995), ‘Correlated individual frailty: An
advantageous approach to survival analysis of bivariate data’, Mathematical Population
Studies 5, 145 – 159.
Yin, G. (2007), ‘Model checking for additive hazards model with multivariate survival data’,
Journal of Multivariate Analysis 98(5), 1018–1032.
Yin, G. (2008), ‘Bayesian transformation cure frailty models with multivariate failure time
data’, Statistics in Medicine 27(28), 5929–5940.
Yin, G. and Ibrahim, J. G. (2005), ‘A class of bayesian shared gamma frailty models with
multivariate failure time data’, Biometrics 61, 208 – 216.
Yu, B. B. (2006), ‘Estimation of shared gamma frailty models by a modified em algorithm’,
Computational Statistics & Data Analysis 50(2), 463–474.
Zahl, P. H. (1997), ‘Frailty modelling for the excess hazard’, Statistics in Medecine 16, 1573
– 1585.
Zhang, J. and Peng, Y. (2007), ‘An alternative estimation method for the accelerated failure
time frailty model’, Computational Statistics and Data Analysis 51(9), 4413–4423.
Zhong, X. and Li, H. (2004), ‘Score tests of genetic association in the presence of linkage
based on the additive genetic gamma frailty model’, Biostatistics 5(2), 307 – 327.
157
